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ABSTRACT 
 
ANDREW DUNCAN SATTERFIELD: 
I.  [1,2]-Brook Rearrangement: Application of Silyl Glyoxylates to a Novel Glycolate 
Aldol Reaction and in a Controlled Oligomerization to Complete the Total Synthesis of 
Zaragozic Acid C 
II.  Progress Towards the Total Synthesis of Pactamycin 
(Under the direction of Professor Jeffrey Scott Johnson) 
 
I. Symbiotic Reagent Activation: Oppenauer Oxidation of Magnesium  
 Alkoxides by Silyl Glyoxylates Triggers Second-Stage Aldolization 
  The treatment of silyl glyoxylates with magnesium alkoxides leads to a Meerwein-
Ponndorf-Verley reduction of the silyl glyoxylate and an Oppenauer oxidation of the alkoxide.  
The symbiotic transfer of a hydride from the alkoxide to the silyl glyoxylate triggers a [1,2]-
Brook rearrangement forming an enolate that undergoes an aldol reaction with the carbonyl 
oxidation product.  The magnesium alkoxide can be generated via deprotonation of primary and 
secondary alcohols with EtMgBr, Grignard addition to aldehydes or CuI-catalyzed alkylation of 
epoxides.  Moderate levels of anti-diastereoselectivity were observered with primary aliphatic 
alkoxides.  Stereoselective as well as catalytic versions of this reaction were also investigated. 
 
II.    Total Synthesis of Zaragozic Acid C via Controlled Oligomerization 
  Tert-butyldimethylsilyl glyoxylate was used as a dipolar glycolic acid synthon to rapidly 
assemble the core of zaragozic acid C by means of a controlled oligomerization.  This new 
methodology facilitated a rapid, stereocontrolled construction of the carbon skeleton while 
minimizing the need for functional group and oxidation state manipulation.   
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III.  Progress Toward the Total Synthesis of Pactamycin 
 A review of literature covering previous synthetic approaches to the core of pactamycin is 
presented.  Work was done on the construction of precursors to an intramolecular cyclization to 
form the densely functionalized core of pactamycin.  The strategies involved using a diazo group 
to block reactivity and allow installation of core functionality.  Subsequent oxidization would 
reveal the requisite electrophile for the cyclization. 
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CHAPTER 1 
 
SYMBIOTIC REAGENT ACTIVATION: OPPENAUER OXIDATION OF MAGNESIUM 
ALKOXIDES BY SILYL GLYOXYLATES TRIGGERS SECOND-STAGE ALDOLIZATION 
 
 
 
1.1 Introduction 
 
The aldol reaction is the preeminent method for the introduction of the β hydroxy 
carbonyl function, and extensive development has made it a valuable tool for organic synthesis.1 
Recent advances have focused on the design of catalysts to achieve a direct aldol reaction 
selectively forming the nucleophilic enol species in the presence of the carbonyl electrophile.2-9  
This has greatly expanded the synthetic utility, but application of the aldol reaction to the 
synthesis of complex molecules is often still hampered by the need for additional measures, such 
as a prior oxidation event, to prepare the requisite electrophile.10  A more efficient direct aldol 
reaction would combine formation of the nucleophilic donor, the electrophilic acceptor and the 
subsequent aldol reaction into one process.  The goal of this project was to develop an efficient, 
direct aldol reaction that formed the requisite electrophile and nucleophile symbiotically using 
silyl glyoxylates11 and metal alkoxides. 
 2 
 
1.2 Background 
 
Scheme 1-1 Oppenauer Oxidation MPV Reduction 
  
This project combined a classic reaction, the Oppenauer oxidation/Meerwein-Ponndorf-
Verley (MPV)12,13 reduction with the unique properties of silyl glyoxylates to accomplish a 
second stage aldol reaction between unactivated substrates.  The Oppenauer oxidation is the 
oxidation of a metal alkoxide by a carbonyl species via hydride transfer; the MPV reduction is the 
reverse process (Scheme 1-1).  The reaction is reversible, but the equilibrium can be shifted to 
favor complete reduction or oxidation by the selective removal of products.  This reaction can be 
promoted by many metals, including lanthanides, aluminum, and magnesium, but often a 
stoichiometric amount of metal is required due to the stability of the product alkoxides.  
Aldehydes, ketones, and in this study silyl glyoxylates, can serve as oxidants with the general 
trend in reactivity favoring oxidation of secondary over primary alkoxides. 
Scheme 1-2 Reactivity of Silyl Glyoxylates 
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Silyl glyoxylates 1 are acyl silanes with a bound electron withdrawing ester group and 
function as dipolar glycolic acid synthon (Scheme 1-2).  Nucleophilic attack on the acyl silane 
portion results in formation of an oxyanion and a subsequent [1,2]-Brook rearrangement,14 
forming a carbanion that can be trapped by an electrophile.  Brook rearrangement is driven by the 
greater stability of the Si-O σ bond (120-130 kcal mol-1) compared the Si-C σ bond (75-85 kcal 
mol-1) as well as stabilization of the carbanion as an enolate by the pendant ester group.  This type 
of reactivity allows silyl glyoxylates to serve as synthetic linchpins in multicomponent couplings. 
Scheme 1-3 MPV/Aldol Origin 
An example of silyl glyoxylates playing the role of conjunctive agent was the use of 1a in 
the coupling of alkynylzinc halides and aldehydes.15 The genesis of the study described herein 
was the observation of hydroxysilane 4 and ynone 5 as minor byproducts in a reaction between 
zinc alkoxide 2 and silyl glyoxylate 1a (Scheme 1-3) that was designed to probe the mechanism 
of the aforementioned three-component coupling. While formation of 3 can be explained by 
proton quench of the expected intermediate zinc alkoxide 2, it was hypothesized that the 
byproducts 4 and 5 resulted from an Oppenauer oxidation MPV reduction6-8 between 2 and 1a. In 
contrast to other nucleophiles that react with 1a, the hydride transfer did not trigger [1,2]-Brook 
rearrangement.16,17 
 Given the observation of products 4 and 5 we proposed a reaction wherein a metal 
alkoxide and a silyl glyoxylate react symbiotically under mild conditions to achieve an aldol 
reaction between unactivated substrates (Scheme 1-4).  If reaction conditions could be suitably 
modified such that the Oppenauer/MPV process did cause C → O silyl migration (8 → 9), the 
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resulting products from the redox reaction would be a glycolate enolate and ketone or aldehyde 
poised to undergo aldolization.  
Scheme 1-4 Proposed Mechanism 
 
 
1.3 Results and Discussion 
 
1.3.1 Reaction Scope 
 
It was projected that the identity of the metal cation would be crucial in governing the 
efficiency of each proposed step; therefore, an evaluation of suitable candidates was initiated.  
For the initial evaluation of the reaction metal alkoxides were generated via deprotonation of 
alcohols by organometallic species using THF as a solvent.  As commonly employed catalysts for 
MPV/Oppenauer reactions, aluminum alkoxides provided a logical starting point for this inquiry 
(Table 1-1).18 Surprisingly, no reaction was observed with MeAlCl2 (entry 1).  Use of nBuLi and 
Bu3La provided only the direct addition/rearrangement product 12 (entries 2 and 3). Selective 
generation of desired aldol product 11a was achieved with a magnesium alkoxide19 generated in 
THF (entry 4).  Using the conditions from entry 4, this reaction was successfully conducted with 
a variety of primary and secondary alcohols.20 
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Table 1-1 Evaluation of Metal Alkoxides 
 
entry R–M result anti:syna 
1 MeAlCl2 no reaction - 
2 n-BuLi 40% of 12b - 
3 Bu3La 58% of 12c - 
4 EtMgBr 71% of 11ac 6:1 
a Determined by 1H NMR spectroscopy.  b 1H NMR yield versus an internal standard. c Isolated yield. 
 
 A more extensive evaluation of reaction variables was undertaken to optimize reaction 
conditions to maximize yield and improve diastereoselectivity (Table 1-2).  The identity of the 
metal cation was investigated further (entries 1-6).  Aluminum and titanium alkoxides were able 
to complete the reaction but in lower yields than the magnesium alkoxides (entries 3 and 6).  The 
identity of the halide present in the magnesium alkoxide was varied and while MgCl alkoxides 
gave comparable yields, the best diastereoselectivity was achieved with MgBr (entries 1, 4 and 
5).  Variation of the silyl group of the silyl glyoxylate to the less sterically demanding triethylsilyl 
glyoxylate and the more encumbering triisopropyl silyl resulted in diminished yields compared to 
the TBS silyl glyoxylate (entries 7 and 8).  As the final variable investigated, a screen of solvent 
systems revealed that a 2:1 mixture of THF/CH2Cl2 improved the yield and diastereoselectivity of 
the reaction (entries 9-20).   
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Table 1-2 Evaluation of Reaction Variables 
 
entry iBuO–M tBuO2CC(O)SiR3 solvent yielda d.r.b 
1 iBuO–MgBr tBuO2CC(O)TBS THF 71% 6:1 
2 Me2AlCl (1 equiv)/ iBuOH 
(1 equiv) 
tBuO2CC(O)TBS THF 0% n.a. 
3 Me2AlCl (0.5 equiv)/ 
iBuOH (1 equiv) 
tBuO2CC(O)TBS THF 42% 5:1 
4 iBuO–MgCl tBuO2CC(O)TBS THF ≈70% 4.8:1 
5 iBuO–MgI tBuO2CC(O)TBS THF <20% 1:1 
6 (iPrO)4Ti tBuO2CC(O)TBS THF <10% n.d. 
7 iBuO–MgBr tBuO2CC(O)TES THF 30% 4.4:1 
8 iBuO–MgBr tBuO2CC(O)TIPS THF 35% 3.7:1 
 
9 iBuO–MgBr tBuO2CC(O)TBS Dioxane 26% 2.0:1 
10 iBuO–MgBr tBuO2CC(O)TBS CH2Cl2 24%  8.0:1 
11 iBuO–MgBr tBuO2CC(O)TBS Et2O 36%  6.0:1 
12 iBuO–MgBr tBuO2CC(O)TBS Toluene 34%  7.0:1 
13 iBuO–MgBr tBuO2CC(O)TBS MTBE/THF 
(1:2) 
76% 7.6:1 
14 iBuO–MgBr tBuO2CC(O)TBS MTBE 83% 5.6:1 
15 iBuO–MgBr tBuO2CC(O)TBS 2-MeTHF n.r. n.a. 
16 iBuO–MgBr tBuO2CC(O)TBS 2-MeTHF/THF 
(1:2) 
56% 7.4:1 
17 iBuO–MgBr tBuO2CC(O)TBS Dioxane/THF 
(1:2) 
31% 2.8:1 
18 iBuO–MgBr tBuO2CC(O)TBS THF/Et2O (2:1) 69% 9.1:1 
19 iBuO–MgBr tBuO2CC(O)TBS THF/toluene 
(2:1) 
57% 10:1 
20 iBuO–MgBr tBuO2CC(O)TBS THF/CH2Cl2 
(2:1) 
>95% 10.6:1 
a 1H NMR yield versus an internal standard; isolated yields for entries 7 and 8.  b Determined by 1H NMR 
spectroscopy.   
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 The optimized reaction conditions, deprotonation of alcohols in 2:1 THF/CH2Cl2 with 
EtMgBr, were then used to evaluate alcohols as coupling partners (Table 1-3). The new 
conditions resulted in a marked improvement in the yields and diastereomer ratio of some 
substrates compared to results obtained using only THF as the solvent (entries 1-3).  Results were 
good for a variety of alcohols with yields from 63 to 97%. Notably, primary aliphatic alcohols 
delivered the aldol products with synthetically useful levels of anti diastereocontrol (entries 1-
4).21-27  The boat-like transition structure 10 may be construed as a tentative model to explain the 
observed anti isomer (vide infra). 
 
 Table 1-3 Alchohol Substrate Scope 
 
entry alcohol product yield (%)b d.r.c 
1d Me2CHCH2OH  
97 10:1 
2d Me(CH2)5OH  
86 7:1 
3d TMS(CH2)3OH  
88 5:1 
4 CH2=CH(CH2)4OH  
63 5:1 
5 PhCH2OH  
90 1.2:1 
6 4-ClPhCH2OH 
 
82 1:1 
7 4-MeOPhCH2OH 
 
85 1:1 
8 PhCH(OH)Me 
 
67 2.5:1 
9 cyclohexanol 
 
68 n.a. 
a Alcohol (1.5 equiv), EtMgBr (2.0 equiv), THF, 0 °C → rt; then 1 (1.0 equiv).  b Isolated yields.  c Determined by 1H 
NMR spectroscopy; the major isomer is shown. d Reaction solvent: 2:1 THF/CH2Cl2 
 
Benzylic alcohols provided the aldol adducts with superior yields but negligible 
diastereocontrol (entries 5-7). Perhaps most strikingly, secondary alcohols function effectively in 
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 8 
this reaction to deliver highly substituted ketone aldol adducts (entries 8 and 9). The success of 
these latter reactions led us to evaluate a three-component coupling strategy wherein the requisite 
secondary alkoxide was formed via Grignard addition to aldehydes (Table 1-4).28 This simple 
one-step protocol facilitated access to more complex ketone aldol adducts with no reduction in 
reaction efficiency. In the case where significant steric differentiation exists between R1 and R2, 
promising levels of diastereocontrol may be achieved (entry 3).   Greater steric bulk of both the 
Grignard reagent and the aldehyde generally resulted in a decreased yield for the reaction. 
 
Table 1-4 Aldehyde Substrate Scope 
 
entry R1 R2 product yield (%)a d.r.b 
1 Et Et 
 
68 n.a. 
2 Ph Et 
 
81 1.8:1 
3 cyclohexyl Me 
 
67 3.5:1 
4 Ph Me 
 
45 2:1 
5 cyclopentyl Me 
 
39 1.6:1 
6 cyclopropyl Me 
 
35 1.2:1 
7 cyclopropyl Et 
 
25 2.7:1 
8 cyclohexyl Et 
 
15 2.4:1 
a Isolated yields. b Determined by 1H NMR spectroscopy; the major isomer is shown when determined. 
R1
O
H
R2MgBr
tBuO
O
O
TBS
tBuO
O
OTBS
R2
HO R1
THF, 0 °C ! rt;
R1
O
R2
MgBr
1b
12
tBuO
O
OTBS
Et
HO Et
12a
tBuO
O
OTBS
HO Et
12b
tBuO
O
OTBS
HO Me
12c
tBuO
O
OTBS
HO Me
12d
tBuO
O
OTBS
HO Me
12e
tBuO
O
OTBS
HO Me
12f
tBuO
O
OTBS
HO Et
12g
tBuO
O
OTBS
HO Et
12h
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Epoxides may also serve as the alkoxide progenitor in conjunction with a Cu(I)-catalyzed 
alkylation (eq 1). On the basis of the similar yield for 12a beginning from either an epoxide or an 
aldehyde (Table 1-3, entry 1) and the ability to run the reaction stoichiometric in copper, it 
appears that CuI does not interfere with the subsequent steps. 
 
1.3.2 Identification and Rationalization of Relative Stereochemistry for Aldol Products 
 
 The relative stereochemistry for aldol products resultant from alcohol-derived alkoxides 
was elucidated previously.29   Silyl ether deprotection of 12c with HF gave 13a and 13b.  
Comparison with the 1H NMR spectrum of known syn diol 13a formed from osmium catalyzed 
dihydroxylation revealed anti 13b as the major diastereomer (Scheme 1-5).  Similarly, reduction 
of the ester and deprotection of the silyl ether of 12b in one pot with LiAlH4 gave triols 15a and 
15b.  Comparison of the supercritical fluid chromatography (SFC) trace with that of triol 15a, 
with a syn configuration of the two secondary alcohols, formed from an osmium catalyzed 
dihydroxylation and LiAlH4 reduction revealed 15a as the major diastereomer.  The syn diol 
orientation seen in 15 goes against the favored anti orientation seen in the aliphatic products.  
This combined with the general trend of a lack of diastereoselectivity with aryl products may 
indicate an alternate mechanism. 
O
+ MeMgBr
CuI 20 mol %
O
MgBr
tBuO
O
O
TBS
tBuO
O
OTBS
HO
Et
Et
 0 °C! rt ,THF
63%
(1)
12a
1b
 10 
  
Scheme 1-5 Stereochemical Proofs 
 
The predominance of the anti isomer in aliphatic products is congruent with the recent 
observation by Evans and co-workers of anti propionates from (Z)-magnesium enolates.30  In this 
system, preference for the (Z)-magnesium enolates may be due to a favorable orbital overlap of 
the C-Si σ bond with the π* orbital of the ester carbonyl (Scheme 1-6).  This orbital overlap could 
facilitate formation of the enolate π bond via [1,2]-Brook rearrangement.  In order to form the 
(E)-enolate, the C-Si σ bond would have to rotate out of alignment with the π* orbital in addition 
to breaking the chelating interaction of magnesium with the two oxygen atoms.   
tBuO
O
OH
HO Me
+
tBuO
O
OH
HO Me
13b
13a
tBuO
O
OTBS
12c
HF
THF
dihydroxylation
O
OtBu
14a
LiAlH4tBuO
O
OTBS
12b
15a
15b
dihydroxylation
LiAlH4
O
OEt
16a
HO
OH
EtHO
HO
OH
EtHO
MeHO
OHEt
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Scheme 1-6 Orbital Overlap 
 
 
Assuming formation of the (Z)-magnesium enolate, the boat-like transition structure 10 
may thus be construed as a tentative model for the observed stereochemical outcome (Scheme 1-
7).  This boat-like transition structure minimizes the unfavorable steric interactions between the 
large group of the carbonyl acceptor and the TBS group and tert-butyl ester of the enolate and 
leads to the observed anti diol orientation. 
Scheme 1-7 Transition State Models 
 
MgBr
OtBu
O
TBSO
MgBr
tBuO
O
TBS
H
O
favored disfavored
tBuO
O
BrMg
OTBS
tBuO O
O
MgBr
TBS
H
MgBr
tBuO
O
TBS
H
O
BrMg
OtBu
O
TBS
H
O
BrMg
OtBu
O
TBS
H
O
!*
C-Si "
!*
C-Si "
OTBS
OtBu
O
O RL
RS
BrMg
OTBS
OtBu
O
O RS
RL
BrMg
RS = smaller group
RL = larger group
OBrMg
O
OTBS
RL
RS
OtBu
OBrMg
O
OTBS
RS
RL
OtBu
tBuO
O
OTBS
tBuO
O
OTBS
syn anti
RL
HO RS
RL
HO RS
tBuO
O
OTBS
syn
RL
HO RS
tBuO
O
OTBS
anti
RL
HO RS
favored
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1.3.3 Attempts to Enhance Selectivity 
 
 To increase the synthetic utility of this methodology attempts were made to convert the 
diastereomeric mixture of products to the potentially thermodynamically favored product and 
increase the selectivity of product formation during the course of the reaction.  The mixture of 
diastereomers resultant from a ketone aldol reaction was subjected to the strong base LDA to 
investigate the possibility of an epimerization to a thermodynamically favored product (eq 2).  
Upon proton quench no change in the diastereomeric ratio of the products was observed. 
 
 By placing a chiral auxiliary on the silyl glyoxylate we sought to block one face of the 
intermediate magnesium enolate.  The auxiliary (-)-8-phenyl menthol Ω was chosen since it was 
easily synthesized in large quantities from pulegone, a compound available from the chiral pool 
(Scheme 1-8).   An alternative synthesis using Ω was developed to make a chiral silyl glyoxylate.  
The procedure differed from the conventional synthesis of 1b31 by starting with diketene, Ω and 
pABSA to form the diazo malonate 17 in one pot. 
tBuO
O
OTBS
HO Et
tBuO
O
OTBS
HO Et
dr 1.8:1 dr 1.8:1
1.5 equiv. LDA
THF
12 h
(2)
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Scheme 1-8 Chiral Silyl Glyoxylate Synthesis 
 
 
Once in hand, the chiral silyl glyoxylate 18 was evaluated with alcohol substrates (Table 
1-5).  Attempts to run the reaction with primary alcohols resulted in product mixtures with limited 
selectivity for 1 diastereomer over three others (entries 1 and 2).  Favorable results were achieved 
with the secondary alcohol isopropanol (entry 3), with a diastereomeric ratio of 19:1. 
OH
O
1) PhMgBr • CuBr
2) 2 N HCl
O
Ph
O
Ph
+
KOH
EtOH
reflux 3 h
O
Ph
Na/Toluene
isopropanol
reflux
57 %
(isolated)
41 % overall
N
H
O
S
O
N3
O
+ + O
O
CH3CN
NaOAc
!O
O O
N2
KOH 15%
CH3CN
!O
O
N2
H
1)TBSOTf, iPr2NEt, ether
2) DMDO, CH2Cl2
O
O
TBS
O
!
!
18
43 %
over 2 steps
77 %
over 2 steps
33 % overall
77 %
17
 14 
 
Table 1-5 Asymmetric Substrate Scope 
 
entry alcohol product yield (%)b d.r.c 
1d Me2CHCH2OH  
62 1.6:1 (X:Σ others) 
2d Me(CH2)5OH  
54 1.7:1 (X:Σ others) 
3d Me2CHOH  
63 19:1 
a Alcohol (1.5 equiv), EtMgBr (2.0 equiv), 2-MeTHF, 0 °C → rt; then 1 (1.0 equiv).  b Isolated yields.  c Determined 
by 1H NMR spectroscopy; the major isomer is shown. 
 
1.3.4 Crossover Experiments 
 
Preliminary conclusions regarding the relative rates of the individual steps of the reaction 
sequence may be drawn from the crossover experiments shown in eq 3 and 4.  Exposing the 
magnesium alkoxide of n-hexanol to 1b and isobutyraldehyde resulted in an approximately 
equimolar mixture of 11b and 11a, revealing that dissociation of the aldehyde from the 
magnesium center is faster than Brook rearrangement and aldolization (eq 3).  The possibility of 
the origin of 11a resulting from formation of an intermediate alkoxide by MPV reduction of 
isobutyraldehyde by n-hexanol alkoxide was eliminated in a control experiment exposing 
isobutyraldehyde to n-hexanol alkoxide (eq 4). 
 
R
!O
O
O
TBS
!O
O
OTBS
R
OH
1) EtMgBr, 
0 °C " rt
2-MeTHF
2)R'
19
R'HO
18
!O
O
TBSO
OH
Me
Me19a
!O
O
OTBS
OH
Me
19b
4
!O
O
OTBS
OH
Me
Me
19c
BrMgEt
tBuO
O
TBS
O
0 °C to r.t. THF, rt
THF tBuO
O
OTBS
OH
Me
4
OH
Me
4
O
Me
Me
+
H
BrMgEt +
0 °C ! rt THF, rt
THF
OH
Me
4
O
Me
Me1)
2) H2O
OH
Me
4
+
O
Me
4
39 : 1
9
H
H
tBuO
O
TBSO
OH
Me
Me
+
1         :         1.2
(3)
(4)
11b 11a
1b
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 Based on the observations from the crossover experiments, it was hypothesized that by 
using a sterically hindered hydride donor, it might be possible to expand the scope of the MPV-
aldol reaction to include electrophilic coupling partners incapable of reducing a silyl glyoxylate to 
promote Brook rearrangement (eq 5).  The magnesium alkoxide 21 generated from ethyl Grignard 
deprotonation of alcohol 20 was able to reduce 1b and promote Brook rearrangement in the 
presence of other aldehydes.  Presumably, ketone 23 formed from the Oppenauer oxidation is too 
sterically hindered to undergo an aldol reaction prior to dissociation allowing the association of 
an alternative aldehyde acceptor to complete aldolization and produce the desired product.  The 
substrates shown in Table 1-6 were inaccessible with the standard MPV reaction protocol.   
 
Table 1-6 Crossover Products 
 
entry aldehyde product yield (%)b 
1d   
64 
2   
33 
a Alcohol 20 (1.4 equiv), EtMgBr (1.5 equiv), THF, 0 °C → rt; then 1b (1.0 equiv) and aldehyde (1.0 equiv).  b 
Isolated yields of major diastereomer.  c D.R. not determined. 
tBuO
O
O
TBS
tBuO
O
OTBS
RTHF, 0 °C ! rt
OH
Me
Me
Me
Me
EtMgBr
O
Me
Me
Me
MgBr
H
O
R
O
Me
Me
Me
Me
OH
Me +
1b
20 22 23
(5)
22
H
O
O
tBuO
O
OTBS
OH
22a
O
H
O
OBn
tBuO
O
OTBS
OH
22b
OBn
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1.3.5 Catalytic Use of Metal 
 
Scheme 1-9 Proposed Catalytic Cycle 
 
 
A system catalytic in metal could function as depicted in Scheme 1-9.  The initial 
magnesium alkoxide would be generated with a substoichiometric amount of alcohol and ethyl 
Grignard.  Addition of silyl glyoxylate 1b and 24 would initiate the cycle with MPV reduction 
and Brook rearrangement followed by aldol reaction to form intermediate alkoxide 25.  
Regeneration of the starting magnesium alkoxide with 24, a species capable of displacing the 
intermediate alkoxide 25, would facilitate turnover.  Compounds 24a, with a trifluoroacetate 
leaving group, and 24b, with a trichlorosilane leaving group, were investigated as possible 
candidates.  With both substrates the resultant desired product was produced from the catalytic 
amount of magnesium alkoxide. 
 With no success in developing a catalytic MPV cycle with magnesium alkoxides, 
alternative hydride and vinyl nucleophilic catalyst systems were examined.  While this strayed 
OH
CH2Cl2, rt
Pyridine 1 equiv, 
(CF3O)2O
O
OH
tBuO
O
OTBS
O H
THF, 0 °C ! rt
EtMgBr
O
MgBr
tBuO
O
O
TBS
tBuO
O
OTBS
MgBr
O
MgBr
O
LG
tBuO
O
OTBS
O H
LG
O
CF3
OH
0 °C ! rt
SiCl4
O
SiCl3
24a
24b
1b
25
24
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from the symbiotic nature of the reaction by replacing the MPV reduction of the silyl glyoxylate 
with an external nucleophile source, it provided the potential for a multicomponent coupling 
system catalytic in metal and the possibility of employing chiral ligands to develop a 
stereoselective reaction. 
 Copper and zinc hydride generated in situ from the stoichiometric hydride source of 
polymethylhydrosiloxane (PMHS) were investigated with cyclohexylcarboxaldehyde as the 
electrophilic coupling partner.   Using CuCl with a racemic 2,2’-bis(diphenylphosphino)-1,1’-
binapthyl (BINAP) ligand and sodium tert-butoxide as an initiator resulted in a 37% yield of 
desired product with poor diastereoselectivity (eq 6).32,33  Switching the catalyst to 
CuF•3PPh3•2EtOH34 with 1,1’-Bis(diphenylphosphino)ferrocene (dppf) ligand improved the yield 
to 53 % with little diastereoselectivity (eq 7).  A system using Zn hydride generated in situ from 
ZnEt2 and PMHS with tetramethylethylene diamine (TMEDA) as a ligand provided the best yield 
of 83% but with no diastereoselectivity (eq 8).35 Besides the poor diastereoselectivities, the 
PMHS catalyst systems suffer from the requirement of harsh basic conditions to free the desired 
product from the polymeric backbone of PMHS. 
 
tBuO
O
O
TBS + H
O
1) 10% CuCl, 12% BINAP,
10% NaOtBu, 4 equiv. PMHS
toluene rt
2) 2 M NaOH
tBuO
O
OTBS
OH
37%
tBuO
O
O
TBS + H
O
1) 10% CuF•3PPh3•2EtOH,
12% dppf, 4 equiv. PMHS
toluene rt
2) 2 M NaOH
tBuO
O
OTBS
OH
 53% dr 1.6:1
tBuO
O
O
TBS + H
O
1) 30% ZnEt2, 30% TMEDA
4 equiv. PMHS, toluene rt
2) 2 M NaOH
tBuO
O
OTBS
OH
83%
Si O
H
n
PMHS
1b
1b
1b
26
26
26
(6)
(7)
(8)
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 With limited success using metal hydride catalysis, attempts were made to adapt a vinyl 
copper catalyst system to a multicomponent coupling with silyl glyoxylates and aldehydes.  The 
original conditions used the aforementioned CuF•3PPh3•2EtOH with dppf ligand  to generate a 
vinyl copper species in situ with trimethoxyvinylsilane serving as the stoichiometric vinyl source 
(eq 9).36  Initial attempts using the same conditions in the presence of silyl glyoxylate and 
benzaldehyde resulted in formation of none of the desired product (eq 10).  A number of other 
metal fluoride sources were also investigated as possible catalysts with no success.  A series of 
lanthanide triisopropoxides were then screened for reactivity with some interesting results.  
Er(iOPr)3 showed the most promise, forming compound 27 (eq 11).   Formation of 27 could arise 
from an MPV reduction of silyl glyoxylate by the Er(iOPr)3, Brook rearrangement with Er enolate 
formation, and then an aldol reaction with benzaldehyde.  Catalyst turnover appeared to occur 
through displacement of the lanthanide alkoxide by trimethoxyvinylsilane.  Compound 27 was 
formed in 30% yield, the maximum theoretical yield given a 10% catalyst loading.  This 
demonstrated the feasibility of an MPV-aldol system catalytic in metal through the use of 
lanthanide isopropoxides with a silane capable of displacing the intermediate lanthanide alkoxide 
with concurrent regeneration of the isopropoxide catalyst. 
 
 
H
O
1) 10% CuF•3PPh3•2EtOH,
12% dppf, 4 equiv. PMHS
toluene, rt
2) TBAF
Si(OMe)3 +
OH
(3 equiv.)
H
O
1) 10% CuF•3PPh3•2EtOH,
12% dppf, 4 equiv. PMHS
toluene, rt
2) TBAF
Si(OMe)3 +
(3 equiv.)
+tBuO
TBS
O
O
tBuO2C
TBSO
OH
0%
H
O 10% Er(O
iPr)3
toluene, 60 ° C
Si(OMe)3 +
(3 equiv.)
+tBuO
TBS
O
O
tBuO2C
O
30%
OTBS
Si
(OMe)2
271b
1b
(9)
(10)
(11)
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1.3.6 Other Coupling Partners 
 
 In addition to hydride nucleophiles to initiate coupling reactions between silyl 
glyoxylates and electrophiles, success was found using stoichiometric amounts of Grignard 
reagents as nucleophiles (Table 1-7).  Methylmagnesium bromide successfully coupled silyl 
glyoxylate with benzaldehyde in a moderate yield with moderate diastereoselectivity (entry 1).  
Vinylmagnesium bromide successfully coupled a benzylidine malonate, a nitroalkene and an 
aldehyde with silyl glyoxylate (entries 2-4).  Interestingly, the products observed with the nitro 
alkene and the benzylidene malonate arose from exclusive addition from the γ position of the 
enolate.  In the case of the aldehyde (entry 4), the high selectivity for the syn diol configuration 
proved useful in a future application of silyl glyoxylates to the synthesis of a complex natural 
product. 
 
Table 1-7 Grignard Coupling Reactions 
 
entry R1 El+ product yield (%)a selectivityb 
1 Me 
  
67 d.r. 2.3:1 
2 Vinyl 
  
45 1 diastereomer 
3 Vinyl 
  
49 (65c) only γ addition 
4d Vinyl 
  
76 syn:anti >95:5 
a Isolated yields. b Determined by 1H NMR spectroscopy; the major isomer is shown when determined. c Reaction 
run in 2:1 THF:CH2Cl2 yield determined by 1H NMR spectroscopy based on the internal standard trimethoxy benzene. d Unpublished result from Xin Linghu. 
 
1.4 Conclusions 
A new method was developed to efficiently conduct an aldol reaction between silyl 
glyoxylates and metal alkoxides with no required prior activation or redox manipulation of 
R1MgBr
tBuO
O
O
TBS
THF, 0 °C ! rt;
+
1b
El+
El+tBuO2C
TBSO R1
28
H
O
tBuO2C
TBSO Me
Ph
28a
Me OH
Ph
CO2Me
CO2Me
28b
tBuO2C
OTBS
Ph
CO2Me
CO2Me
NO2
Ph
tBuO2C
OTBS
Ph
NO2
28c
H
O
28d OH
tBuO2C
TBSO
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substrates.  The reaction is conducted under mild conditions to achieve synthetically useful yields 
of desired glycolate aldol products with moderate diastereoselectivity in some cases.  In addition, 
the utility of silyl glyoxylate 1 as a conjunctive reagent was explored in the coupling of other 
nucleophiles and electrophiles.  The scope of this new mild aldol reaction was demonstrated as 
well as the reactivity of the silyl glyoxylate reagent. 
 
1.5 Experimental 
 
General Information. Infrared (IR) spectra were obtained using a Nicolet 560-E.S.P. infrared 
spectrometer.  Proton and carbon nuclear magnetic resonance spectra (1H and 13C NMR) were 
recorded on the following instruments: Bruker model Avance 400 (1H NMR at 400 MHz and 13C 
NMR at 100 MHz) and Varian Gemini 300 (1H NMR at 300 MHz and 13C at 75 MHz) 
spectrometers with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.24 ppm and 
13C NMR: CDCl3 at 77.0 ppm).  1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sep = septet, m = 
multiplet), coupling constants (Hz), and integration.  Combustion analyses were performed by 
Atlantic Microlab Inc., Norcross, GA.  Analytical thin layer chromatography (TLC) was 
performed on Whatman 0.25 mm silica gel 60 plates.  Visualization was accomplished with UV 
light and aqueous ceric ammonium nitrate molybdate solution followed by heating.  Purification 
of the reaction products was carried out by flash chromatography using Sorbent Technologies 
silica gel 60 (32-63 µm).  All alcohols for general procedure (A) were distilled from magnesium 
prior to use.  All alcohols for general procedure (C) were distilled from sodium prior to use.  
Aldehydes were extracted from an aq. sat. NaHCO3 solution with ether, concentrated, and 
distilled.  THF was distilled from sodium and benzophenone.  Analytical chromatography was 
performed on a Berger Supercritical Fluid Chromatograph (SFC) model FCM 1100/1200 
equipped with an Agilent 1100 series UV-Vis detector.  Silyl glyoxylate 1 was prepared 
 21 
according to the literature procedure.31,37  (-)-8-phenylmenthol Ω was prepared according to the 
literature procedure.38  Yields and diastereomer ratios are reported for a specific experiment and 
as a result may differ slightly from those found in the tables, which are averages of at least two 
experiments. 
 
Representative Procedure (A) for the optimization of reaction conditions (Table 1.1 and 
Table 1.2). A dry round-bottomed flask with a magnetic stir bar was charged with alcohol (1.5 
equiv) and 2 mL of solvent. To the resulting solution, ethylmagnesium bromide (1.0 M in THF) 
(2.0 equiv) was added via syringe at 0 °C under an argon atmosphere. The reaction temperature 
was allowed to warm to 25 °C for 5 min. To the reaction solution was added dropwise via 
cannula the silylglyoxylate (1.0 equiv., ca. 0.4 mmol) in 2 mL of solvent. The reaction was stirred 
for 10 min before 5 mL of a saturated NH4Cl solution and 15 mL of Et2O were added. The 
organic layer was separated and the aqueous layer was extracted with two 10 mL portions of 
Et2O. The organic extracts were combined, dried (Na2SO4), and the solvent was removed with a 
rotary evaporator. To the crude product was added a known quantity of 1,3,5-trimethoxybenzene 
as the internal standard, and the yield and the diastereomer ratio of the reaction were determined 
by 1H NMR spectroscopy. 
 
tert-Butyl-2-tert-butyldimethylsilyloxy-2-isobutoxyacetate (11).  Analytical data for title 
compound: IR (thin film, cm-1) 2957, 2930, 2858, 1755, 1472, 1367, 1254, 1130, 1072, 839, 782; 
1H NMR (400 MHz, CDCl3)  δ 4.94 (s, 1H), 3.32 (ABX, JAB = 8.8 Hz, JAX = 6.8 Hz, 2H), 1.87 
(sep, J = 6.8 Hz, 1H), 1.48 (s, 9H), 0.92 (s, 9H), 0.91 (d, 6H, one peak overlapped with 0.92 
peak), 0.135 (s, 3H), 0.131 (s, 3H); 13C NMR (75 MHz, CDCl3) 168.0, 93.9, 81.6, 73.2, 28.4, 
27.9, 25.63, 25.56, 19.3, 18.2, 17.5, -4.6, -4.8 
tBuO
O
O
OTBS
Me
Me
11
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tert-Butyl-2-triethylsilyloxy-3-hydroxy-4-methylbutanoate (11j).  The title compound was 
prepared according to General Procedure A using 100 mg (0.41 mmol) of tert-butyl 
triethylsilylglyoxylate in THF (2 mL), 46 mg (0.60 mmol) of isobutanol in THF (2 mL), and 0.7 
mL (0.7 mmol) of EtMgBr (1 M in THF). The crude product was extracted with Et2O and 
purified by flash chromatography with 15:1 hexanes/EtOAc to afford 40 mg (30%) of the product 
as a clear oil (4.4:1 ratio of two diastereomers). Analytical data for title compound:  1H NMR 
(400 MHz, CDCl3) (major diastereomer) δ 4.11 (d, J = 4.9 Hz, 1H), 3.44 (t, J = 5.7, 1H), 2.45 (br 
s, 1H), 1.80 (dq, J = 13.4, 6.7 Hz, 1H), 1.46 (s, 9H), 0.94 (t, J = 7.75 Hz, 9H), 0.94 (m, 6H), 0.61 
(q, J = 7.79 Hz, 6H). 
 
tert-Butyl-2-triisopropylsilyloxy-3-hydroxy-4-methylbutanoate (11h).  The title compound 
was prepared according to General Procedure A using 100 mg (0.41 mmol) of tert-butyl 
triisopropylsilylglyoxylate in THF (2 mL), 46 mg (0.60 mmol) of isobutanol in THF (2 mL), and 
0.7 mL (0.7 mmol) of EtMgBr (1 M in THF). The crude product was extracted with Et2O and 
purified by flash chromatography with 15:1 hexanes/EtOAc to afford 45 mg (36%) of the product 
as a clear oil. Analytical data for title compound:  1H NMR (400 MHz, CDCl3) (major 
diastereomer) δ 4.31 (d, J = 3.6 Hz, 1H), 3.40 (dd, J = 8.4, 3.5 1H), 1.72 (sep, J = 8.2 Hz, 1H), 
1.45 (s, 12H), 1.2-0.85 (m, 24H). 
 
General procedure (B) for tandem Oppenauer oxidation/Brook rearrangement/aldolization 
(Table 1-3). A dry round bottomed flask with a magnetic stir bar was charged with alcohol (1.5 
BrMgEt HO+
tBuO
O
TES
O
0 °C to r.t. THF, r.t.
THF
tBuO
O
TESO
OH
11jMe
Me Me
Me
BrMgEt HO+
tBuO
O
TIPS
O
0 °C to r.t. THF, r.t.
THF
tBuO
O
TIPSO
OH
11hMe
Me Me
Me
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equiv), and 1-2 mL of solvent. To the resulting solution, ethylmagnesium bromide (1.0 M in 
THF) (1.75-2.0 equiv) was added via syringe at 0 °C under an argon atmosphere. The reaction 
temperature was allowed to warm to 25 °C for 5 min. To the reaction solution was added 
dropwise via cannula the silylglyoxylate (1.0 equiv, ca. 0.4 mmol) in 1-2 mL of solvent. The 
reaction was stirred at the same temperature for 10 min before 5 mL of a saturated NH4Cl 
solution and 15 mL of Et2O or CH2Cl2 were added. The organic layer was separated and the 
aqueous layer was extracted with two 10 mL portions of Et2O or CH2Cl2. The organic extracts 
were combined and dried (Na2SO4). Concentration of the organic phase by rotary evaporation 
afforded the crude product which was purified by flash chromatography using the specified 
solvent system. 
 
tert-Butyl-2-tert-butyldimethylsilyloxy-3-hydroxy-4-methylbutanoate (11a).  The title 
compound was prepared according to General Procedure B using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in 1:1 (v/v) THF/CH2Cl2 (1 mL), 46 mg (0.60 mmol) of 
isobutanol in 1:1 (v/v) THF/CH2Cl2 (1 mL), and 0.7 mL (0.7 mmol) of EtMgBr (1 M in THF). 
The crude product was extracted with CH2Cl2 and purified by flash chromatography with 15:1 
hexanes/EtOAc to afford 123 mg (95%) of the product as a clear oil (10:1 ratio of two 
diastereomers). Analytical data for title compound: IR (thin film, cm-1) 3502 (br), 2962, 2936, 
2859, 1750, 1473, 1392, 1368, 1289, 1253, 1144, 1005, 940, 877, 840, 778; 1H NMR (300 MHz, 
CDCl3) (major diastereomer) δ 4.11 (d, J = 5.1 Hz, 1H), 3.46 (dd, J = 6.0, 5.1 Hz, 1H), 2.37 (br s, 
1H), 1.81 (sep, J = 6.6 Hz, 1H), 1.46 (s, 9H), 0.96 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 6.9 Hz, 3H), 
0.89 (s, 9H),  0.082 (s, 3H), 0.051 (s, 3H); 13C NMR (75 MHz, CDCl3) (major diastereomer) δ 
171.0, 81.6, 78.7, 74.1, 29.5, 28.0, 25.7, 19.6, 18.2, 17.5, -4.7, -5.4; TLC (10:1 hexanes/EtOAc) 
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Rf of major diastereomer  0.25, Rf of minor diastereomer  0.30; Anal. Calcd. for C16H34O4Si: C, 
60.33; H, 10.76. Found: C, 60.31; H, 10.78. 
 
tert-Butyl-2-tert-butyldimethylsilyloxy-3-hydroxyoctanoate (11b).  The title compound was 
prepared according to General Procedure B using 100 mg (0.41 mmol) of tert-butyl tert-
butyldimethylsilylglyoxylate in 1:1 (v/v) THF/CH2Cl2 (1 mL), 63 mg (0.61 mmol) of hexanol in 
1:1 (v/v) THF/CH2Cl2 (1 mL), and 0.7 mL (0.7 mmol) of EtMgBr (1 M in THF). The crude 
product was extracted with CH2Cl2 and purified by flash chromatography with 17:1 
hexanes/EtOAc to afford 126 mg (89%) of the product as a clear oil (7.5:1 ratio of two 
diastereomers). Analytical data for title compound: IR (thin film, cm-1) 3476 (br), 2955, 2930, 
2858, 1750, 1472, 1368, 1254, 1145, 874, 838, 780; 1H NMR (400 MHz, CDCl3) (major 
diastereomer) δ 4.03 (d, J = 4.4 Hz, 1H), 3.74 (br m, 1H), 2.25 (br s, 1H), 1.46 (s, 9H), 1.48-1.40 
(underneath the peak of 1.46, 2H) 1.36-1.33 (m, 6H), 0.89 (s, 9H), 0.87 (t, J = 6.8 Hz, 3H), 0.085 
(s, 3H), 0.048 (s, 3H); 13C NMR (100 MHz, CDCl3) (major diastereomer) δ 170.8, 81.5, 75.7, 
73.5, 31.9, 31.7, 28.0, 25.7, 25.3, 22.5, 18.2, 14.0, -4.7, -5.4; TLC (15:1 hexanes/EtOAc) Rf  0.25; 
Anal. Calcd. for C18H38O4Si: C, 62.38; H, 11.05. Found: C, 62.75; H, 10.93. 
 
tert-Butyl-2-tert-butyldimethylsilyloxy-3-hydroxy-5-trimethylsilylpentanoate (11c).  The title 
compound was prepared according to General Procedure B using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in 1:1 (v/v) THF/CH2Cl2 (1 mL), 81 mg (0.61 mmol) of 3-
trimethylsilylpropanol in 1:1 (v/v) THF/CH2Cl2 (1 mL),  and 0.7 mL (0.7 mmol) of EtMgBr (1 M 
in THF). The crude product was extracted with CH2Cl2 and purified by flash chromatography 
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with 17:1 hexanes/EtOAc to afford 130 mg (84%) of the product as a clear oil (5:1 ratio of two 
diastereomers). Analytical data for title compound: IR (thin film, cm-1) 3495 (br), 2952, 2930, 
2859, 1748, 1724,  1472, 1368, 1250, 1146, 862, 838, 779; 1H NMR (300 MHz, CDCl3) (major 
diastereomer) δ 4.04 (d, J = 4.5 Hz, 1H), 3.66 (quint, J = 4.5 Hz, 1H), 2.33 (br s, 1H), 1.45 (s, 
9H), 0.90 (s, 9H), 0.75-0.63 (m, 2H), 0.50-0.38 (m, 2H), 0.085 (s, 3H), 0.050 (s, 3H), -0.035 (s, 
9H); 13C NMR (75 MHz, CDCl3) (major diastereomer) δ 170.9, 81.5, 76.0, 75.4, 28.0, 26.4, 25.7, 
18.2, 12.1, -1.86, -4.7, -5.4; TLC (15:1 hexanes/EtOAc) Rf 0.25; Anal. Calcd. for C18H40O4Si2: C, 
57.39; H, 10.70. Found: C, 57.71; H, 10.51. 
 
General procedure (E) for reactions in Table 1-4.  A dry round bottomed flask with a magnetic 
stir bar was charged with aldehyde (1.5 equiv), and 2 mL of THF. To the resulting solution, 
alkylmagnesium bromide (1.0 M in THF) (2.0 equiv) was added via syringe at 0 °C under an 
argon atmosphere. The reaction temperature was allowed to warm to 25 °C for 5 min. To the 
reaction solution was added dropwise via cannula silylglyoxylate (1.0 equiv, ca. 0.4 mmol) in 2 
mL of THF. The reaction was stirred at the same temperature for 10 min before 5 mL of a 
saturated NH4Cl solution and 15 mL of Et2O were added. The organic layer was separated and the 
aqueous layer was extracted with two 10 mL portions of Et2O. The organic extracts were 
combined and dried (Na2SO4). Concentration of the organic phase by rotary evaporation afforded 
the crude product which was purified by flash chromatography using the specified solvent 
system. 
 
Tert-butyl 2-(tert-butyldimethylsilyloxy)-3-ethyl-3-hydroxypentanoate (12a).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 36 mg (0.61 mmol) of propanal in THF (2 
BrMgEt O+
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mL), and 0.82 mL (0.82 mmol) of EtMgBr (1 M in THF). The crude product was purified by 
flash chromatography with 30:1-20:1 hexanes/EtOAc to afford 93 mg (68%) of the product as a 
clear oil. Analytical data for title compound: IR (thin film, cm-1) 3567 (br), 2961, 2936, 2887, 
2860, 1746, 1472, 1393, 1369, 1253, 1159, 1131, 876, 839, 780; 1H NMR (300 MHz, CDCl3)  δ 
3.98 (s, 1H), 2.68 (s, 1H), 1.4-1.6 (m, 4H), 1.47 (s, 9H), 0.86-0.91 (m, 6H), 0.91 (s, 9H),  0.06 (s, 
3H), 0.04 (s, 3H); 13C NMR (100 MHz, CDCl3)  δ 171.0, 81.7, 76.2, 75.8, 28.0, 27.2, 26.8, 25.7, 
18.1, 7.7, 7.6, -4.7, -5.4; TLC (20:1 hexanes/EtOAc) Rf 0.26; Anal. Calcd. for C17H36O4Si: C, 
61.40; H, 10.91. Found: C, 61.05; H, 10.90. 
 
Tert-butyl-2-(tert-butyldimethylsilyloxy)-3-hydroxy-3-phenylpentanoate (12b).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 65 mg (0.61 mmol) of benzaldehyde in 
THF (2 mL), and 0.82 mL (0.82 mmol) of EtMgBr (1 M in THF). The crude product was purified 
by flash chromatography with 30:1-20:1 hexanes/EtOAc to afford 127 mg (81%) of the product 
as a clear oil (2:1 ratio of two diastereomers). Analytical data for title compound: IR (thin film, 
cm-1) 3463 (br), 2961, 2932, 2857, 1741, 1694, 1368, 1255, 1137, 876, 839, 780; 1H NMR (400 
MHz, CDCl3) (major diastereomer) δ 7.17-7.46 (m, 5H), 4.17 (s, 1H), 3.73 (d, J = 1.2 Hz, 1 H), 
1.98 (sep, J = 7.2 Hz, 2H), 1.27 (s, 9H), 0.84 (s, 9H), 0.70 (t, J = 7.2 Hz, 3H), 0.08 (s, 3H), 0.04 
(s, 3H); 13C NMR (100 MHz, CDCl3) (major diastereomer)  δ 127.7, 126.2, 82.1, 79.3, 31.1, 
27.7, 25.6, 7.5, -5.0, -5.7; TLC (20:1 hexanes/EtOAc) Rf (both diastereomers) 0.33. 
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Tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclohexyl-3-hydroxybutanoate (12c).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 69 mg (0.61 mmol) of 
cyclohexylcarbaldehyde in THF (2 mL), and 0.82 mL (0.82 mmol) of EtMgBr (1 M in THF). The 
crude product was purified by flash chromatography with 30:1-20:1 hexanes/EtOAc to afford 102 
mg (67%) of the product as a clear oil (3.5:1 ratio of two diastereomers). Analytical data for title 
compound: IR (thin film, cm-1) 3481 (br), 2928, 2857, 1745, 1723, 1472, 1368, 1257, 1144, 839, 
778; 1H NMR (400 MHz, CDCl3) (major diastereomer) δ 4.01 (s, 1H), 1.60-1.94 (m, 6H), 1.48 
(s, 9H), 1.09 (s, 3H), 0.91 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H); 13C NMR (100 MHz, CDCl3) (major 
diastereomer)  δ 171.3, 81.7, 76.1, 44.1, 26.8, 26.7, 26.6, 25.7, 20.4, 18.1, -5.0, -5.7; TLC (20:1 
hexanes/EtOAc) Rf (both diastereomers) 0.33; Anal. Calcd. for C20H40O4Si: C, 64.47; H, 10.82. 
Found: C, 64.25; H, 10.89. 
 
Tert-butyl-2-(tert-butyldimethylsilyloxy)-3-hydroxy-3-phenylbutanoate (12d).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 65 mg (0.61 mmol) of benzaldehyde in 
THF (2 mL), and 0.22 mL (0.66 mmol) of MeMgBr (3 M in THF). The crude product was 
purified by flash chromatography with 30:1-20:1 hexanes/EtOAc to afford 67 mg (45%) of the 
product as a clear oil (2:1 ratio of two diastereomers). Analytical data for title compound: 1H 
NMR (400 MHz, CDCl3) (major diastereomer) δ 7.20-7.50 (m, 5H), 4.18 (s, 1H), 3.72 (s, 1 H), 
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O
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HO Me
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1.53 (s, 3H), 1.31 (s, 9H), 0.83 (s, 9H), -0.03 (s, 3H), -0.17 (s, 3H); TLC (20:1 hexanes/EtOAc) 
Rf (both diastereomers) 0.2. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclopentyl-3-hydroxybutanoate (12e).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 60 mg (0.61 mmol) of 
cyclopentanecarboxaldehyde in THF (2 mL), and 0.27 mL (0.66 mmol) of MeMgBr (3 M in 
THF). The crude product was purified by flash chromatography with 30:1-20:1 hexanes/EtOAc to 
afford 52 mg (39%) of the product as a clear oil (1.6:1 ratio of two diastereomers). Analytical 
data for title compound: 1H NMR (400 MHz, CDCl3) (major diastereomer) δ 3.9 (s, 1H), 2.77 (s, 
1 H), 1.95 (td, J = 9.9, 4.65 Hz, 1H), 1.75-1.4 (m, 8H), 1.47 (s, 9H), 1.15 (s, 3H), 0.9 (s, 9H), 0.06 
(s, 3H), 0.04 (s, 3H); TLC (20:1 hexanes/EtOAc) Rf  0.22, 0.29. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclopropyl-3-hydroxybutanoate (12f).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 43 mg (0.61 mmol) of 
cyclopropanecarboxaldehyde in THF (2 mL), and 0.27 mL (0.66 mmol) of MeMgBr (3 M in 
THF). The crude product was purified by flash chromatography with 30:1-20:1 hexanes/EtOAc to 
afford 47 mg (35%) of the product as a clear oil (1.2:1 ratio of two diastereomers). Analytical 
data for title compound: 1H NMR (400 MHz, CDCl3) (major diastereomer) δ 3.95 (s, 1H), 2.90 
(s, 1 H), 1.48 (s, 9H), 1.15 (s, 3H), 0.92 (s, 9H), 0.4-0.28 (m, 5H), 0.07 (s, 3H), 0.05 (s, 3H); TLC 
(20:1 hexanes/EtOAc) Rf (both diastereomers) 0.33. 
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tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclopropyl-3-hydroxypentanoate (12g).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 43 mg (0.61 mmol) of 
cyclopropanecarboxaldehyde in THF (2 mL), and 0.8 mL (0.8 mmol) of EtMgBr (1 M in THF). 
The crude product was purified by flash chromatography with 30:1-20:1 hexanes/EtOAc to afford 
47 mg (35%) of the product as a clear oil (2.7:1 ratio of two diastereomers). Analytical data for 
title compound: 1H NMR (400 MHz, CDCl3) (major diastereomer) δ 4.02 (s, 1H), 2.74 (s, 1 H), 
1.69-1.64 (m, 2H) 1.48 (s, 9H), 0.93 (m, 3H), 0.91 (s, 9H), 0.41-0.14 (m, 5H), 0.07 (s, 3H), 0.05 
(s, 3H); TLC (20:1 hexanes/EtOAc) Rf (both diastereomers) 0.39. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclohexyl-3-hydroxybutanoate (12h).  The title 
compound was prepared according to General Procedure E using 100 mg (0.41 mmol) of tert-
butyl tert-butyldimethylsilylglyoxylate in THF (2 mL), 69 mg (0.61 mmol) of 
cyclohexylcarbaldehyde in THF (2 mL), and 0.82 mL (0.82 mmol) of EtMgBr (1 M in THF). The 
crude product was purified by flash chromatography with 30:1-20:1 hexanes/EtOAc to afford 27 
mg (15%) of the product as a clear oil (2.4:1 ratio of two diastereomers). Analytical data for title 
compound: 1H NMR (400 MHz, CDCl3) (major diastereomer) δ 4.14 (s, 1H), 2.77 (s, 1H) 1.60-
1.9 (m, 6H), 1.48 (s, 9H), 1.17 (m, 2H), 0.93-0.87 (m, 3H), 0.91 (s, 9H), 0.06 (s, 3H), 0.04 (s, 
3H); TLC (20:1 hexanes/EtOAc) Rf (both diastereomers) 0.33. 
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General procedure (C) for Horner-Wadsworth-Emmons reactions (step 1 of stereochemical 
proof for Table 3). A dry round bottomed flask with a magnetic stir bar was charged 
phosphonoacetate ester (1.0 equiv), and 5 mL of THF. To the resulting solution, sodium hydride 
(1.1 equiv) was added in one portion.  The solution was stirred at room temperature for 30 
minutes. To the reaction solution was added dropwise via cannula the ketone (1.0 equiv.) in 5 mL 
of THF. The resulting solution was stirred for 20 h.  The product was then extracted from an aq. 
sat. NaHCO3 solution with 15 mL of ether. The organic layer was separated and the aqueous layer 
was extracted with two 10 mL portions of Et2O. The organic extracts were combined and dried 
(MgSO4). Concentration of the organic phase by rotary evaporation afforded the crude product, 
which was purified by flash chromatography using the specified solvent system. 
 
General procedure (D) for lithium aluminum hydride reductions. A dry round bottomed flask 
with a magnetic stir bar was charged lithium aluminum hydride (5.0 equiv), and 5 mL of THF at 
0 ºC. To the resulting solution the ester was added dropwise (1.0 equiv) in 5 mL of THF.  The 
solution was warmed to room temperature and stirred for 1.5 hours. To the solution was added X 
µL of H2O where X is equivalent to the number of mg of lithium aluminum hydride used in the 
reaction.  This was followed by the addition of X µL 15% NaOH solution and then 5X µL of 
additional H2O. The solid precipitates were filtered. Concentration of the organic phase by rotary 
evaporation afforded the crude product, which was purified by flash chromatography using the 
specified solvent system. 
 
General procedure (E) for dihydroxylations. A dry round bottomed flask with a magnetic stir 
bar was charged with alkene (1.0 equiv), DABCO (0.3 equiv), 4-methylmorpholine N-oxide (2 
equiv), methanesulfonamide (1 equiv) and acetone (20 ml).  The solution was cooled to 0 °C and 
potassium osmate dihydrate (0.15 equiv in 1 mL H2O) was added dropwise followed by addition 
of t-BuOH (1.5 mL).  The reaction was allowed to stir for 4 days and progress was monitored by 
 31 
TLC. When all starting material was consumed the homogenous solution was stirred with Na2SO3 
for 2 hours.  The solution was then extracted with three 20 mL portions of CH2Cl2.  Concentration 
of the organic phase by rotary evaporation afforded the crude product which was purified by flash 
chromatography using the specified solvent system. 
 
(E)-ethyl 3-phenylpent-2-enoate.  The title compound was prepared according to General 
Procedure F using 1 g (7.5 mmol) of propiophenone, 1.69 g (7.5 mmol) of 
triethylphosphonoacetate, 199 mg NaH (8.3 mmol) and 10 mL of THF. The crude product was 
purified by flash chromatography with 20:1 hexanes/ether to afford 346 mg (24%) of the product 
as a clear oil. Analytical data for title compound: 1H NMR (400 MHz, CDCl3) δ 7.34-7.44 (m, 
5H), 6.0 (s, 1H), 4.2 (q,  J = 7.2 Hz, 2H), 3.09 (q, J = 7.2 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H), 1.06 
(t, J = 7.2 Hz, 3H); TLC (20:1 hexanes/ether) Rf (E) 0.29; the 1H NMR spectrum matched that 
reported previously.39 
 
Ethyl 2,3-dihydroxy-3-phenylpentanoate.  The title compound was prepared according to 
General Procedure H using 100 mg (0.53 mmol) of alkene, 29 mg (0.08 mmol) of potassium 
osmate dihydrate, 18 mg (0.15 mmol) of DABCO, 123 mg (1.05 mmol) of NMO, 50 mg (0.53 
mmol) of methanesulfonamide, 1.5 mL tBuOH and 20 mL of acetone. The crude product was 
purified by flash chromatography with 5:1 hexanes/ether to afford 100 mg (80%) of the product 
as a clear oil. Analytical data for title compound: 1H NMR (400 MHz, CDCl3) δ 7.20-7.46 (m, 
5H), 4.35 (s, 1H), 4.15 (q,  J = 7.2 Hz, 2H), 1.99 (dq,  J = 7.2 Hz, 1H), 1.93 (dq,  J = 7.2 Hz, 1H) 
1.14 (t, J = 7.2 Hz, 3H), 0.80 (t, J = 7.2 Hz, 3H). 
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3-phenylpentane-1,2,3-triol (15a).  The title compound was prepared according to General 
Procedure G using 100 mg (0.26 mmol) of diol, 50 mg (1.3 mmol) of lithium aluminum hydride, 
and 1.5 mL of THF. The crude product was purified by flash chromatography with ethyl acetate 
to afford 35 mg (56%) of the product as a clear oil. Analytical data for title compound: IR (thin 
film, cm-1) 3410 (br), 2969, 2939, 2881, 1647, 1600, 1447, 1071, 1026, 702; 1H NMR (400 MHz, 
CDCl3) δ 7.2-7.40 (m, 5H), 3.77-3.85 (m, 3H), 3.12 (s, 1H), 2.62-2.68 (m, 2H), 1.83 (q, J = 9.6 
Hz, 2H), 0.67 (t, J = 9.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 143.1, 128.67, 128.54, 128.48, 
126.1, 125.9, 79.4, 63.1, 30.5, 7.8; TLC (ethyl acetate) Rf 0.37; CSP-SFC analysis: Chiralpak AS, 
0-10% MeOH (ramp 0.5%/min), 1.5 mL/min, 150 bar, 40 °C, 240 nm, tr  19.8, 20.3 min; Anal. 
Calcd. for C11H16O3: C, 67.32; H, 8.22. Found: C, 67.03; H, 8.24.  
This material was compared (using SFC analysis) to the mixture of 20a/20b prepared from 
reduction of 12b. 
 
3-phenylpentane-1,2,3-triol (15a/b).  The title compound was prepared according to General 
Procedure G using 115 mg (0.30 mmol) of 12b, 57 mg (1.5 mmol) of lithium aluminum hydride, 
and 1.5 mL of THF. The crude product was purified by flash chromatography with ethyl acetate 
to afford 45 mg (63%) of the product as a clear oil. Analytical data for title compound: 1H NMR 
(400 MHz, CDCl3) (major diastereomer) δ 7.2-7.40 (m, 5H), 3.77-3.85 (m, 3H), 3.12 (s, 1H), 
2.62-2.68 (m, 2H), 1.83 (q, J = 9.6 Hz, 2H), 0.67 (t, J = 9.6 Hz, 3H); TLC (ethyl acetate) Rf 0.37; 
CSP-SFC analysis: Chiralpak AS, 0-10% MeOH. (ramp 0.5%/min), 1.5 mL/min, 150 bar, 40 °C, 
240 nm, tr(major) 20.0, 20.6 min, tr(minor) 17.6, 19.1 min; Anal. See above. 
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(E)-tert-Butyl 3-cyclohexylbut-2-enoate.  The title compound was prepared according to 
General Procedure F using 0.67 g (5.3 mmol) of ketone, 1.34 g (5.3 mmol) of tert-Butyl diethyl 
phosphonoacetate, 146 mg of NaH (6.1 mmol) and 10 mL of THF. The crude product was 
purified by flash chromatography with 99:1-20:1 hexanes/ether to afford 760 mg (64%) of the 
product E isomer, as a clear oil. Analytical data for title compound: IR (thin film, cm-1) 3500 (br), 
2977, 2928, 2854, 1720, 1642, 1450, 1366, 1237, 1142; 1H NMR (400 MHz, CDCl3) δ 5.54 (s, 
1H), 2.07 (s, 3H), 1.64-1.94 (m, 6H), 1.45 (s, 9H), 1.1-1.29 (m, 5H), 13C NMR (100 MHz, 
CDCl3) δ 166.9, 163.1, 115.7, 79.3, 49.0, 31.3, 30.8, 28.3, 26.5, 26.4, 17.1; TLC (20:1 
hexanes/ether) Rf (E) 0.30. For the NOESY spectrum, see below. 
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Fig 1-1 NOESY in CDCl3 of (E)-tert-butyl 3-cyclohexylbut-2-enoate 
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tert-butyl 3-cyclohexyl-2,3-dihydroxybutanoate (13a).  The title compound was prepared 
according to General Procedure H using 200 mg (0.89 mmol) of alkene, 49  mg (0.13 mmol) of 
potassium osmate dihydrate, 30 mg (0.15 mmol) of DABCO, 209 mg (1.05 mmol) of NMO, 84 
mg (0.53 mmol) of methanesulfonamide, 2.6 mL tBuOH and 34 mL of acetone. The crude 
product was purified by flash chromatography with 5:1 hexanes/ether to afford 147 mg (64%) of 
the product as a clear oil. Analytical data for title compound: IR (thin film, cm-1) 3378 (br), 2974, 
2919, 2851, 1729, 1367, 1151; 1H NMR (400 MHz, CDCl3) δ 4.04 (d, J = 6.8 Hz, 1H), 3.09 (d, J 
= 6.8 Hz, 1H), 2.23 (s, 1H), 1.62-1.88 (m, 6H) 1.50 (s, 9H), 1.13-1.24 (m, 5H), 1.08 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 74.17, 44.0, 28.06, 27.8, 26.7, 26.6, 26.5, 26.2, 19.3; TLC (10:1 
hexanes:EtOAc) Rf 0.2. 
 
Tert-butyl 3-cyclohexyl-2,3-dihydroxybutanoate (13a/b).  The title compound was prepared by 
adding 22 mg (0.06 mmol) of 12c, 2 mL HF (49% aq.) and 2 mL of THF to a round bottom flask.  
The solution was stirred overnight and the crude product was isolated as a clear oil.  Upon 
comparison of the 1H NMR spectrum with the spectrum of 13a derived from dihydroxylation of 
the (E)-alkene, it was determined that the major isomer had the anti orientation.  1H NMR data 
for 13b (400 MHz, CDCl3) (major diastereomer) δ 3.99 (d, J = 6.4 Hz, 1H), 3.07 (m, 1H), 2.23 (s, 
1H), 1.62-1.88 (m, 6H) 1.51 (s, 9H), 1.13-1.24 (m, 5H), 1.11(s, 3H); TLC (10:1 hexanes:EtOAc) 
Rf 0.2. 
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(1R,2S,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl 2-diazoacetate (17).  The title 
compound was prepared by adding 9.92 g (41 mmol) of 4-acetamidobenzenesulfonyl azide, 0.633 
g (7.5 mmol) of NaOAc, 6 g (26 mmol) of Ω and 21 mL of CH3CN to a round bottom flask.  The 
solution was brought to reflux.  To the flask 4.34 g (52 mmol) of diketene (distilled from 
stabilizer prior to use) was added dropwise via syringe in 5 mL of CH3CN.  After addition the 
reaction was removed from heat and allowed to stir overnight.  By TLC reaction was not 
complete so 3.13 g (31 mmol) of Et3N and 1.24 g (5 mmol) of 4-acetamidobenzenesulfonyl azide 
were added. After stirring for an additional 6 h reaction was complete.  The solution was diluted 
with Et2O (50 mL) and H2O (50 mL).  The aqueous layer was extracted with Et2O (3 x 20 mL).  
The organic layer was then washed with saturated aqueous NH4Cl (40 mL), washed with brine, 
dried over MgSO4 and concentrated in vacuo to reveal a yellow oil.  The crude material was taken 
up in CH3CN (50 mL) and stirred with a 15% aqueous KOH solution (50 mL) overnight.  The 
solution was diluted with Et2O (50 mL) and H2O (50 mL).  The aqueous layer was extracted with 
Et2O (3 x 20 mL).  The organic layer was then washed with saturated aqueous NH4Cl (40 mL),  
brine (40 mL), dried over MgSO4 and concentrated in vacuo to yield 6 g (77%) of the product as a 
pale yellow oil.  Crude product was not purified.  Analytical data for title compound:  1H NMR 
data for 21b (400 MHz, CDCl3) δ 7.28-7.10 (m, 5 H), 4.87 (td, J = 10.73, 4.24 Hz, 1H), 4.2 (s, 
1H), 1.98 (ddd, J = 12.25, 6.63, 3.45 Hz, 1H), 1.9 (m, 1H), 1.65 (m, 2H), 1.49-0.85 (m, 4H) 1.3 
(s, 3H), 1.21 (s, 3H), 0.85 (d, J = 6.51 Hz, 3H); TLC (10:1 hexanes:EtOAc) Rf 0.3. 
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8-phenylmenthol silyl glyoxylate (18).  The title compound was prepared by adding 6 g (20 
mmol) of X and 75 mL of Et2O to a round bottom flask under an atmosphere of Ar.  To the 
solution was added 2.85 g (34 mmol) of diisopropylethyl amine.  The solution was stirred and 
cooled to -10 ˚C and 8.15 g (34 mmol) of tert-butylsimethylsilyl trifluromethanesulfonate was 
added slowly via syringe.  After addition the solution was allowed to warm slowly to 23 ˚C and 
stirred for 12 h.  When reaction was complete by TLC the solution was filtered to remove salts 
and concentrated in vacuo. A 1 L, three-necked, round-bottomed flask was fitted with an 
overhead mechanical stirrer (fitted with a 6.0 x 2.0 cm Teflon paddle) and a thermometer.  The 
flask was charged with sodium bicarbonate (6.7 g, 80 mmol), deionized water (250 mL) and 
acetone (200 mL) through the open neck. The mixture was mechanically stirred (600 rpm) and 
cooled to 0 °C in an ice-bath. Oxone® (24.56 g, 40 mmol) was added in several portions.  A 
solution of the crude material from step 1 in dichloromethane (30 mL) was added to the reaction 
mixture all at once. The resulting yellow mixture was stirred and slowly allowed to warm to 23 
°C over 12 h. The progress of the reaction was monitored by TLC until no starting material was 
present. The insoluble salts were removed by filtration through Celite and the pad was washed 
with two 25-mL portions of dichloromethane. Deionized water (150 mL) was added to the filtrate 
and the organic layer was separated and the aqueous phase was extracted with two 50-mL 
portions of dichloromethane. The combined organic extracts were dried with Na2SO4 (ca. 50 g) 
for 10 min, then were filtered through a funnel packed with glass wool, and concentrated by 
rotary evaporation (30 °C bath temperature, 70 torr).  The crude product was purified by flash 
column chromatography with 20:1 petroleum ether/acetone, to yield 3.4 g (43 % for two steps) of 
1)TBSOtf, iPr2NEt, ether
2) DMDO, CH2Cl2
O
O
TBS
O
18
!O
O
N2
H
17
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product as a yellow oil.  Analytical data for title compound:  1H NMR data for 18 (400 MHz, 
CDCl3) δ 7.20-7.06 (m, 5 H), 4.86 (td, J = 10.76, 4.45 Hz, 1H), 1.98 (ddd, J = 12.10, 10.79, 3.31 
Hz, 1H), 1.91-0.74 (m, 7H) 1.29 (s, 3H), 1.23 (s, 3H), 0.90 (s, 9H), 0.86 (d, J = 6.56 Hz, 3H), 
0.23 (s, 3H), 0.20 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 128.0, 125.5, 125.3, 76.5, 50.5, 41.5, 
40.0, 34.4, 31.4, 26.9, 26.4, 26.2, 21.7, 16.9, 14.1, 6.7; TLC (20:1 Hexanes:Acetone) Rf 0.35. 
 
General procedure (F) for asymmetric tandem Oppenauer oxidation/Brook 
rearrangement/aldolization (Table 1-5). A dry round bottomed flask with a magnetic stir bar 
was charged with alcohol (1.5 equiv), and 1-2 mL of solvent. To the resulting solution, 
ethylmagnesium bromide (1.0 M in 2-MeTHF) (1.75-2.0 equiv) was added via syringe at 0 °C 
under an argon atmosphere. The reaction temperature was allowed to warm to 25 °C for 5 min. 
To the reaction solution was added dropwise via cannula the silylglyoxylate (1.0 equiv, ca. 0.4 
mmol) in 1-2 mL of solvent. The reaction was stirred at the same temperature for 10 min before 5 
mL of a saturated NH4Cl solution and 15 mL of Et2O or CH2Cl2 were added. The organic layer 
was separated and the aqueous layer was extracted with two 10 mL portions of Et2O or CH2Cl2. 
The organic extracts were combined and dried (Na2SO4). Concentration of the organic phase by 
rotary evaporation afforded the crude product which was purified by flash chromatography using 
the specified solvent system. 
 
(2R,3R)-((1R,2S,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl) 2-(tert-
butyldimethylsilyloxy)-3-hydroxy-4-methylpentanoate (19a).  The title compound was 
prepared according to General Procedure B using 100 mg (0.2 mmol) of X in 2-MeTHF (2 mL), 
22 mg (0.30 mmol) of isobutanol in 2-MeTHF (2 mL), and 0.4 mL (0.4 mmol) of EtMgBr (1 M 
in THF). The crude product was extracted with CH2Cl2 and purified by flash chromatography 
BrMgEt HO+
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O
TBS
O
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Me
Me
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O
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OH
Me
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with 20:1 hexanes/EtOAc to afford 51 mg (51%) of the product as a clear oil (1.9:Σ others ratio of 
four diastereomers). Analytical data for title compound:  1H NMR (400 MHz, CDCl3) (major 
diastereomer) δ 7.28-7.13 (m, 5 H), 4.80 (td, J = 10.68, 4.01 Hz, 1H), 3.66 (d, J = 4.36 Hz, 1H), 
3.18 (q, J = 5.10 Hz, 1H), 2.04 (d, J = 5.49 Hz, 1H), 2.13-0.79 (m, 8H) 1.30 (s, 3H), 1.19 (s, 3H), 
0.90 (s, 9H), 0.85 (t, J = 6.99 Hz, 6H), 0.80 (d, J = 6.79 Hz, 3H), 0.11 (s, 3H), 0.05 (s, 3H); TLC 
(20:1 hexanes/EtOAc) Rf of mixture diastereomers  0.32. 
 
(2R,3R)-((1R,2S,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl) 2-(tert-
butyldimethylsilyloxy)-3-hydroxyoctanoate (19b).  The title compound was prepared according 
to General Procedure B using 100 mg (0.2 mmol) of X in 2-MeTHF (2 mL), 30 mg (0.30 mmol) 
of hexanol in 2-MeTHF (2 mL), and 0.4 mL (0.4 mmol) of EtMgBr (1 M in THF). The crude 
product was extracted with CH2Cl2 and purified by flash chromatography with 20:1 
hexanes/EtOAc to afford 67 mg (54%) of the product as a clear oil (1.7:Σ others ratio of four 
diastereomers). Analytical data for title compound:  1H NMR (400 MHz, CDCl3) (major 
diastereomer) δ 7.28-7.14 (m, 5 H), 4.76 (td, J = 10.77, 4.10 Hz, 1H), 3.56 (d, J = 3.71 Hz, 1H), 
3.43-3.37 (m, 1H), 2.04 (td, J = 11.33, 2.64 Hz, 1H), 2.05-0.79 (m, 15H) 1.81, (d, J = 7.35 Hz, 
1H), 1.28 (s, 3H), 1.18 (s, 3H), 0.90 (s, 9H), 0.88-0.83 (m, 6H), 0.11 (s, 3H), 0.05 (s, 3H); TLC 
(20:1 hexanes/EtOAc) Rf of mixture diastereomers  0.30. 
 
(R)-((1R,2S,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl) 2-(tert-butyldimethylsilyloxy)-
3-hydroxy-3-methylbutanoate (19c).  The title compound was prepared according to General 
Procedure B using 100 mg (0.2 mmol) of X in 2-MeTHF (2 mL), 18 mg (0.30 mmol) of 
BrMgEt +
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O
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isopropanol in 2-MeTHF (2 mL), and 0.4 mL (0.4 mmol) of EtMgBr (1 M in THF). The crude 
product was extracted with CH2Cl2 and purified by flash chromatography with 20:1 
hexanes/EtOAc to afford 72 mg (63%) of the product as a clear oil (19:1 ratio of two 
diastereomers). Analytical data for title compound:  1H NMR (400 MHz, CDCl3) (major 
diastereomer) δ 7.28-7.12 (m, 5 H), 4.76 (td, J = 10.75, 4.06 Hz, 1H), 3.29 (s, 1H), 2.58 (s, 1H), 
2.14-0.84 (m, 11H) 1.30 (s, 3H), 1.18 (s, 3H), 0.92 (s, 9H), 0.11 (s, 3H), 0.06 (s, 3H); 13C NMR 
(100 MHz, CDCl3) d 170.8, 151.9, 128, 125.2, 78.17, 76.3872.02, 50.33, 41.25, 39.62, 34.6, 
31.37, 27.72, 26.77, 26.68, 25.95, 25.77, 25.39, 25.15, 21.72, 18.26, -4.42, -5.19; TLC (10:1 
hexanes/EtOAc) Rf of mixture diastereomers  0.22. 
 
General procedure (G) for crossover tandem Oppenauer oxidation/Brook 
rearrangement/aldolization (Table 1-6). A dry round bottomed flask with a magnetic stir bar 
was charged with 2,4-dimethylpentan-3-ol 20 (1.4 equiv), and 1-2 mL of THF. To the resulting 
solution, ethylmagnesium bromide (1.0 M in 2-MeTHF) (1.5 equiv) was added via syringe at 0 
°C under an argon atmosphere. The reaction temperature was allowed to warm to 25 °C for 5 
min. To the reaction solution was added dropwise via cannula the silylglyoxylate (1.0 equiv, ca. 
0.4 mmol) and the aldehyde (1 equiv) in 1-2 mL of THF. The reaction was stirred at the same 
temperature for 1 h before 5 mL of a saturated NH4Cl solution and 15 mL of Et2O or CH2Cl2 
were added. The organic layer was separated and the aqueous layer was extracted with two 10 
mL portions of Et2O or CH2Cl2. The organic extracts were combined and dried (Na2SO4). 
Concentration of the organic phase by rotary evaporation afforded the crude product which was 
purified by flash chromatography using the specified solvent system. 
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tert-butyl 2-(tert-butyldimethylsilyloxy)-3-(furan-2-yl)-3-hydroxypropanoate(22a).  The title 
compound was prepared according to General Procedure G using 67 mg (0.57 mmol) of 20 in 
THF (2 mL), 100 mg (0.4 mmol) of 1b and 36 mg (0.4 mmol) of furfural in THF (2 mL), and 
0.61 mL (0.6 mmol) of EtMgBr (1 M in THF). The crude product was extracted with CH2Cl2 and 
purified by flash chromatography with 20:1 hexanes/EtOAc to afford 89 mg (64%) of the product 
as a clear oil (1 diastereomer isolated). Analytical data for title compound:  1H NMR (400 MHz, 
CDCl3) (major diastereomer) δ 7.34 (t, J = 0.83 Hz, 1 H), 6.3 (m, 2H), 4.93 (dd, J = 8.37, 3.27 
Hz, 1H), 4.38 (dd, J = 3.5, 0.24 Hz, 1H), 2.96 (d, J = 8.78 Hz, 1H), 1.43 (s, 9H), 0.82 (s, 9H), 
0.02 (s, 3H), -0.06 (s, 3H); TLC (10:1 hexanes/EtOAc) Rf of mixture diastereomers  0.22. 
 
tert-butyl 4-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-3-hydroxybutanoate (22b).  The title 
compound was prepared according to General Procedure G using 67 mg (0.57 mmol) of 20 in 
THF (2 mL), 100 mg (0.4 mmol) of 1b and 62 mg (0.4 mmol) of α-benzloxy acetaldehyde in 
THF (2 mL), and 0.61 mL (0.6 mmol) of EtMgBr (1 M in THF). The crude product was extracted 
with CH2Cl2 and purified by flash chromatography with 20:1 hexanes/EtOAc to afford 54 mg 
(33%) of the product as a clear oil (1 diastereomer isolated). Analytical data for title compound:  
1H NMR (400 MHz, CDCl3) (major diastereomer) δ 7.35-7.27 (m, 5 H), 4.55 (d, J = 6.14 Hz, 
2H), 4.16 (d, J = 5.67 Hz, 1H), 4.00 (m, 1H), 3.59 (d, J = 4.92 Hz, 2H), 2.5 (d, J = 5.84 Hz, 1H), 
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1.50 (s, 9H), 0.90 (s, 9H), 0.10 (s, 3H), 0.06 (s, 3H); TLC (10:1 hexanes/EtOAc) Rf of mixture 
diastereomers  0.15. 
 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclohexyl-3-hydroxypropanoate (26).  The title 
compound was prepared according to following procedure in an inert atmosphere glove box: A 
flame dried scintillation vial was charged with 38 mg (0.04 mmol) of CuF(PPh3)2 2 • EtOH 
complex34, 27 mg (0.05 mmol) of diphenylphosphinoferrocene(dppf) and 2 mL of toluene.  
Solution was stirred for 20 minutes, 107 mg (1 mmol) of PMHS was added and solution was 
stirred another 20 minutes.  A solution of 46 mg (0.4 mmol) of cyclohexylcarboxaldehyde and 
100 mg (0.4 mmol) of silyl glyoxylate 1b in 2 mL of toluene was then added dropwise.  Solution 
was stirred for 16 h and then poured over 2.5 M aqueous NaOH (3 mL) and stirred for 4 h.  The 
aqueous layer was extracted with Et2O (2 x 5mL).  The organic layer was washed with brine (3 
mL), dried over MgSO4 and concentrated in vacuo. The crude product was purified by flash 
chromatography with 20:1 hexanes/EtOAc to afford 77 mg (53%) of the product as a clear oil 
(1.6:1 diastereomer ratio). Analytical data for title compound:  1H NMR (300 MHz, CDCl3) δ 
4.16 (d, J = 2.6 Hz, 1H), 3.49 – 3.34 (m, 1H), 2.08 (d, J = 9.4 Hz, 1H), 2.01 (d, J = 12.7 Hz, 1H), 
1.82 – 1.53 (m, 3H), 1.45 (s, 9H), 1.39 – 0.94 (m, 5H), 0.90 (s, 9H), 0.11 (s, 3H), 0.04 (s, 3H); 
TLC (10:1 hexanes/EtOAc) Rf of mixture diastereomers  0.15. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-cyclohexyl-3-hydroxypropanoate(X).  The title 
compound was prepared according to following procedure under an inert atmosphere of Ar: A 
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flame dried scintillation vial was charged with 0.5 mL of toluene, 54 µL (0.1 mmol) of ZnEt2 (1 
M in hexanes) and 14 mg (0.1 mmol) of tetramethylethylenediamine.  The solution was stirred for 
15 min, 107 mg (1 mmol) of PMHS was added and the solution was stirred another 20 minutes.  
A solution of 50 mg (0.45 mmol) of cyclohexylcarboxaldehyde and 100 mg (0.4 mmol) of silyl 
glyoxylate X in 1 mL of toluene was then added dropwise.  Solution was stirred for 30 min and 
then poured over 2.5 M aqueous NaOH (3 mL) and stirred for 4 h.  The aqueous layer was 
extracted with Et2O (2 x 5mL).  The organic layer was washed with brine (3 mL), dried over 
MgSO4 and concentrated in vacuo. The crude product was purified by flash chromatography with 
20:1 hexanes/EtOAc to afford 121 mg (83%) of the product as a clear oil (1:1 diastereomer ratio). 
Analytical data for title compound:  1H NMR (300 MHz, CDCl3) δ 4.16 (d, J = 2.6 Hz, 1H), 3.49 
– 3.34 (m, 1H), 2.08 (d, J = 9.4 Hz, 1H), 2.01 (d, J = 12.7 Hz, 1H), 1.82 – 1.53 (m, 3H), 1.45 (s, 
9H), 1.39 – 0.94 (m, 5H), 0.90 (s, 9H), 0.11 (s, 3H), 0.04 (s, 3H); TLC (10:1 hexanes/EtOAc) Rf 
of mixture diastereomers  0.15. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-(dimethoxy(vinyl)silyloxy)-3-phenylpropanoate 
(27).  The title compound was prepared according to following procedure under an inert 
atmosphere of Ar: A flame dried scintillation vial was charged with 2 mL of toluene, 161 mg (1.2 
mmol) of trimethoxyvinyl silane and 14 mg (0.04 mmol) of Erbium triisopropoxide.  The solution 
was stirred for 15 min and a solution of 61 mg (0.45 mmol) of benzaldehyde and 100 mg (0.4 
mmol) of silyl glyoxylate 1b in 2 mL of toluene was then added dropwise.  The solution was 
heated to 60 ˚C and stirred for 3 days.  After consumption of starting material was verified by 
TLC the reaction was concentrated in vacuo. The crude product was purified by flash 
chromatography with 10:1 hexanes/EtOAc to afford 40 mg (21%) of the product as a clear oil 
(1.25:1 diastereomer ratio). Analytical data for title compound:  1H NMR (400 MHz, CDCl3) δ 
H
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7.43 – 7.17 (m, 5H), 6.03 (t, J = 4.2 Hz, 1H), 5.92 – 5.88 (m, 1H), 5.79 – 5.73 (m, 1H), 4.99 (d, J 
= 7.1 Hz, 1H), 4.08 (d, J = 7.2 Hz, 1H), 3.37 (s, 3H), 1.44 (s, 9H), 0.72 (s, 9H), -0.14 (s, 3H), -
0.35 (s, 3H).; TLC (20:1 hexanes/EtOAc) Rf of mixture diastereomers  0.30. 
 
General procedure (H) for multicomponent Grignard initiated multicomponent coupling of 
silyl glyoxylate and electrophiles (Table 1-7). A dry round bottomed flask with a magnetic stir 
bar was purged with Ar and charged with silylglyoxylate (1.0 equiv, ca. 0.4 mmol) and the 
electrophile (1 equiv) in 2 mL of THF.  The solution was stirred and Grignard reagent (1.5 equiv) 
was then added via syringe under an argon atmosphere. The solution was stirred until 
consumption of all starting material by TLC.  The reaction was quenched with 3 mL of a 
saturated NH4Cl solution and 5 mL of Et2O were added. The organic layer was separated and the 
aqueous layer was extracted with two 5 mL portions of Et2O. The organic extracts were combined 
and dried (Na2SO4). Concentration of the organic phase by rotary evaporation afforded the crude 
product which was purified by flash chromatography using the specified solvent system. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-3-hydroxy-2-methyl-3-phenylbutanoate (28a).  The title 
compound was prepared according to General Procedure H using 100 mg (0.41 mmol) of silyl 
glyoxylate 1b and 49 mg (0.4 mmol) of acetophenone in THF (2 mL), and 20 µL (0.6 mmol) of 
MeMgBr (3 M in THF). The crude product was purified by flash chromatography with 20:1 
hexanes/EtOAc to afford 104 mg (67%) of the product as a clear oil (2.4:1 ratio of two 
diastereomers). Analytical data for title compound: 1H NMR (400 MHz, CDCl3) (major 
diastereomer) δ 4.14 (s, 1H), 2.77 (s, 1H) 1.60-1.9 (m, 6H), 1.48 (s, 9H), 1.17 (m, 2H), 0.93-0.87 
(m, 3H), 0.91 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H); 13C NMR (100 MHz, CDCl3) (both 
diastereomers) δ 174.13, 144.94, 127.57, 127.12, 127.06, 126.85, 126.79, 82.43, 77.84, 77.73, 
O
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27.94, 27.74, 26.16, 26.03, 24.87, 24.24, 22.48, 21.74, 18.57, 18.47, -2.57, -2.79, -2.96. TLC 
(20:1 hexanes/EtOAc) Rf (both diastereomers) 0.30. 
 
5-tert-butyl 1,1-dimethyl 5-(tert-butyldimethylsilyloxy)-2-phenylpent-4-ene-1,1,5-tricarboxylate 
(28b).  The title compound was prepared according to General Procedure H using 100 mg (0.41 
mmol) of silyl glyoxylate 1b and 90 mg (0.4 mmol) of dimethyl 2-benzylidenemalonate in THF (2 
mL), and 0.57 mL (0.6 mmol) of vinyl Grignard (1 M in THF). The crude product was purified 
by flash chromatography with 10:1 hexanes/EtOAc to afford 88 mg (45%) of the product as a 
clear oil (1 diastereomer). Analytical data for title compound: 1H NMR (400 MHz, CDCl3) (1 
diastereomer) δ 7.21 (ddd, J = 21.5, 16.0, 8.3 Hz, 5H), 5.59 (t, J = 7.0 Hz, 1H), 3.87 – 3.76 
(m, 1H), 3.71 (s, 3H), 3.54 – 3.44 (m, 1H), 3.40 (s, 3H), 2.67 – 2.57 (m, 1H), 2.50 – 2.38 
(m, 1H), 1.38 (s, 9H), 0.91 (s, 9H), 0.10 (s, 3H), 0.07 (s, 3H); TLC (20:1 hexanes/EtOAc) Rf 
0.13. 
 
tert-butyl 2-(tert-butyldimethylsilyloxy)-6-nitro-5-phenylhex-2-enoate (28c).  The title compound 
was prepared according to General Procedure H with the following differences: Reaction was run 
at a temperature of -78 ˚C for 4 h after addition of vinyl magnesium bromide before being 
allowed to warm to rt before quenching using 100 mg (0.41 mmol) of silyl glyoxylate 1b and 61 
mg (0.4 mmol) of (Z)-(2-nitrovinyl)benzene in THF (2 mL), and 0.57 mL (0.6 mmol) of vinyl 
magnesium bromide (1 M in THF). The crude product was purified by flash chromatography with 
10:1 hexanes/EtOAc to afford 85 mg (49%) of the product as a clear oil (1 diastereomer). 
Analytical data for title compound: 1H NMR (400 MHz, CDCl3) (1 diastereomer) δ 7.36 – 7.13 
(m, 5H), 5.75 (dd, J = 8.5, 6.4 Hz, 1H), 4.59 – 4.55 (m, 2H), 3.62 – 3.49 (m, 1H), 2.66 
O
TBStBuO2C
+
MgBr
THF
0!23 °C
Ph
CO2Me
CO2Me
1b 28b
tBuO2C
OTBS
Ph
CO2Me
CO2Me
O
TBStBuO2C
+
MgBr
NO2
Ph
tBuO2C
OTBS
Ph
NO2THF
-78 °C!23 °C
 46 
(dt, J = 14.9, 8.2 Hz, 1H), 2.46 (ddd, J = 14.8, 7.2, 6.5 Hz, 1H), 1.45 (s, 9H), 0.97 – 0.95 
(m, 9H), 0.17 (s, 3H), 0.14 (s, 3H); TLC (20:1 hexanes/EtOAc) Rf 0.19. 
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CHAPTER 2  
 
TOTAL SYNTHESIS OF ZARAGOZIC ACID C VIA CONTROLLED OLIGOMERIZATION 
 
 
 
2.1 Introduction 
 
The use of small repeating subunits in the construction of complex molecules is 
ubiquitous in Nature.  Many of the structures that make life possible on the molecular level 
adhere to this synthetic formula: proteins consist of amino acids; DNA and RNA are made up of 
nucleotides and nucleosides; and oligosaccharides contain saccharides.  This efficient synthetic 
strategy is the result of billions of years of evolution.  Many elegant solutions have developed to 
control construction of the large molecules through facilitated chemical linkage of the small 
subunits such as ribosomes in the manufacture proteins from the polymerization of amino acids. 
In the realm of materials chemistry this strategy is applied in the preparation of 
production-scale quantities of stereochemically defined polymers from selective repetitive 
incorporation of prochiral monomers.  While these processes are well suited to making high 
molecular weight molecules, application of this same strategy to the synthesis of small molecules 
is a relatively unexplored area.  Many chiral natural products such as polyketides, 
oligosaccharides, and peptides contain repeating subunits.  Conventional synthetic strategies to 
construct these types of molecules would involve stepwise convergent linear routes.  A more 
efficient approach would be a controlled oligomerization of the subunits for the concurrent 
creation of carbon skeletal frameworks and tetrahedral stereochemistry (Scheme 2-1).  
Development of this largely uncultivated tactic for total synthesis could have a drastic impact on 
the way synthetic chemists construct molecules.1   
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Scheme 2-1 Oligomerization Strategy 
 
 
2.2 Background 
 
Scheme 2-2 The Zaragozic Acids 
 
 
The zaragozic acids are picomolar inhibitors of squalene synthase, the enzyme catalyzing 
the first committed step in the production of cholesterol.2,3 The compounds have also been shown 
to potentiate radiochemotherapy in the destruction of acute myeloid leukemia (AML) cell lines.4  
First isolated from fungal metabolites in 1991 and 1992, the zaragozic acids derive their name 
from the origin of one of the fungi, ATCC20986, Zaragoza, Spain.  Each compound features the 
same core differing in the makeup of the side chains (Scheme 2-2). 
While the biological activity initially garnered interest for possible pharmaceutical 
application to lowering cholesterol, the densely functionalized structure of the core has attracted 
the attention of synthetic chemists.  The highly oxygenated 2,8-dioxabicyclo[3.2.1]octane-3,4,5-
tricarboxylic acid core of zaragozic acid C (1) features six contiguous asymmetric centers that 
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comprise the principal obstacle to synthesis.  The two fully substituted centers at C4 and C5 in the 
core have been particularly nettlesome in extant syntheses.5-25The synthetic challenges presented 
by zaragozic acid C have inspired the development of a number of innovative solutions.  
A strategy common to many syntheses involves formation of the core through acid 
catalyzed ketalization of a linear precursor.  Two examples of this strategy include a total 
synthesis completed by Evans and coworkers11 that was previously the shortest route to zaragozic 
acid C and a total synthesis completed by Carreira and Dubois9,10 that is relevant to our study. 
 
Scheme 2-3 Evans Zaragozic Acid C Total Synthesis 
 
 
The Evans group started from chiral di-tert-butyl-D-tartrate and built up the linear 
precursor to the core in a sequence converging with addition of the alkyl side chain as the 
organolithium species to lactone 2 (Scheme 2-3).  After 3 subsequent steps the bicyclic core was 
assembled by acid catalyzed ketalization of 3 to form 4.  The C6 and C7 hydroxyls of 4 are 
differentiated to allow for selective acylation of the C6 hydroxyl with the acyl side chain.  
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Differentiating the C6 and C7 hydroxyls is a difficulty commonly encountered in the syntheses of 
1 and this problem was solved early in this synthesis.  Following benzyl deprotection the acyl 
side chain was attached and the synthesis of zaragozic acid C was completed in 2 additional steps 
for a total length of 24.   
 
Scheme 2-4 Carreira Total Synthesis 
 
 
The synthesis completed by Carreira and Du Bois also used acid catalyzed ketalization to 
form the core of the molecule and served as a useful resource over the course of our study 
(Scheme 2-4).  Beginning with D-erythronic γ lactone 5, intermediate 6 was reached in 9 steps.  
Formation of the organolithium species from 6 and addition to aldehyde 7 followed by Dess-
Martin oxidation gave ynone 8.  Semi reduction with [Cr(OAc)2·H2O]2 in aqueous THF was 
followed by silyl ether deprotection and Sharpless dihydroxylation formed 9.  Exposure of 9 to 
acid resulted in formation of the desired bicylclic ketal 10.  In 16 additional steps tri-acetate 
intermediate 11 was reached with all core functionality present in the correct oxidation state.  At 
this stage in the synthesis the problem of C6 and C7 hydroxyl differentiation was addressed.  It 
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has been observed that the C6 hydroxyl group is more sterically accessible, a result of being 
oriented away from the core of the molecule, and that the C7 hydroxyl is more acidic due to the 
electron withdrawing effect of the two ketal oxygens.21 Upon hydrolysis of the C6 and C7 
hydroxyl groups Carierra was able to selectively Boc (tert-butoxy carbonyl) protect the C7 
hydroxyl using 4-pyrolidinopyridine as an acylation catalyst.  The acyl side chain was then 
attached followed by a global deprotection to complete the synthesis. 
 
Scheme 2-5 Hashimoto Zaragozic Acid C Synthesis 
 
 
As an alternative to using acid catalyzed ketalization to form the core a few other 
strategies have been developed.  A total synthesis by the Hashimoto group started from chiral di-
tert-butyl-D-tartrate building up to 13, a diazo precursor to bicyclic core formation in 17 steps 
(Scheme 2-5).14  The core was formed in a rhodium catalyzed 1,3 dipolar cycloaddition using an 
alkynyl ketone as the dipolarophile.  In 5 additional steps intermediate 15 was achieved with 
desired differentiation of the C6 and C7 hydroxyl groups.  From 15 it took 12 steps to reach 
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Scheme 2-6 Nagaoka Core Synthesis 
 
 
Nagaoka also completed a synthesis of the bicyclic core by means other than acid 
catalyzed ketalization (Scheme 2-6).26  While a total synthesis was not completed, a unique 
strategy for core formation was developed.  Benzyl protection of furan 16 followed by a Diels-
Alder reaction with dimethyl acetylenedicarboxylate (DMAD) and selective epoxidation gave 17.  
It was possible to differentiate the esters of 17 through an enzyme-catalyzed hydrolysis, which 
provides the potential for an asymmetric synthesis.  With the necessary carbon skeleton present in 
17 this synthesis was carried on racemically.  The next 16 steps installed the required oxygen 
functionality to form key intermediate 18.  The core was then formed in one pot through a Grob 
fragmentation27-reduction-iodoacetalisation process.  Deprotonation with potassium 
hexamethyldisilazide (KHMDS) in dioxane led to formation of intermediate 19, which was 
reduced with NaBH4 and exposed to iodine to give 20.  Introduction of the side chains and 
oxidation of the core would complete a racemic total synthesis of 1 from 20. 
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As seen in the representative examples of previous syntheses of zaragozic acid C, 
solutions to the challenges inherent in construction of this densely functionalized oxygenated core 
commonly involve multistep sequences of oxidation state, functional group, and/or protecting 
group adjustment.  Our goal was to develop a more efficient route based on the concept of a 
controlled oligomerization to assemble the core with adherence to a synthetic plan predicated on 
the minimization of oxidation state variance and protecting group manipulation. 
2.3 Results and Discussion 
 
2.3.1 Retrosynthesis and Oligomerization 
 
Scheme 2-7 Retrosynthesis 
 
What we found striking about zaragozic acid C was that the global complexity masks a 
rather elementary composition of simple building blocks.  A retrosynthetic analysis of zaragozic 
acid C through bond disconnection into its constituent synthons (Scheme 2-7, blue arrows) 
reveals a repeating series of glycolic acid fragments.   
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Scheme 2-8 Silyl Glyoxylate as a Glycolic Acid Synthon 
 
 
In contemplating efficient connections that would enable the rapid construction of 21 or 
its equivalent, we were compelled to consider a “self-consistent sequence,” one that concurrently 
merges carbon skeletal buildup with the introduction of stereochemistry, as a method that would 
be uniquely efficient.28-30  Thus, a self-consistent synthesis of the zaragozic acid core would be 
one with connection of the glycolic acid subunits in the correct relative configuration and 
oxidation state (red arrows).  The successful implementation of this strategy requires a synthetic 
equivalent to the unusual geminal dipolar glycolic acid synthon 22.  We developed the silyl 
glyoxylate 23 to function as a reagent for the geminal grafting of complementary nucleophilic and 
electrophilic reagents onto a protected glycolic acid.31-33  The reactivity pattern exhibited by 23 is 
summarized in Scheme 2-8.  Nucleophilic attack on the silyl glyoxylate facilitates C→O silicon 
migration (Brook rearrangement)34 to form a stabilized carbanion.  This nascent enolate reacts 
with an electrophile giving rise to a product wherein two new bonds have been formed at the 
same carbon atom. 
Given the retrosynthetic analysis presented in Scheme 2-5 and the surrogacy of 23 for 22, 
we tested the hypothesis that enchainment of >1 equivalent of 23 could be used to assemble the 
zaragozic acid backbone in one step (Scheme 2-9).  The addition of one equivalent of 
vinylmagnesium bromide to two equivalents of 23 at -78 °C initiates the oligomerization detailed 
in Scheme 2-9.  The initial adduct rearranges to provide a new carbon nucleophile that enchains a 
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second equivalent of 23.  A second Brook rearrangement delivers the second magnesium enolate 
of the cascade.  The oligomerization of further equivalents of 23 stops at this point, possibly due 
to steric constraints of the enolate intermediate, and the sequence is terminated via the 
introduction of tert-butyl glyoxylate (24).  The α-hydroxy ester 25 was obtained in 45-50% yield 
on a 15 g scale with a diastereoselection >10:1 (25:Σ others), the structure of which was 
determined from an X-ray diffraction study.35 The remainder of the mass balance was attributed 
to γ addition of the initially formed enolate to an additional equivalent of 23 with subsequent 
enchainment of a third equivalent of 23.  Careful control of the reaction conditions, specifically 
the regulation of temperature and slow addition of silyl glyoxylate 23 to a solution of vinyl 
Grignard, allowed us to favor formation of the desired product.   
 
Scheme 2-9 Oligomerization 
 
 
Three contiguous stereogenic centers of the carbon skeleton were assembled in the 
correct oxidation state.  The direct delivery of the needed functional array meant that no oxidation 
state adjustment was required in this domain for the remainder of the synthesis.  Beyond the 
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the synthesis (vide infra).  Moreover, the reaction achieved its secondary design purpose of 
providing an ideal protecting group scheme that masked every functional group except the 
secondary alcohol that would participate in the subsequent reaction. 
 
The product obtained possessed the correct relative stereochemistry for the challenging 
C4 and C5 tertiary alcohols, while the stereocenter that would eventually become C3 of the core 
required inversion.  Epimerization of 25 with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was 
possible at this stage (eq 1), but multiple downstream operations were unsuccessful with epi-25.  
For this reason, compound 25 bearing the incorrect C3 configuration was advanced with the 
expectation that it could be rectified later in the synthesis. 
 
2.3.2 Intramolecular Aldol Reaction 
 
The racemic α-hydroxy ester (±)-25 was subjected to a vanadium-catalyzed oxidative 
kinetic resolution using O2 as the stoichiometric oxidant (Scheme 2-10).36  The resolution yielded 
48% (of a maximum 50%) of (−)-25 with an enantiomer ratio (er) of 90:10.  In anticipation of a 
projected intramolecular aldol reaction to introduce the C6/C7 diol, the C3 hydroxyl group was 
converted to its derived ester 26 with α-benzyloxyacetyl chloride.  Neither the resolution nor the 
acylation was successful with epi-25.  The requisite C6 electrophile was then revealed through 
ozonolysis of the vinyl group to provide aldehyde 27.  
tBuO2C
tBuO2C OTBS
CO2
tBu
OH
TBSO
25
DBU, 
THF tBuO2C
tBuO2C OTBS
CO2
tBu
OH
TBSO
73%
epi-25
(1)
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Scheme 2-10 Intramolecular Aldol Reaction 
 
 
A completely diastereoselective intramolecular aldol reaction under carefully prescribed 
conditions fashioned the C6−C7 bond and led to ε-lactone 29.37  Aldolization to form ε-lactones 
is unusual38,39 and this case may be assisted by the high level of substitution in the connecting 
carbon atoms.40  The ring closure is proposed to proceed via the illustrated transition structure 
11‡ (based on the X-ray diffraction study of 29) and gives the correct stereochemistry at C7 but 
the incorrect configuration at C6.  Epimerization of 29 was possible to correct the C3 
stereochemistry at this stage, but once again the correct C3 epimer was found to be unsuitable in 
subsequent manipulations.  The C1 sidechain was appended by means of a nucleophilic addition 
of the organolithium 3041 to the ε-lactone 29 resulting in a mixture of lactol and ketol species.  
With 14 in hand we were ready to assemble the core of the molecule through an acid catalyzed 
ketalization. 
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2.3.3 Acid Catalyzed Ketalization 
 
Initially, the ketalization was attempted with conditions similar to those used in previous 
syntheses of zaragozic acid C involving TFA(trifluoroacetic acid) in CH2Cl2 but these conditions 
proved incompatible with the benzyl ether protecting scheme we were using for the alkyl side 
chain.  Therefore, alternative ketalization conditions were sought (Table 2-1).  The first 
conditions used to obtain the desired ketalization involved treatment of the ketol/lactol mixture 
with H2SO4  (0.1 M in MeOH) for 72 h and afforded three products:  a tricyclic ketal with the 
tertiary alcohol protected as the TBS ether 33 (13%), the same ketal lacking the silyl ether 32 
(50%) as the major product, and an unidentified isomeric ketal 34 (20%) (entry 1).  The undesired 
δ-lactone present in the tricyclic ketal products 32 and 33 was a consequence of the incorrect 
stereochemical configuration at C3 and C6.   
Subsequent findings would show that TBS-protected 33 was the desired product at this 
stage.  The two other products were easily converged to the desired tricyclic ketal 33.  
Resubmission of the isomeric ketal to the ketalization conditions, combination with the 
unprotected tricyclic lactone, and silylation of the C4 hydroxyl group provided an acceptable 
combined yield of 33. 
While ketalization with H2SO4 provided acceptable yields of the desired product 33 after 
convergence of products, we sought to optimize this reaction to improve two areas.  We desired 
to minimize efforts needed to channel the material to the desired product 33 and to avoid the 
transesterification of the tert-butyl esters to methyl esters (Table 2-1).  To ease analysis of 
products as well as limit the unnecessary use of the alkyl side chain a model system with an n-
butyl side chain 31b, synthesized from n-BuLi addition to 29, was employed.  Attempts to avoid 
transesterification by using tert-butyl alcohol as a solvent or using conditions to saponify the 
esters followed by re-esterification with isourea42 35 were unsuccessful (entries 4 and 5).  
Camphorsulfonic acid and p-toluenesulfonic acid (TsOH) both catalyzed ketalization in methanol 
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(entries 2 and 3) but TsOH gave the best results forming a mixture of only the desired 
unprotected lactone 32b (71%) and the isomeric ketal 34b.  While the TsOH conditions did not 
form the desired TBS protected lactone it was operationally convenient to isolate and protect 32 
rather then deal with a mixture of three products. 
 
Table 2-1 Ketalization Conditions 
 
entry R2 conditions 32 33 34 
1 θ 0.1 M H2SO4 in MeOH, reflux 72 h  50% 13% 20% 
2 nBu 0.1 M TsOH, MeOH, reflux 72 h 71% 0% 26% 
3 nBu 0.1 M CSA, dry MeOH, reflux 72 h 52% 0% 26% 
4 nBu 0.1 M H2SO4, tBuOH, reflux 72 h 0% 0% 0% 
5 nBu 
1) 0.1M TsOH, THF:H2O 20:1,reflux 
72 h 
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 Exposure of 31, with the correct alkyl side chain, to the optimized conditions in a scaled 
up reaction resulted in a mixture of the three products as seen in the H2SO4 ketalization but with 
better yields: 32, 57%; 33, 6%; and 34, 11% (eq 2). 
 
2.3.4 Lactone Opening and Correction of C6 and C3 Stereocenters 
 
 
The presence of the δ-lactone in 33 highlights the remaining stereochemical problem: the 
incorrect configurations at C6 and C3.  While this lactone was a consequence of the incorrect 
stereochemistry it also provided a means for resolution of the problem.  In initial attempts to open 
the lactone, by exposure to KOtBu in tBuOH followed by re-esterification of the partially 
saponified esters with 35, the lactone opened with surprising concomitant inversion of the C6 
stereocenter (eq 3).  A retro-aldol/aldol sequence is the probable mechanism accounting for this 
fortuitous stereochemical correction (Scheme 2-11).43 Attack of the alkoxide opens the lactone 
and initiates a retro-aldol reaction.  Rotation about the C6/C7 C-C bond reorients the intermediate 
aldehyde.  An intramolecular aldol reaction between the reoriented aldehyde and the methyl ester 
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enolate terminates the cascade reforming the C5/C6 bond with C6 in the desired configuration.  
This unanticipated process would have been impossible in the absence of functional groups in the 
correct oxidation state.  Epimerization of the inconsequential mixture of esters (36) with NaOMe 
in MeOH achieved the desired configuration of the C3 stereocenter.  All of the ester groups were 
unexpectedly cleaved in this reaction; re-esterification of the resulting triacid using 35 gave the 
zaragozic acid core 37 with the required stereochemistry and in the correct oxidation state.  While 
this process led to formation of the desired core and corrected the stereochemical configurations 
at C3 and C6 the yield was 11% over the four steps.   
Scheme 2-11 Retro-aldol/Aldol Cascade 
 
As a consequence of the low yield, a large number of conditions were evaluated to find 
the optimal way to accomplish this reaction (Table 2-2).  Ideally, lactone opening, the retro-
aldol/aldol sequence and epimerization of C3 would all occur in one process with 
transesterification of the Me esters to desired tBu esters.  Attempts to open the lactone without 
protection of the tertiary alcohol as the silyl ether were unsuccessful (entries 1 and 5).  An attempt 
to open the lactone and conduct the epimerization with NaOMe in MeOH resulted in only ester 
saponification (entry 4).  The use of molecular sieves led to lactone opening and C6 inversion but 
in a lower yield and with saponification (entry 8).  Using KOtBu in different alcoholic as well as 
ethereal solvents and in the presence of 18-crown-6 (with the aim of increasing alkoxide 
nucleophilicity), resulted in only saponification or decomposition (entries 3, 6, 7 and 9).  Various 
transesterification protocols including; a KOtBu complex in tBuOAc44, Mg(OMe)2 in MeOH, and 
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a La(OTf)3 derived catalyst45,46 had no effect or led to saponification of the esters(entries 5,6 and 
12-14).  Since saponification seemed inevitable and tBu esters were necessary a number of 
saponification conditions geared toward lactone opening were also evaluated to no avail.  We also 
thought that the strained ring system might be susceptible to photochemical cleavage but upon 
photoirradiation no reaction was seen (entry 21). 
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Table 2-2 Lactone Opening 
 
entry R1= R2= conditions result 
1 H θ 5 equiv. KOtBu, tBuOAc Ester saponification 
2 TBS θ 5 equiv. KOtBu, tBuOAc Ester saponification 
3 TBS θ 5 equiv. KOtBu, tBuOH, 18-c-6; 35 Ester saponification 
4 TBS θ NaOMe. MeOH; 35 Ester saponification 
5 H nBu 5 equiv. KOtBu, tBuOH No desired products 
6 TBS nBu 5 equiv. KOtBu, tamyl alcohol; 35 Ester saponification 
7 TBS nBu 5 equiv. KOtBu, EtOH; 35 Ester saponification 
8 TBS nBu 4 Å Mol. Sieves, 5 equiv. KO
tBu,     
      tBuOH; 35 16%  yield 36 
9 TBS nBu 5 equiv. KOtBu, THF No desired products 
10 TBS nBu 10 equiv. KO
tBu, 4 equiv. H2O, 
Et2O No desired products 
11 TBS nBu Cs2CO3, dry MeOH; 35 No desired products 
12 TBS nBu Mg(OMe)2, tBuOH 
Recovered starting 
material 
13 TBS nBu Mg(OMe)2, MeOH, reflux 24 h 
Recovered starting 
material 
14 TBS nBu La(OTf)2, NaOMe, MeOH, reflux 24 h 
Recovered starting 
material 
15 TBS nBu LiOOH, THF:H2O; 35 
Recovered starting 
material 
16 TBS nBu LiSEt No desired prodcuts 
17 TBS nBu KOTMS, dry THF, rt; 35 Ester saponification 
18 TBS nBu 4.5 equiv. TMSI, DCM Debenzylation 
19 TBS nBu NaI, TMSCl, CH3CN, reflux 
Debenzylation, 
saponification, TBS 
deprotection 
20 TBS nBu BI3, Diethylaniline, Benzene; H2O No desired products 
21 TBS nBu hv, solvent Recovered starting material 
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 One interesting result from the screen occurred with the use of trimethylsilyl iodide 
(TMSI) (entry 18).47  The proposed mechanism for lactone opening involved silyl Lewis acid 
coordination of the lactone with nucleophilic attack at C6 by I- (eq 4).  This would have led to 
formation of iodide 38.  In addition to ester cleavage, TMSI is also known to readily cleave 
benzyl ethers, which was the result obtained upon exposure of the lactone to TMSI (eq 5).  We 
investigated other conditions, including BI3 and methods of in situ TMSI formation, to effect this 
kind of lactone opening but all efforts resulted in decomposition of starting materials or ether and 
methyl ester cleavage (entries 19 and 20). 
 
 The difficulty in achieving the desired lactone opening and subsequent transformations in 
synthetically useful yields led us to investigate alternatives.  By reducing the lactone to the lactol 
we thought that it may be possible to induce base promoted lactone opening.  When lactone 33 
was subjected to DIBAL-H it appeared that TBS ether deprotection and ester reduction occurred 
prior to reduction of the lactone (eq 6).  We also thought that conversion of the lactone to the 
vinyl ether may facilitate ring opening but dimethyl titanocene and the Tebbe reagent were 
unreactive with 33 (eq 7). 
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 At this point with little success taking other directions we assessed what could be done to 
best optimize the current lactone opening protocol.  Much of the recovered starting material from 
the evaluation of lactone opening conditions contained a mixture of tBu and Me esters following 
exposure to 35.  During the ongoing search for a better lactone opening protocol, the recovered 
starting material was being brought through the KOtBu/tBuOH protocol to work on post lactone 
opening aspects of the synthesis.  A careful examination of the results of these reactions led to the 
conclusion that when bulkier tBu esters were present on the tricyclic lactone the yields for the 
lactone opening were greater.  To test the hypothesis that bulkier esters may improve the yield, 
tamyl isourea 40 was synthesized to install tamyl esters on the saponified δ-lactone. 
The best yield of recovered starting material with the most conversion of Me esters to tBu 
esters had been observed with 5 equiv of KOtBu in tamyl alcohol followed by exposure of the 
crude mixture to isourea 35.  To ensure maximum saponification 10 equiv of KOtBu were used 
and the reaction was heated gently (eq 10).  Normally, the lactone opening was a slow process 
taking 12-16 h to complete.  In this case, the reaction showed saponification of the starting 
material in 45 min.  Exposure of the crude mixture to 40 and purification revealed an unexpected 
mixture of products.  Desired δ-lactone 41 with tamyl esters was isolated in a 25% yield but the 
major product turned out to be the desired opened lactone 36 as a mixture of esters in a 32% 
yield, a yield higher than previously achieved by any other means.  Optimization of the reaction 
conditions and application to δ-lactone 33 with the correct alkyl side chain resulted in a 63% 
yield of the desired product 36 as an inconsequential mixture of esters over 2 steps (eq 11).  
Epimerization of C3 with NaOMe in MeOH led to complete saponification and formation of 37 
iPrHN
Otamyl
NiPr
iPrN C NiPr + HO
CuCl
1) KOtBu
tBuOH
rt
iPrHN
OtBu
NiPr
2)
R1 = TBS
R3= tamyl
O
O
H
H O
OOBn
OR1
CO2R
3
H
R3O2C
R2
3
6
7
O
OR
2
H
HO H CO2R
OBn
OH
CO2R
H
RO2C
increased yield?
3
6
7
(8)
(9)
40
   70 
in 60% yield over 2 steps.  While the yield was only 38% over 4 steps this was almost a 4 fold 
improvement over previous results of 11% and the taking into account recovered starting material 
in formation of 36 the yield was even greater. 
 
2.3.5 Benzyl Ether Deprotection 
 
  At this stage in the synthesis the C6 and C7 alcohols were favorably differentiated with 
the C7 hydroxyl group protected as a benzyl ether allowing for selective installation of the acyl 
side chain on the C6 hydroxyl.  Compound 37b, with nBu in place of the alkyl side chain, served 
as a model system for side chain addition.  Coupling of the acyl side chain under standard 
conditions with the coupling agent dicyclohexylcarbodiimide (DCC) was achieved in 56% yield 
(eq 12).  Compound 43 formed by acylation of the C7 hydroxyl with propionic anhydride was 
used to screen debenzylation conditions (eq 13).   
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 The presence of alkene functionality on the acyl side chain prevented simply using Pd 
catalyzed hydrogenation to remove the benzyl ethers forcing us to consider alternative 
deprotection protocols compatible with the presence of olefins.  The array of dense functionality 
on the core of the molecule made this a particularly challenging problem.  Single electron 
reductants lithium napthenalide and lithium 4,4’-di-tert-butylbiphenylide (LDBB) were evaluated 
first and under a variety of conditions led only to decomposition (entries 1 and 2).48  Lewis acid 
deprotection was also unsuccessful leading to decomposition (entries 3 and 4).  This was not 
surprising considering the number of Lewis basic sites present in this molecule.  TMSI, which 
selectively cleaved the benzyl ether on the δ-lactone, stripped the molecule of functionality 
cleaving the benzyl ether, all the esters and removing the acyl side chain (entry 5).  Unfortunately 
TMSI cleavage of the tBu esters was more facile than Me esters that existed on the δ-lactone.  
Based on these results it appears tBu ester cleavage occurs at a similar rate to that of benzyl 
ethers.  An attempt to oxidatively cleave the benzyl ether using 2,3 dichloro-5,6-
dicyanobenzoquinone (DDQ) was unsuccessful but also was mild enough to allow recovered 
starting material (entry 6). 
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Table 2-3 Debenzylation Conditions 
 
entry conditions result 
1 lithium napthanelide, THF Decomposition 
2 LDBB, THF Decomposition 
3 FeCl3, CH2Cl2, 0 ºC Decomposition 
4 Ph3C+ BF4-, CH2Cl2 Decomposition 
5 TMSI, CH2Cl2 Saponification, removal of side chain 
6 DDQ 1.5 equiv., CH3CN Recovered starting material 
 
 The use of DDQ in the presence of photoirradiation leads to increased rates of benzyl 
ether deprotection.49 When this protocol was applied using compound 43, deprotection proceeded 
cleanly giving the product 44 in 86% yield (eq 14).  This protocol is less effective in the presence 
of alkene functionality and this was apparent when it was applied to compound 42 containing the 
real acyl side chain as only decomposition resulted. 
 
 Despite the desirable differentiation of hydroxyl groups present in 37, installation of the 
acyl side chain rendered subsequent debenzylation impractical in our hands.  Therefore, we 
investigated removal of the benzyl groups earlier in the synthesis.  In the absence of the acyl side 
chain Pd catalyzed hydrogenation readily cleaved the benzyl ether from the core.  Removal of the 
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benzyl ether from compound 31b occurred quantitatively but resulted in unsuccessful subsequent 
ketalization (eq 16).  Removal of the benzyl group and protection of the free alcohols as silyl 
ethers immediately following ketalization resulted in isolation of only 25% of the desired 
bis(silylated) product 46 (eq 17).  Attempted lactone opening of 46 was then unsuccessful.   
 
 
2.3.6 Total Synthesis of Zaragozic Acid C 
 
Given the observed changes in reactivity in the absence of the benzyl ether, it was 
thought that the use of an alternative protecting group earlier in the synthesis, such as 
paramethoxybenzyl (PMB) ether, could have a deleterious effect on the subsequent reactions. 
This led to the final solution for debenzylation of compound 37.  Pd catalyzed hydrogenative 
debenzylation gave triol 47 in quantitative yield.  Acetylation of 47 under standard conditions 
using DMAP and acetic anhydride formed the triacetate 11, a compound utilized by Carreira in 
the total synthesis of zaragozic acid C in 90% yield.9,10  The analytical data were in full accord 
with those reported (1H NMR in CDCl3 and 13C NMR in both CD3OD10 and CDCl3,7 IR, TLC, 
sign of rotation).  The preparation of 11 thus constituted a formal synthesis of zaragozic acid C.  
As illustrated in Scheme 2-10, we applied the Carreira protocol to complete the synthesis of 
zaragozic acid C (1) in four steps from triacetate 11.  Unreacted starting material was recovered 
in both the BOC protection and the DCC coupling of the acyl side chain and this is not reflected 
in the yields seen in Scheme 2-12.  The synthetic material was identical to a sample of natural 
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material.  The total synthesis was accomplished in 18 total steps making it the shortest synthesis 
of zaragozic acid C to date. 
 
Scheme 2-12 Final Endgame 
 
 
2.4 Conclusions 
 
The total synthesis of zaragozic acid C was achieved along with the goal of concurrent 
creation of the carbon skeleton and tetrahedral stereochemistry (Scheme 2-13).  This efficient 
sequence contained only one oxidation state change (alkene ozonolysis) and no functional group 
repair in the core synthesis.  Adhering to these ideals made this an efficient “self-consistent” 
synthesis and made possible key reactions such as the retro-aldol/aldol sequence which would not 
have occurred without the presence of the core functionality in the correct oxidation state.  This 
study highlights the utility of silyl glyoxylates as glycolic acid synthons and demonstrates 
application of controlled oligomerization to small molecule synthesis.  The brevity of this 
sequence is a testament to the efficiency possible when employing the tactic of controlled 
oligmerization. 
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Scheme 2-13 Total Synthesis of Zaragozic Acid C 
 
 
2.5 Experimental 
 
Materials and Methods: General.  Infrared (IR) spectra were obtained using a Nicolet 560-
E.S.P. infrared spectrometer.  Proton and carbon nuclear magnetic resonance spectra (1H and 13C 
NMR) were recorded on either a Bruker model Avance 500 (1H at 500 MHz and 13C NMR at 125 
MHz), Bruker model Avance 400 (1H NMR at 400 MHz and 13C NMR at 100 MHz), or a Varian 
Gemini 300 (1H NMR at 300 MHz and 13C at 75 MHz) spectrometer with solvent resonance as 
the internal standard (1H NMR: CDCl3 at 7.23 ppm; C6D6 at 7.15 ppm and 13C NMR: CDCl3 at 
77.0 ppm and C6D6 at 128.62 ppm).  1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, q = quartet, sept = septet, m 
= multiplet), coupling constants (Hz), and integration.  Enantiomeric excesses were obtained 
using a Berger Supercritical Fluid Chromatograph model FCM 1100/1200 equipped with an 
Agilent 1100 series UV-Vis detector using a Chiralcel Chiralpak AS HPLC column. Samples 
were eluted with SFC grade CO2 at the indicated percentage of MeOH.  Combustion analyses 
diastereoselection 
>20:1
b,ctBuO2C
tBuO2C OTBS
CO2
tBu
OH
TBSO
tBuO2C
tBuO2C OTBS
CO2
tBu
O
TBSO
X
O
OBn
X = CH2
e
7
6
73%
3
(±)-25 26
27
a -78 ! "45 ! -78 °C; tBuO2CCHO; H2O 
 b V(O)(OiPr)3 (5 mol %), A (5.5 mol %), O2 (1 atm), toluene, 23 °C. 
c EtMgBr, Et2O; BnOCH2C(O)Cl.
d O3, CH2Cl2/MeOH/pyridine; then Me2S.
e LDA, LiBr, 2-MeTHF, -78 ! -55
°C; TMSCl. f 30, Et2O, -78 °C.
g TsOH, MeOH, reflux, 72 h (+ 1 recycle). h TBSOTf, Et3N, CH2Cl2.
i KOtBu,
tamylOH. j 35, toluene. k NaOMe, MeOH. l Pd/C, H2.
m Ac2O, DMAP.
n K2CO3, MeOH.
o (tBuO2C)2O, 4-
pyrrolidinopyridine. p cHexN=C=NcHex, 12, CH2Cl2. 
q TFA.
Key:
d
58% from (")-25
X = O
O
O
OBn
TMSO
TBSO
TBSO
tBuO2C
tBuO2C
CO2
tBu
3
7
6
f
29
O
OR
1
H
HO H CO2R
OBn
OH
CO2R
H
RO2C
36 (mix of esters)
60%
i,j
O
OR
1
HO H
OBn
OH
CO2
tBu
CO2
tBu
tBuO2C
O
O
AcO H
OAc
OH
CO2
tBu
CO2
tBu
tBuO2C
OAc
Me
Bn
O
O
O H
OH
OH
CO2H
CO2H
HO2C
O
AcO
Me
Me
Bn
Bn zaragozic 
acid C
3711 (Carreira triacetate)
65%
k,j
30%n,o,p,q
6
7
diastereoselection 8:1
90%
l,m
OBn
Me
Bn
iPrN NHiPr
OtBu
Me
Bn
35R1
tBu
tBu
OH
N
OH
OBn
Me
Bn Li
HtBu
CO2H
30
31
O
OBnO
TBSO
MeO2C
3
7
6MeO2C
O
H
O
O
H
H O
OOBn
OTBS
CO2Me
H
MeO2C
R1
3
6
33
BnO Bn
Me
g,h 62% from 12
7
O
OBn
TMSO
TBSO
TBSO
tBuO2C
tBuO2C
CO2
tBu
BnO Bn
Me
OH
H
O
33
3
6
tBuO2C
O
TBS
2 equiv.
MgBr
+
a
50%
   76 
were performed by Atlantic Microlab Inc., Norcross, GA.  Analytical thin layer chromatography 
(TLC) was performed on Whatman 0.25 mm silica gel 60 plates.  Visualization was accomplished 
with UV light and aqueous ceric ammonium molybdate solution followed by heating.  
Purification of the reaction products was carried out by flash chromatography using Sorbent 
Technologies silica gel 60 (32-63 µm).  All reactions were carried out under an atmosphere of 
nitrogen in oven-dried glassware with magnetic stirring.  Yield refers to isolated yield of 
analytically pure material.  Yields are reported for a specific experiment and as a result may differ 
slightly from those found in the figures, which are averages of at least two experiments.  Diethyl 
ether, tetrahydrofuran, and toluene were dried by passage through a column of neutral alumina 
under nitrogen prior to use. Unless otherwise noted, reagents were obtained from commercial 
sources and used without further purification.  Triethylamine was freshly distilled from CaH2 
under Ar prior to use.  Side chains 53 and 30 were prepared according to the literature 
procedure.41 
 
3-tert-Butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-hydroxy-2-vinyl-
pentanedioic acid di-tert-butyl ester (25).  A solution of 31.7 mL (31.7 mmol, 1.1 equiv) of 
vinylmagnesium bromide in THF (150 mL) was cooled to -78 °C and a solution of 15 mL (57.7 
mmol, 1.1 equiv) of tert-butyl tert-butyldimethylsilyl glyoxylate (23) in THF (50 mL) was added 
via cannula down the wall of the flask over 15 min.  Once addition of the silyl glyoxylate was 
complete, the reaction was slowly warmed to -45 °C over 15 min.  Once the cooling bath had 
reached -45 °C, the reaction was again cooled to -78 °C and 4.9 mL (43.3 mmol, 1.5 equiv) of 
tert-butyl glyoxylate was added via syringe.  After stirring for 1 h at -78 °C, the reaction was 
quenched with 30 mL of saturated aqueous ammonium chloride solution.  The two layers were 
separated and the aqueous layer was extracted with Et2O (3 x 40 mL).  The combined organic 
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layers were dried (MgSO4) and concentrated in vacuo to furnish the crude product which was 
purified by flash chromatography (1:2 CH2Cl2: petroleum ether linear gradient to 4:1 
CH2Cl2:petroleum ether) to furnish 8.3 g (44%) of the pure product (25).  The product crystallized 
slowly (ca. 24 h) from a small amount (ca. 15 mL) of petroleum ether and yielded crystals 
suitable for X-ray analysis.  Analytical data for 7: IR (thin film, cm-1) 3534, 2931, 2856, 1734, 
1645, 1472, 1393, 1368, 1248, 1147, 1001; 1H NMR (400 MHz, CDCl3) δ 6.30 (dd, 18.0, 10.8 
Hz, 1H), 5.17 (d, J = 11.6 Hz, 1H), 5.17 (d, J = 16.8, 1H), 4.56 (d, J = 10.4, 1H), 3.64 (d, J = 10.8 
Hz, 1H), 1.52 (s, 9H), 1.50 (s, 9H), 1.44 (s, 9H), 0.92 (s, 9H), 0.81 (s, 9H), 0.22 (s, 3H), 0.12 (s, 
3H), 0.11 (s, 3H), 0.09 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.6, 169.2, 169.1, 138.0, 117.2, 
83.8, 83.0, 82.1, 77.4, 75.8, 74.7, 28.7, 28.6, 28.4, 26.9, 26.7, 19.7, 19.2, -1.0, -1.1, -1.5, -1.6; 
TLC (5:95 EtOAc: petroleum ether) Rf 0.33. Anal. Calcd for C32H62O9Si2: C, 59.40; H, 9.66. 
Found: C, 59.47; H, 9.74. 
 
3-tert-Butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-hydroxy-2-vinyl-
pentanedioic acid di-tert-butyl ester (25).  A 50 mL round bottomed flask equipped with a 
stirbar was purged with O2 and charged with 82.2 mg (0.246 mmol, 0.055 equiv) of the salen 
ligand in dry toluene (11.3 mL) and treated with 53 µL (0.224 mmol, 0.05 equiv) of VO(OiPr)3 
under a dry O2 atmosphere.  The resultant dark brown solution was stirred for 30 min.  A solution 
of 2.9 g (4.48 mmol, 1.0 equiv) of racemic alcohol 7 in toluene (11.3 mL) was added via cannula 
to the catalyst solution.  After 48 h, the reaction was passed through a plug of silica gel eluted 
with 1:9 Et2O:petroleum ether.  After concentration of collected fractions in vacuo, 1H NMR 
analysis revealed 50% conversion to α-keto ester 50.  The alcohol was purified by flash 
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chromatography (5:95 Et2O:petroleum ether) to furnish 1.5 g (51%) of alcohol 7 (e.r. 90:10).  The 
enantiomer ratio was determined by CSP-SFC analysis of lactone 51. 
 
 
3,4-Dihydroxy-5-oxo-2-vinyl-tetrahydrofuran-2,3-dicarboxylic acid di-tert-butyl ester (51).  
A solution of 150 mg (0.23 mmol, 1.0 equiv) of bis-TBS ether 7 in THF (3.0 mL) at -45 °C was 
treated with 0.51 mL (0.51 mmol, 2.2 equiv) of a 1.0 M solution of tetrabutylammonium fluoride 
in THF.  The solution was warmed to -20 °C and maintained at that temperature.  After 1 h, 1.0 
mL of H2O was added and the reaction was extracted with CH2Cl2 (3 x 5 mL).  The combined 
extracts were dried (Na2SO4) and concentrated in vacuo to furnish the crude diol which was 
purified by flash chromatography (2:3 EtOAc: petroleum ether), to furnish 63 mg (80%) of the 
pure diol (22) as a white foam.  Analytical data for 51: IR (Nujol mull, cm-1) 3525, 3439, 2912, 
2858, 1801, 1760, 1729, 1458, 1377, 1304, 1258, 1146, 1124; [α]Na -18.8 (c = 1.09, CH2Cl2); 1H 
NMR (500 MHz, CDCl3) δ 6.01 (dd, J = 17.0, 10.5 Hz, 1H), 5.49 (d, J = 17.0 Hz, 1H), 5.31 (d, J 
= 11.0 Hz, 1H), 4.65 (d, J = 10.5 Hz, 1H), 4.28 (s, 1H), 3.01 (d, J = 11.0 Hz, 1H), 1.52 (s, 9H), 
1.47 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 171.5, 167.7, 164.2, 131.4, 117.5, 88.1, 86.3, 84.8, 
80.5, 72.0, 28.1, 28.0; CSP-SFC analysis (Chiralpak AS column, 5% MeOH, 1.5 mL/min, 150 
psi, 40 °C, 240 nm, tr-minor 6.3 min, tr-major 18.6 min; TLC (30:70 EtOAc: petroleum ether) Rf 
0.17. Anal. Calcd for C16H24O8: C, 55.81; H, 7.02. Found: C, 55.79; H, 7.16. 
 
3-tert-Butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-hydroxy-2-vinyl-
pentanedioic acid di-tert-butyl ester (epi-25).  To a solution of 750 mg (1.15 mmol, 1.0 equiv) 
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of the alcohol (7) in THF (10 mL) was added 86 µL (0.57 mmol, 0.5 equiv) of 1,8-
diazabicyclo[5.4.0]undec-7-ene.  After 5 h, 1 mL of saturated aqueous ammonium chloride was 
added and the layers were separated.  The aqueous layer was extracted with Et2O (3 x 8 mL) and 
the combined organic layers were dried (MgSO4) and concentrated in vacuo.  Purification of the 
crude material (5:95 Et2O: petroleum ether) furnished 551 mg (73%) of the alcohol epi-7 as an 
oil.  Analytical data for epi-25: IR (thin film, cm-1) 3428, 2930, 2857, 1746, 1729, 1713, 1473, 
1393, 1369, 1255, 1155; 1H NMR (300 MHz, CDCl3) δ 6.49 (dd, J = 17.1, 10.8 Hz, 1H), 5.45 
(dd, J = 17.1, 1.2 Hz, 1H), 5.10 (dd, J = 10.5, 1.5 Hz, 1H), 4.63 (s, 1H), 4.03 (s, 1H), 1.52 (s, 9H), 
1.42 (s, 18H), 0.93 (s, 9H), 0.87 (s, 9H), 0.20 (s, 3H), 0.11 s, 3H), -0.01 (s, 3H), -0.02 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.7, 170.1, 170.0, 137.6, 123.5, 85.5, 83.6, 82.8, 81.4, 74.6, 28.5, 
28.2, 26.8, 26.1, 25.8, 19.7, 18.3, -1.8, -2.5, -4.3, -4.5 (two overlapping resonances); TLC (5:95 
Et2O: petroleum ether) Rf 0.29. Anal. Calcd for C32H62O9Si2: C, 59.40; H, 9.66. Found: C, 59.57; 
H, 9.78. 
 
4-(2-Benzyloxy-acetoxy)-3-tert-butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-2-
vinyl-pentanedioic acid di-tert-butyl ester (26).  To a solution of 680 mg (1.1 mmol, 1.0 equiv) 
of the alcohol (25) in Et2O (14 mL) at 0 °C was added 1.3 mL of a 1.0 M EtMgBr solution in 
THF (1.26 mmol, 1.2 equiv).  This solution was warmed to 23 °C and resulted in a thick slurry.  
Following stirring for 1 h, a solution of 0.32 mL (2.1 mmol, 2.0 equiv) of the acid chloride in 
Et2O (4 mL) was added via cannula (1 mL rinse).  The reaction was stirred at 23 °C for 18 h, then 
quenched by the addition of 6 mL of saturated aqueous ammonium chloride solution.  After the 
layers were separated, the aqueous layer was extracted with additional Et2O (3 X 10 mL).  The 
combined organic layers were dried (MgSO4) and concentrated in vacuo.  1H NMR analysis of 
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the crude reaction revealed 74% conversion of the starting material.  Purification of the crude 
reaction by flash chromatography (5:95 EtOAc: petroleum ether) yielded 540 mg (65%, 88% 
based on recovered starting material) of the acylated alcohol (26).  Analytical data for 26: IR 
(thin film, cm-1) 2930, 2855, 1757, 1744, 1725, 1594, 1369, 1250, 1152; [α]Hg -3.8 (c = 2.15, 
CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.34-7.22 (m, 5H), 6.39 (dd, J = 18.0, 11.2 Hz, 1H), 6.17 
(s, 1H), 5.26 (d, J = 10.8 Hz, 1H), 5.23 (d, J = 18.0 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.53 (d, J 
= 11.6, 1H), 4.06 (s, 2H), 1.56 (s, 9H), 1.39 (s, 9H), 1.37 (s, 9H), 0.89 (s, 9H), 0.85 (s, 9H), 0.30 
(s, 3H), 0.14 (s, 3H), 0.11 (s, 3H), 0.09 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 169.3, 168.9, 
167.9, 164.7, 137.2, 136.8, 128.7, 128.3, 128.2, 118.4, 87.0, 85.7, 83.9, 83.2, 83.0, 75.7, 73.5, 
67.1, 28.7, 28.6, 28.5, 27.5, 26.9, 20.1, 19.4, -0.5, -0.7, -1.4, -1.7; TLC (5:95 EtOAc: petroleum 
ether) Rf 0.23. Anal. Calcd for C41H70O11Si2 C, 61.93; H, 8.87. Found: C, 62.73; H, 9.01. 
 
4-(2-Benzyloxy-acetoxy)-3-tert-butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-2-
formyl-pentane dioic acid di-tert-butyl ester (27).  A solution of 646 mg (0.81 mmol, 1.0 
equiv) of alkene 26 in 8.9 mL of CH2Cl2/MeOH/pyridine (10:1:1) was cooled to -78 °C.  O3 was 
bubbled slowly through the solution at -78 °C and the reaction was monitored by TLC.  After 1 h 
(reaction complete by TLC), the reaction was purged with Ar for 15 min.  Dimethylsulfide (300 
µL, 4.1 mmol, 5.0 equiv) was then added via syringe and the reaction was warmed to ambient 
temperature and stirred for 2 h.  Concentration of the crude reaction in vacuo followed by flash 
chromatography (5:95 EtOAc: petroleum ether) afforded 550 mg (85%) of the pure aldehyde (27) 
as a white foam.  Analytical data for 27: IR (thin film, cm-1) 2977, 2929, 2859, 1758, 1745, 
1728, 1473, 1394, 1368, 1253, 1152, 1129; [α]D -6.7 (c = 0.73, CH2Cl2); 1H NMR (400 MHz, 
CDCl3) δ 9.86 (s, 1H), 7.34-7.23 (m, 5H), 6.32 (s, 1H), 4.65 (d, J = 11.6 Hz, 1H), 4.57 (d, J = 
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12.0 Hz, 1H); 4.07 (d, J = 16.8 Hz, 1H), 4.02 (d, J = 16.8 Hz, 1H), 1.51 (s, 9H), 1.37 (s, 18H), 
0.90 (s, 9H), 0.81 (s, 9H), 0.29 (s, 3H), 0.11 (s, 3H), 0.067 (s, 3H), 0.034 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 193.4, 169.0, 166.8, 166.4, 165.2, 137.1, 128.7, 128.3, 128.2, 87.1, 86.2, 84.4, 
84.0, 83.9, 74.9, 73.5, 67.1, 28.4, 28.3, 27.0, 26.7, -1.2, -1.4, -1.9, -2.7 (two overlapping 
resonances); TLC (1:9 EtOAc: petroleum ether) Rf 0.39. Anal. Calcd for C40H68O12Si2: C, 60.27; 
H, 8.60. Found: C, 60.45; H, 8.65. 
 
6-Benzyloxy-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-7-oxo-5-hydroxy-oxepane-2,3,4-
tricarboxylic acid tri-tert-butyl ester (52).  To a solution of 41 µL of diisopropylamine (0.29 
mmol, 2.2 equiv) in 2-methyltetrahydrofuran (0.8 mL) at 0 °C under an Ar atmosphere was added 
180 µL of a 1.5 M n-butyllithium solution in hexane (0.50 mmol, 2.0 equiv).  The LDA solution 
was stirred for 15 min at 0 °C, then added via cannula to a solution of 105 mg (0.13 mmol, 1.0 
equiv) of aldehyde 27 and 46 mg (0.53 mmol, 4.0 equiv) of LiBr in 2-methyltetrahydrofuran (1.0 
mL) at -78 °C.  Once addition was complete (0.4 mL wash), the yellow solution was warmed 
slowly (ca. 15 min) to -50 °C.  After 1 h, the reaction was quenched at -50 °C by the addition of 
1.5 mL of a saturated aqueous ammonium chloride solution.  The reaction was extracted with 
Et2O (3 x 5mL) and the combined extracts were dried (MgSO4) and concentrated in vacuo.  The 
crude material was purified by flash chromatography (5:95 EtOAc: petroleum ether), to afford 80 
mg (76%) of the pure aldol (52) as white solid.  Analytical data for 52: IR (thin film, cm-1) 3943, 
2930, 2858, 1766, 1706, 1471, 1371, 1255, 1138, 1004; 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J 
= 6.8 Hz, 2H), 7.32-7.22 (m, 3H), 5.39 (d, J = 11.6 Hz, 1H), 5.28 (s, 1H), 4.89 (d, J = 10.8 Hz, 
1H), 4.67 (d, J = 1.6 Hz, 1H), 4.42 (d, J = 11.2 Hz, 1H), 4.34 (dd, J = 12.0, 2.0 Hz, 1H), 1.59 (s, 
9H), 1.51 (s, 9H), 1.47 (s, 9H), 0.87 (s, 9H), 0.82 (s, 9H), 0.28 (s, 3H), 0.24 (s, 3H), 0.23 (s, 3H), 
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0.08 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 169.0, 167.8, 167.5, 164.4, 137.2, 129.0, 128.6, 
128.3, 87.4, 86.8, 85.2, 83.8, 83.0, 77.3, 76.8, 74.1, 72.9, 28.6, 28.2, 28.1, 27.1, 27.0, 19.9, 19.8, -
0.8, -1.0 (four overlapping resonances); TLC (1:9 EtOAc: petroleum ether) Rf 0.29. Anal. Calcd 
for C40H68O12Si2: C, 60.27; H, 8.60. Found: C, 60.51; H, 8.66. 
 
6-Benzyloxy-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-7-oxo-5-trimethylsilanyloxy-oxepane-
2,3,4-tricarboxylic acid tri-tert-butyl ester (29).  To a solution of 80 µL of diisopropylamine 
(0.55 mmol, 2.2 equiv) in 2-methyltetrahydrofuran (0.6 mL) at 0 °C under an Ar atmosphere was 
added 360 µL of a 1.4 M n-butyllithium solution in hexane (0.50 mmol, 2.0 equiv).  The LDA 
solution was stirred for 15 min at 0 °C, then added via cannula to a solution of 200 mg (0.25 
mmol, 1.0 equiv) of aldehyde 27 and 87 mg (1.0 mmol, 4.0 equiv) of LiBr in 2-
methyltetrahydrofuran (1.0 mL) at -78 °C.  Once addition was complete (0.4 mL wash), the 
yellow solution was warmed slowly (ca. 15 min) to -45°C and maintained at that temperature.  
After 1 h, 130 µL of chlorotrimethylsilane was added at -45°C.  The reaction was stirred for 15 
min, then quenched by the addition of saturated aqueous ammonium chloride solution (1.0 mL).  
The reaction was extracted with Et2O (3 x 8 mL) and the combined extracts were dried (MgSO4) 
and concentrated in vacuo.  The crude material was purified by flash chromatography (1:9 Et2O: 
petroleum ether), to afford 145 mg (67%) of the pure aldol (29) as a crystalline solid.  Analytical 
data for 29: IR (thin film, cm-1) 2976, 2929, 2858, 1761, 1733, 1471, 1369, 1252, 1152, 1121, 
1004; [α]D  -6.8 (c = 1.06, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.38-7.24 (m, 5H), 5.24 (s, 
1H), 4.92 (d, J = 10.0 Hz, 1H), 4.85 (s, 1H), 4.39 (s, 1H), 4.33 (d, J = 10.0 Hz, 1H), 1.53 (s, 9H), 
1.50 (s, 9H), 1.47 (s, 9H), 0.99 (s, 9H), 0.81 (s, 9H), 0.34 (s, 3H), 0.28 (s, 3H), 0.18 (s, 3H), 0.14 
(s, 3H), 0.049 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 167.1, 167.0, 166.7, 165.1, 137.2, 128.9, 
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128.5, 128.2, 87.3, 84.1, 83.7, 83.3, 81.6, 78.5, 77.7, 75.0, 72.9, 28.9, 28.4, 28.2, 27.7, 27.6, 20.4, 
20.3, 1.5, -0.008, -0.3, -0.6, -0.8; TLC (1:9 Et2O: petroleum ether) Rf 0.32. Anal. Calcd for 
C43H76O12Si3: C, 59.41; H, 8.81. Found: C, 59.64; H, 8.87. 
 
6-Benzyloxy-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-7-oxo-5-hydroxy-oxepane-2,3,4-
tricarboxylic acid tri-tert-butyl ester (epi-52).  To a solution of 60 mg (0.075 mmol, 1.0 equiv) 
of lactone 52 in Et2O (1.0 mL) was added 56 µL (0.38 mmol, 5.0 equiv) of DBU.  After 3 h, 0.5 
mL of saturated aqueous ammonium chloride was added.  The reaction was extracted with Et2O 
(3 X 3 mL), dried (MgSO4), and concentrated in vacuo to furnish an 85:15 ratio of diastereomers 
as judged by 1H NMR analysis.  Purification of the reaction mixture by flash chromatography 
(5:95 EtOAc: petroleum ether), afforded 44 mg (73%) of epi-52 as an oil.  Analytical data for epi-
52: 1H NMR (400 MHz, CDCl3) δ 7.41-7.23 (m, 5H), 5.16 (d, J = 11.6 Hz, 1H), 4.94 (d, J = 11.6 
Hz, 1H), 4.89 (s, 1H), 4.30 (d, J = 9.6 Hz, 1H), 3.91 (dd, J = 9.6, 6.4 Hz, 1H), 3.61 (d, J = 6.0 Hz, 
1H), 1.48 (s, 9H), 1.42 (s, 9H), 1.31 (s, 9H), 0.93 (s, 9H), 0.84 (s, 9H), 0.24 (s, 3H), 0.05 (s, 3H), 
0.03 (s, 3H), 0.01 (s, 3H); TLC (1:9 EtOAc: petroleum ether) Rf 0.39. 
 
(2R,3S,4R,5S,6R)-tri-tert-butyl 6-(benzyloxy)-7-((4R,5R)-4-(benzyloxy)-5-methyl-6-
phenylhexyl)-3,4-bis(tert-butyldimethylsilyloxy)-7-hydroxy-5-(trimethylsilyloxy)oxepane-
2,3,4-tricarboxylate (31).  A solution of 94 mg (0.23 mmol, 5.0 equiv) of iodide 53 in Et2O (0.6 
mL) was cooled to -78 °C under an Ar atmosphere and 220 µL of a 1.7 M solution of tBuli (0.368 
mmol, 8.0 equiv) was added via syringe.  After 5 min, a solution of 40 mg (0.032 mmol, 1.0 
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equiv) of lactone 29 in Et2O (0.35 mL) was added via cannula (0.35 mL rinse).  After 15 min the 
reaction was quenched with 1.0 mL of saturated aqueous ammonium chloride.  The aqueous layer 
was extracted with Et2O (3 X 5 mL).  The combined extracts were dried dried (MgSO4), and 
concentrated in vacuo.  1H NMR analysis of the unpurified reaction mixture revealed an isomeric 
mixture of lactols and ketol.  The inseparable isomers were purified by flash chromatography 
(5:95 EtOAc: petroleum ether), to afford 53 mg (94%) of 31 as mixture of isomers.  Analytical 
data for 31 (reported as a mixture of lactol and ketol isomers): 1H NMR (400 MHz, CDCl3) δ 
7.39-7.10 (m), 4.85-4.55 (m), 4.54-4.42 (m), 4.12-4.09 (m), 3.31-3.18 (m), 2.88-2.71 (m), 2.40-
2.14 (m), 2.12-1.95 (m), 1.95-1.82 (m), 1.58 (s), 1.41 (s), 1.20 (s), 1.03 (s), 0.84 (s), 0.45 (s), 0.36 
(s), 0.32 (s), 0.29 (s), 0.25 (s), 0.18 (s), 0.16 (s), 0.14 (s), 0.11 (s). 0.07 (s); TLC (1:9 EtOAc: 
petroleum ether) Rf 0.29.  
 
 
C4 O-tert-butyldimethylsilyl tricyclic ketal δ-lactone (33).  To a solution of 103 mg of 31 
(0.089 mmol. 1.0 equiv)) in 7 mL of methanol, 136 mg of p-toluenesulfonic acid (0.715 mmol, 
8.0 equiv) was added.  The reaction flask was fitted with a reflux condenser and heated to reflux 
for 72 h.  Heating was discontinued and the reaction was allowed to cool to 23 °C.  5 mL of 
distilled water was added and the MeOH was removed in vacuo.  The resulting aqueous layer was 
extracted with EtOAc (4 x 5 mL), the combined extracts were dried (Na2SO4), and concentrated 
in vacuo.  The crude material was purified by flash chromatography (2:8 EtOAc: petroleum ether 
to 1:1 EtOAc: petroleum ether linear gradient), to afford 10 mg (15%) of silyl-protected lactone 
(33), 29 mg (48%) of δ-lactone 32, and 9 mg (15%) of ketal (34).  Analytical data for 116: IR 
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(thin film, cm-1) 3566, 2954, 2926, 2857, 2359, 1801, 1772, 1747, 1646, 1496, 1365, 1257, 1028; 
[α]Na  -18.7 (c = 0.05, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.35-7.24 (m, 12H), 7.17-7.08 
(m, 3H), 4.84 (m, 2H), 4.52 (m, 3H), 4.44 (s, 1H), 3.81 (s, 3H), 3.75 (s, 3H), 3.53 (d, J = 7 Hz),  
3.25-3.21 (m, 1H), 2.86 (dd, J =  13, 4.5 Hz, 1H), 2.23-2.25 (m, 1H), 2.00-1.92 (m, 2H), 1.69-
1.65 (m, 1H), 1.53-1.38 (m, 5H), 1.24-1.22 (m, 1H), 0.84 (s, 9H), 0.81 (d, J = 7 Hz, 3H), 0.24 (s, 
3H), 0.01 (s, 3H); 13C NMR (400 MHz, CDCl3) δ 171.7, 166.2, 165.5, 141.6, 139.1, 136.6, 129.1, 
128.7, 128.4, 128.3, 128.2, 127.7, 127.4, 125.7, 107.0, 90.5, 82.2, 80.3, 74.0, 72.4, 71.6, 53.2, 
52.8, 38.6, 37.7, 34.1, 30.3, 25.6, 18.9, 18.4, 14.5, -2.28, -4.04; TLC (3:7 EtOAc: petroleum 
ether) Rf 0.65. HRMS (ESI) exact mass calculated for C44H56O11Na [M + Na]+ 811.3489. 
Found: 811.3390. 
C4-hydroxy-tricyclic ketal δ-lactone (32). 1H NMR (400 MHz, CDCl3) δ 7.36-7.25 (m, 11H), 
7.19-7.10 (m, 4H), 4.90 (d, J = 6.8, 1H), 4.82 (d, J = 12 Hz, 1H), 4.57-4.49 (m, 3H), 4.46 (s, 1H), 
4.18 (s, 1H), 3.86 (s, 3H), 3.85 (s, 3H),  3.55 (d, J = 6.8, 1H), 3.27-3.24 (m, 1H), 2.93-2.81 (m, 
1H), 2.40-2.30 (m, 1H), 2.01-1.98 (m, 2H), 1.70-1.49 (m, 6H), 0.83 (d, J = 6.8 Hz, 3H).  
(1R,3S,4R,5S,6R)-dimethyl 6-(benzyloxy)-1-((4R,5R)-4-(benzyloxy)-5-methyl-6-
phenylhexyl)-5-hydroxy-3-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2,7-
dioxabicyclo[2.2.1]heptane-3,4-dicarboxylate (34). 1H NMR (300 MHz, CDCl3) δ 7.35-7.19 
(m, 11H), 7.11-7.09 (m, 4H), 5.67 (d, J = 5.1 Hz, 1H), 5.00 (s, 1H), 4.76 (d, J = 10.5 Hz, 1H), 
4.66 (d, J = 4.8 Hz, 1H), 4.56 (d, J = 12 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1 H), 4.32 (d, J = 10.8 Hz, 
1H),  3.92 (d, J = 5.4 Hz, 1H), 3.82 (s, 3H), 3.60 (s, 3H), 3.56-3.52 (m, 1H), 3.23-3.19 (m, 1H), 
3.07 (s, 3H), 2.90 (dd, J = 13.8, 5.7 Hz, 1H), 2.36-2.32 (m, 1H), 2.05-1.97 (m, 1H), 1.76-1.41 (m, 
5H), 0.86 (d, J = 5.1 Hz, 3H). 
   86 
 
C4-hydroxy-tricyclic ketal δ-lactone (32).  To a solution of 16 mg of 34 (0.023 mmol. 1.0 
equiv)) in 3 mL of methanol, 46 mg of p-toluenesulfonic acid (0.242 mmol, 8.0 equiv) was 
added.  The reaction flask was fitted with a reflux condenser and heated to reflux for 72 h.  
Heating was discontinued and the reaction was allowed to cool to 23 °C.  Distilled water (5 mL) 
was added and the MeOH was removed in vacuo.  The resulting aqueous layer was extracted with 
EtOAc (4 x 5 mL), the combined extracts were dried (Na2SO4), and concentrated in vacuo.  The 
crude material was purified by flash chromatography (2:8 EtOAc: petroleum ether to 1:1 EtOAc: 
petroleum ether linear gradient), to afford 11 mg (73%) of  δ-lactone 32. 
 
C4 O-tert-butyldimethylsilyl tricyclic ketal δ-lactone (33): To a solution of 51 mg (0.076 
mmol) of tertiary alcohol 32 in 0.75 mL CH2Cl2 at 0 °C under an Ar atmosphere, was added 42 
µL (0.308 mmol, 4.0 equiv) of NEt3, and 35 µL (0.154 mmol, 2.0 equiv) of TBSOTf.  The 
reaction was warmed to 23 °C.  After stirring for 15 min, an additional 42 µL (0.308 mmol, 4.0 
equiv) of NEt3, and 35 µL (0.154 mmol, 2.0 equiv) of TBSOTf was added.  After 1 h, 0.5 mL of 
saturated NaHCO3 (aq) was added.  The solution was extracted with CH2Cl2 (3 x 5 mL).  The 
combined extracts were dried (Na2SO4) and concentrated in vacuo, affording the crude silyl 
ether, which was purified by flash chromatography (1:5 EtOAc: petroleum ether), to furnish 52 
mg (87%) of silyl ether δ-lactone 33. 
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(1S,3R,4S,5R,6R,7R)-3,4-di-tert-butyl 5-methyl 7-(benzyloxy)-1-((4R,5R)-4-(benzyloxy)-5-
methyl-6-phenylhexyl)-4,6-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate 
(36).  To a solution of 15 mg (0.019 mmol, 1.0 equiv) of lactone 33 in t-amyl alcohol (1.0 mL, 
freshly distilled from Na) was added a solution of 23 mg KOtBu (0.204 mmol, 11 equiv) in 0.75 
mL t-amyl alcohol via cannula.  The solution was warmed to 35 °C and stirred under an Ar 
atmosphere for 40 min, at which point it was cooled to 23 °C. The reaction was quenched with 2 
mL of 1 M HCl.  The aqueous layer was extracted with EtOAc (3 x 5 mL).  The combined 
extracts were dried (Na2SO4) and concentrated in vacuo, affording the crude dicarboxylic acid.  
The crude material was dissolved in 1 mL toluene and 88 µL (0.367 mmol, 19 equiv) of N,N’-
diisopropyl-O-tert-butylisourea was added.  The solution was warmed to 75 °C under an Ar 
atmosphere and stirred at 75 °C.  After 2 h the solution was cooled to 23 °C, diluted with diethyl 
ether and filtered through celite.  Concentration in vacuo afforded the crude triester.  The crude 
material was purified by flash chromatography (1:9 EtOAc:petroleum ether to 2:3 
EtOAc:petroleum ether, linear gradient), to afford 9.5 mg (63%) of the product as a mixture of 
esters, and 4.5 mg (27%) of starting material with t-butyl esters. Distribution of products: 6.5 mg 
(43%) of di-t-butyl ester 36; 2.0 mg (13%) of tri-t-butyl ester; 1.0 mg of mono-t-butyl ester (7%); 
90% yield BRSM.  Analytical data for 36: IR (thin film, cm-1) 2922, 2851, 1737, 1635, 1456, 
1370, 1262, 1151; [α]Hg-16.0 (c = 0.135, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.38-7.29 (m, 
9H), 7.26-7.24 (m, 2H), 7.18-7.10 (m, 3H), 5.09 (dd, J = 8.0, 3.5 Hz, 1H), 4.78 (d, J = 12.5 Hz, 
1H), 4.66 (d, J = 12.5 Hz, 1H), 4.55 (d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.5 Hz, 1 H), 4.46 (s, 1H), 
4.14 (s, 1H), 3.81 (s, 3H), 3.61 (d, J = 3.5, 1H), 3.25 (s, 1H), 2.85 (dd, J = 13.5, 5.0 Hz, 1 H), 2.37 
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(m, 1H), 2.00-1.93 (m, 2H), 1.80-175 (m, 2H), 1.56 (s, 9H), 1.52 (m, 3H), 1.45 (s, 9H), 1.21 (m, 
1H), 0.84 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.0, 167.4, 167.2, 141.6, 139.3, 
137.8, 129.1, 128.4, 128.3, 128.2, 12 8.1, 127.8, 127.6, 127.3, 125.6, 106.4, 94.2, 87.1, 84.9, 82.6, 
82.1, 80.6, 72.2, 71.5, 52.4, 39.0, 37.7, 33.9, 30.6, 29.7, 28.1, 28.0, 19.1, 14.2; TLC (2:3 EtOAc: 
petroleum ether) Rf 0.24. HRMS (ESI) exact mass calculated for C45H58O12Na [M+Na]+ 
813.3825. Found: 813.3827. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 7-(benzyloxy)-1-((4R,5R)-4-(benzyloxy)-5-methyl-6-
phenylhexyl)-4,6-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (37).   0.75 
mL of a 1 M solution of NaOMe in MeOH (distilled from Mg metal) was added to 14 mg (0.019 
mmol, 1.0 equiv) of 36, as a mix of esters, in a shell vial that had been purged with Ar.  The 
solution was stirred for 2 hours monitoring by TLC (2:5 EtOAc:petroleum ether) until no starting 
material remained.  The solution was poured into 1 mL of 1 M HCl.  The aqueous layer was 
extracted with EtOAc (3 x 5 mL).  The combined extracts were dried (Na2SO4) and concentrated 
in vacuo, affording the crude tricarboxylic acid.  The crude material was dissolved in 1 mL of 
toluene and 81 µL (0.343 mmol, 18 equiv) of N,N’-diisopropyl-O-tert-butylisourea was added.  
The solution was warmed to 75 °C under an Ar atmosphere and stirred at 75 °C.  After 2 h the 
solution was cooled to 23 °C, diluted with diethyl ether and filtered through celite.  The filtrate 
was concentrated in vacuo and the residue was purified by flash chromatography (1:5 
EtOAc:petroleum ether to 3:10 EtOAc:petroleum ether, linear gradient) to afford 11 mg (69%) of 
the product as a mixture of epimers (8:1) in favor of the correct C3-(S) configuration.  The 
epimers were separable at the stage of the triacetate 11.  Analytical data for 37: IR (thin film, cm-
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1) 3443, 3031, 2878, 1697, 1616, 1506, 1395, 1367, 1258, 1198, 1149; [α]Na  -12.7 (c = 0.16, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.33-7.21 (m, 9H), 7.15-7.13 (m, 2H), 7.13-7.09 (d, J = 
16 Hz, 4H), 5.11 (s, 1H), 4.92 (s, 1H), 4.72 (d, J = 12.0 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.54 
(d, J = 11.5 Hz, 1 H), 4.47 (d,J = 11.5 Hz, 1H), 3.83 (s, 1H), 3.78 (s, 1H), 3.27 (s, 1H), 2.83 (dd, J 
= 13.0, 4.5 Hz, 1 H), 2.36 (t,J = 9.5 Hz, 1H), 2.00-1.80 (m, 3H), 1.60-1.40 (m, 4H), 1.56 (s, 9H), 
1.45 (s, 9H), 1.42 (s, 9H), 1.21 (m, 1H), 0.81 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
169.0, 167.4, 166.6, 141.8, 139.3, 137.3, 129.2, 128.5, 128.3, 128.2, 128.1, 127.7, 127.6, 127.3, 
125.5, 104.7, 91.3, 87.7, 84.7, 84.2, 83.0, 82.3, 80.6, 75.3, 74.3, 72.8, 71.5, 39.1, 37.8, 36.2, 34.4, 
30.3, 29.7, 28.2, 28.0, 19.5, 14.1; TLC (1:5 EtOAc: petroleum ether) Rf 0.19. HRMS (ESI) exact 
mass calculated for C48H64O12Na [M+Na]+ 855.4295. Found: 855.4296. 
 
tert-pentyl N,N'-diisopropylcarbamimidate (40).  A round-bottomed flask was flame dried and 
purged with Ar for 5 minutes.  The flask was charged with a stir bar, 5 mL (32 mmol, 1 equiv) of 
N,N’-diisopropyldicarbodiimide, 320 mg (37 mmol, 0.1 equiv) of CuCl and 3.74 mL (37 mmol, 
1.15 equiv) of tert-amyl alcohol.  The solution was stirred for 5 days.  Hexane (15 mL) was added 
to the solution forming a solid precipitate.  The solution was filtered using a fine frit and 
concentrated in vacuo.  The crude product was distilled under reduced pressure (10 torr) with a bp 
of 75-80 °C to yield 2.48g (36%) of 40.  Analytical data for 40: 1H NMR (400 MHz, CDCl3) δ 
3.77 – 3.57 (m, 1H), 3.25 – 2.99 (m, 1H), 1.78 (q, J = 7.5 Hz, 2H), 1.41 (s, 6H), 1.06 (d, J = 6.4 
Hz, 6H), 1.00 (d, J = 6.1 Hz, 6H), 0.84 (t, J = 7.5 Hz, 3H). 
 
C4 O-tert-butyldimethylsilyl C7 hydroxyl tricyclic ketal δ-lactone (39).  A dry scintillation 
vial was purged with Ar for 5 minutes and was charged with 10 mg (0.018 mmol, 1 equiv) of 
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33b, a stir bar, and 1 mL of CH2Cl2.  To this solution was added 11 µL (0.08 mmol, 4 equiv) of 
TMSI dropwise via syringe.  The solution was stirred in the absence of light for 12 h.  The 
reaction was quenched with H2O (1 mL).  The layers were separated and the organic layer was 
extracted with saturated aqueous NaHCO3 (1 mL), aqueous Na2S2O8 (1 mL) and brine (1 mL).  
The organic layer was dried over Na2SO4 and concentrated in vacuo.  The crude product purified 
by flash column (1:5 EtOAc: petroleum ether) to yield 4.5 mg (56%) of 39 as a clear oil.  
Analytical data for 39: 1H NMR (500 MHz, CDCl3) δ 4.89 (d, J = 7.2 Hz, 1H), 4.44 (s, 1H), 3.95 
– 3.88 (m, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 2.79 (d, J = 12.7 Hz, 1H), 1.91 (dd, J = 16.9, 8.9 Hz, 
1H), 1.77 (dd, J = 14.8, 5.7 Hz, 1H), 1.44 (d, J = 39.6 Hz, 1H), 1.40 – 1.16 (m, 4H), 0.96 – 0.85 
(m, 2H), 0.83 (s, 9H), 0.20 (s, 3H), 0.00 (s, 3H); TLC (1:5 EtOAc: petroleum ether) Rf 0.16. 
 
(1S,3R,4R,5R,6R,7S)-tri-tert-butyl 7-(benzyloxy)-1-butyl-4-hydroxy-6-(propionyloxy)-2,8-
dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (43).  A dry scintillation vial was purged with 
Ar for 5 minutes and was charged with 10 mg (0.016 mmol, 1 equiv) of 37b, a stir bar, and 1 mL 
of CH2Cl2.  The solution was cooled to 0 °C.  To this solution was added 7 µL (0.05 mmol, 3 
equiv) of Et3N dropwise via syringe, 2 mg (0.016 mmol, 1 equiv) of DMAP and 6 µL (0.05 
mmol, 3 equiv) of propionic anhydride dropwise via syringe.  The solution was stirred for 3 h.  
The reaction was quenched with aqueous 1 M KH2PO4 (1 mL).  The layers were separated and 
the aqueuous layer was extracted with CH2Cl2 (3 x 3 mL).  The organic layer was dried over 
Na2SO4 and concentrated in vacuo.  The crude product purified by flash column (1:5 EtOAc: 
petroleum ether) to yield 7 mg (64%) of 43 as a clear oil.  Analytical data for 43: 1H NMR (500 
MHz, CDCl3) δ 7.34 – 7.25 (m, 5H), 6.48 (s, 1H), 5.07 (s, 1H), 4.82 (d, J = 12.1 Hz, 1H), 4.52 (d, 
J = 12.1 Hz, 1H), 4.00 (s, 1H), 3.75 (s, 1H), 2.31 – 2.23 (m, 2H), 1.94 – 1.76 (m, 2H), 1.47 – 1.35 
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(m, 27H), 1.35 – 1.18 (m, 4H), 1.13 (t, J = 7.5 Hz, 3H), 0.85 (t, J = 7.2 Hz, 3H); TLC (1:5 EtOAc: 
petroleum ether) Rf 0.27. 
 
(1S,3R,4R,5R,6R,7R)-tri-tert-butyl 1-butyl-4,7-dihydroxy-6-(propionyloxy)-2,8-
dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (44a).  A dry scintillation vial was purged with 
Ar for 5 minutes and was charged with 4 mg (0.006 mmol, 1 equiv) of 43, 4 mg (0.012 mmol, 2 
equiv) of DDQ, a stir bar, and 0.005 mL of CH3CN.  The solution was then irradiated with a 450 
watt 365nm mercury vapor lamp at a distance of 15 cm for 4 h.  To this solution was added 7 µL 
(0.05 mmol, 3 equiv) of Et3N dropwise via syringe, 2 mg (0.016 mmol, 1 equiv) of DMAP and 6 
µL (0.05 mmol, 3 equiv) of propionic anhydride dropwise via syringe.  The solution was stirred 
for 3 h.  The reaction was quenched with aqueous saturated NaHCO3 (1 mL).  The layers were 
separated and the aqueuous layer was extracted with CH2Cl2 (3 x 3 mL).  The organic layer was 
dried over Na2SO4 and concentrated in vacuo.  The crude product purified by flash column (1:5 
EtOAc: petroleum ether) to yield 3 mg (86%) of 44 as a clear oil.  Analytical data for 27a: 1H 
NMR (500 MHz, CDCl3) δ 5.91 (s, 3H), 4.99 (s, 1H), 3.99 (s, 1H), 2.76 (s, 1H), 2.35 (dd, J = 
14.2, 7.6 Hz, 2H), 1.95 (t, J = 27.8 Hz, 3H), 1.56 (s, 9H), 1.46 (s, 9H), 1.43 (s, 9H), 1.39 – 1.31 
(m, 2H), 1.14 (t, J = 7.5 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H); TLC (1:5 EtOAc: petroleum ether) Rf 
0.30. 
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A solution of acyl side chain acid 12 (7 mg, 0.030 mmol, 2 equiv) and DCC (6 mg, 0.030 mmol, 
2 equiv) in 485 µl of CH2Cl2 was stirred under Ar for 15 minutes.  To a solution of 37b (9.0 mg, 
0.015 mmol, 1.0 equiv) and DMAP (4 mg, 0.035 mmol, 2.3 equiv) in CH2Cl2 (1.5 mL,) was 
added the acyl side chain-DCC solution.  The reaction was stirred at 23 °C under Ar in a sealed 
vial for 40 hours.  The reaction was quenched with 1.5 mL of 50% aqueous satd. NaHCO3 
solution.  The aqueous layer was extracted with Et2O (4 x 2 mL).  The combined extracts were 
dried (Na2SO4) and concentrated in vacuo, affording the crude product.  The crude material was 
purified by flash chromatography (1:5 EtOAc:hexanes), to give product 42b as a colorless film 
6.0 mg (50%).  Analytical data for 42b: IR (thin film, cm-1) 3398 broad, 2929, 2851, 2347, 1724, 
1594, 1451, 1377; 1172; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.08 (m, 10H), 6.47 (s, 1H), 5.30 
(s, 2H), 5.05 (s, 1H), 4.80 (d, J = 11.9 Hz, 1H), 4.49 (d, J = 11.9 Hz, 1H), 4.00 (s, 1H), 3.74 (s, 
1H), 2.53 (t, J = 7.1 Hz, 2H), 2.34 – 2.22 (m, 4H), 2.04 (s, 2H), 1.95 – 1.70 (m, 3H), 1.61 (s, 9H), 
1.41 (s, 18H), 1.33 – 1.21 (m, 6H), 0.94 – 0.79 (m, 6H); TLC (1:4 EtOAc: petroleum ether) Rf 
0.25.  
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 4,6,7-trihydroxy-1-((4R,5R)-4-hydroxy-5-methyl-6-phenylhexyl)-
2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (45).  A scintillation vial was charged with 28 
mg (0.030 mmol) of ketol/lactol mixture 31b, capped with a rubber septum and purged with Ar 
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for 5 minutes.  EtOH (2 mL) was added followed by a spatula tip of 10% Pd/C.  The rubber 
septum was pierced with an 18 gauge needle and the vial was placed in a bomb.  The bomb was 
purged with hydrogen gas 7 times and then pressurized to 800 psi.  The reaction was stirred in the 
bomb at 800 psi for 20 hours.  The bomb was depressurized and the solution was filtered through 
celite with diethyl ether.  Concentration in vacuo afforded the debenzylated triester. The material 
was analyzed by 1H NMR spectroscopy and to reveal a complex mixture of lactol/ketol isomers 
but contained no benzyl ether peaks.  The ketol/lactol mixture was used in the next step without 
further purification.  Analytical data for 45: 1H NMR (300 MHz, CDCl3) δ 1H NMR (300 MHz, 
CDCl3) δ 5.00 (d, J = 3.6 Hz, 1H), 4.93 (s, 1H), 3.80 (d, J = 5.0 Hz, 1H), 3.76 – 3.61 (m, 4H), 
3.08 (s, 5H), 1.66 – 1.16 (m, 97H), 1.00 – 0.76 (m, 58H), 0.35 (s, 2H), 0.30 – -0.05 (m, 27H); 
TLC (2:5 EtOAc: petroleum ether) Rf 0.3 (mixture of products). 
 
C7 hydroxyl tricyclic ketal δ-lactone (54).  A scintillation vial was charged with 28 mg (0.064 
mmol) of lactone 33b, capped with a rubber septum and purged with Ar for 5 minutes.  EtOH (2 
mL) was added followed by a spatula tip of 10% Pd/C.  The rubber septum was pierced with an 
18 gauge needle and the vial was placed in a bomb.  The bomb was purged with hydrogen gas 7 
times and then pressurized to 800 psi.  The reaction was stirred in the bomb at 800 psi for 20 
hours.  The bomb was depressurized and the solution was filtered through celite with diethyl 
ether.  Concentration in vacuo afforded the debenzylated triester. The crude material was purified 
by flash column (20:1 petroleum ether:EtOAc) to give 22 mg (100%) of 54 as a clear oil.   
Analytical data for 54: 1H NMR (400 MHz, CDCl3) δ 4.92 (d, J = 7.2 Hz, 1H), 4.47 (s, 1H), 3.84 
(s, 3H), 3.82 (s, 3H), 2.94 (d, J = 11.9 Hz, 1H), 1.98 – 1.89 (m, 1H), 1.81 – 1.70 (m, 1H), 1.56 – 
1.40 (m, 2H), 1.40 – 1.26 (m, 2H), 1.21 (dd, J = 8.3, 6.0 Hz, 2H), 0.88 (t, J = 7.3 Hz, 3H); TLC 
(1:1 EtOAc:petroleum ether) Rf 0.28. 
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C4 O-tert-butyldimethylsilyl tricyclic ketal δ-lactone (46): To a solution of 11 mg (0.076 
mmol) of diol 53in 0.5 mL CH2Cl2 at 0 °C under an Ar atmosphere, was added 27 µL (0.1 mmol, 
4.0 equiv) of DBU, and 15 µL (0.05 mmol, 2.0 equiv) of TBSOTf.  The reaction was warmed to 
23 °C.  After stirring for 15 min, an additional 27 µL (0.308 mmol, 4.0 equiv) of DBU, and 15 µL 
(0.05 mmol, 2.0 equiv) of TBSOTf was added.  After 2 h, 0.5 mL of saturated NaHCO3 (aq) was 
added.  The solution was extracted with CH2Cl2 (3 x 5 mL).  The combined extracts were dried 
(Na2SO4) and concentrated in vacuo, affording the crude silyl ether, which was purified by flash 
chromatography (1:5 EtOAc: petroleum ether), to furnish 5 mg (27%) of bissilyl ether δ-lactone 
46. Analytical data for 46: 1H NMR  (500 MHz, CDCl3) δ 4.75 (s, 1H), 4.41 (d, J = 1.8 Hz, 1H), 
3.81 (s, 3H), 3.71 (s, 3H), 1.93 – 1.82 (m, 1H), 1.70 – 1.62 (m, 1H), 1.57 – 1.17 (m, 4H), 0.90 (s, 
9H), 0.88 (s, 3H), 0.81 (s, 9H), 0.20 (s, 3H), 0.12 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H).; TLC (2:5 
EtOAc: petroleum ether) Rf 0.35. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 4,6,7-trihydroxy-1-((4R,5R)-4-hydroxy-5-methyl-6-
phenylhexyl)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (47).  A scintillation vial was 
charged with 11 mg (0.013 mmol) of tri-ester 17, capped with a rubber septum and purged with 
Ar for 5 minutes.  EtOH (2 mL) was added followed by a spatula tip of 10% Pd/C.  The rubber 
septum was pierced with an 18 gauge needle and the vial was placed in a bomb.  The bomb was 
purged with hydrogen gas 7 times and then pressurized to 800 psi.  The reaction was stirred in the 
bomb at 800 psi for 20 hours.  The bomb was depressurized and the solution was filtered through 
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celite with diethyl ether.  Concentration in vacuo afforded the debenzylated triester. The material 
was pure by 1H NMR spectroscopy and was used in the next step without further purification.  
Analytical data for 47: IR (thin film, cm-1) 3443, 3031, 2878, 1697, 1616, 1506, 1395, 1367, 
1258, 1198, 1149; [α]Na  +11.6 (c = 0.09, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.23 (m, 3H), 
7.13 (d, J = 7.5 Hz, 2H), 4.98 (s, 1H), 4.91 (s, 1H), 4.09 (s, 1H), 3.96 (s broad, 1H), 3.51 (s broad, 
1H), 2.76 (dd, J = 13.3, 6.0 Hz, 1 H), 2.39 (dd, J = 10.0 Hz, J = 9.0 Hz, 1H), 2.00-1.89 (m, 3H), 
1.80-1.50 (m, 4H), 1.55 (s, 9H), 1.45 (s, 9H), 1.41 (s, 9H), 0.82 (d, J = 4.0 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 168.7, 166.4, 166.2, 143.5, 141.3, 129.2, 128.2, 125.7, 105.3, 91.3, 85.1, 
84.3, 83.4, 82.4, 78.8, 75.1, 74.3, 74.1, 58.5, 40.7, 39.8, 35.1, 33.8, 30.3, 30.0, 28.3, 28.1, 28.0, 
19.7, 13.3; TLC (1:1 EtOAc: petroleum ether) Rf 0.07. HRMS (ESI) exact mass calculated for 
C34H52O12Na [M+Na]+ 675.3356. Found: 675.3357. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 6,7-diacetoxy-1-((4R,5R)-4-acetoxy-5-methyl-6-
phenylhexyl)-4-hydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (11).  To a 
solution of 11.8 mg (0.018 mmol, 1.0 equiv) of triester 47 and 4 mg (0.036 mmol, 2.0 equiv) of 
DMAP in dichloromethane (1.5 mL,) was added 17 µl (0.1 mmol, 10 equiv) of acetic anhydride 
via syringe.  The solution was stirred at 23 °C under Ar for 3 hours until no starting material 
remained by TLC (1:1 EtOAc:petroleum ether).  The reaction was quenched with 1.5 mL aqueous 
satd. NaHCO3 solution.  The aqueous layer was extracted with CH2Cl2 (3 x 5 mL).  The 
combined extracts were dried (Na2SO4) and concentrated in vacuo, affording the crude tri-
acetate.  The crude material was purified by flash chromatography (1:5 EtOAc: petroleum ether 
to 3:10 EtOAc: petroleum ether, linear gradient), to afford 9 mg (65%) of the desired major 
diastereomer 11, and 2.5 mg (18%) of the minor diastereomer.  Analytical data for 11: IR (thin 
film, cm-1) 3434 (br), 2930, 2861, 1724, 1651, 1594, 1374, 1233, 1172, 1034; [α]Na  +11.1 (c = 
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0.325, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ  7.27-7.24 (m, 2H), 7.17 (t, J = 7.5 Hz, H), 7.13 
(d, J = 7.5 Hz, 2H), 6.33 (d, J = 1.5 Hz, 1H), 5.08 (d, J = 2 Hz, 1H), 4.88 (s, 1H), 4.88-4.86 (m, 
1H), 4.07 (s, 1H), 2.76 (dd, J = 13.3, 4.5 Hz, 1 H), 2.30 (dd, J = 10.5 Hz, J = 13.5 Hz, 1H), 2.14 
(s, 3H), 2.07 (s, 3H), 2.05 (s, 3H), 2.05-1.90 (m, 3H), 1.70-1.50 (m, 4H), 1.61 (s, 9H), 1.46 (s, 
9H), 1.45 (s, 9H), 0.83 (d, J = 7 Hz, 3H); 13C NMR (125 MHz, CD3OD) δ 173.0, 171.1, 170.2, 
168.7, 167.4, 165.6, 141.9, 130.2, 129.3, 127.0, 105.6, 91.2, 86.4, 85.3, 85.0, 81.6, 77.9 (2 lines), 
76.9, 75.6, 40.6, 39.7, 36.5, 32.3, 28.5, 28.4 (3 lines), 21.1, 20.7, 20.5, 20.1, 14.3; (125 MHz, 
CDCl3) δ 170.9, 169.5, 168.7, 168.5, 165.5, 163.9, 140.7, 129.1, 128.2, 125.8, 104.1, 89.7, 86.1, 
84.1, 83.6, 80.4, 76.4, 75.2, 73.8, 39.3, 38.1, 35.7, 30.8, 28.1, 27.9, 21.2, 20.7, 20.6, 19.0, 13.9;  
TLC (1:2 EtOAc:hexanes) Rf 0.46. HRMS (ESI) exact mass calculated for C40H58O15 [M+Na]+ 
801.3673. Found: 801.3674.  
The spectroscopic data match those reported by Carreira10 and Rizzacasa7. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 1-((4R,5R)-4-acetoxy-5-methyl-6-phenylhexyl)-4,6,7-
trihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (55).  A solution of 6 mg (0.008 
mmol, 1.0 equiv) of triacetate 11 in 1.2 mL of 0.2% K2CO3 in MeOH was stirred at 23 °C under 
Ar for 30 minutes.  The reaction was quenched with 1.5 mL 0.3 M KH2PO4 solution.  The 
aqueous layer was extracted with Et2O (5 x 3 mL).  The combined extracts were dried (Na2SO4) 
and concentrated in vacuo, affording the crude mono-acetate.  The crude material was purified by 
flash chromatography (2:5 EtOAc:hexanes to 1:1 EtOAc:hexanes, linear gradient), to afford 4 mg 
(75%) of the triol 55.  Analytical data for 55: IR (thin film, cm-1) 3460 (broad), 2927, 1732, 
1371, 1258, 1159; 1H NMR (500 MHz, CD3OD) δ 7.24 (t, J = 7.5 Hz, 2H), 7.14-7.15 (m, 3H), 
4.97-4.96 (2H), 3.99 (d, J = 2.0 Hz, 1H), 2.75 (dd, J = 13.5, 5.5 Hz, 1 H), 2.36 (dd, J = 9.5 Hz, J 
= 13.3 Hz, 1H), 2.06 (s, 3H),  2.05-2.0 (m, 1H), 1.95-1.70 (m, 2H), 1.70-1.60 (m, 2H), 1.60-1.20 
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(m, 2H), 1.60 (s, 9H), 1.46 (s, 9H), 1.45 (s, 9H), 0.87 (d, J = 7.0 Hz, 3H), one proton obscured by 
residual water; 13C NMR (125 MHz, CD3OD) δ 173.0, 169.8, 168.3, 167.4, 142.0, 130.2, 129.3, 
126.9, 106.4, 93.2, 85.4, 84.2 (2 lines), 79.9, 78.2, 76.8, 76.0, 40.6, 39.5, 36.6, 32.5, 28.7, 28.5, 
28.4, 21.1, 20.1, 14.2; TLC (2:5 EtOAc: petroleum ether) Rf 0.17. HRMS (ESI) exact mass 
calculated for C36H54O13Na [M+Na]+ 717.3461. Found: 717.3463. 
The spectroscopic data match those reported by Carreira.10 In addition to the published spectral 
data, we found the scanned spectrum in the Supporting Information for the Armstrong synthesis 
to be useful for comparison purposes.5 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 1-((4R,5R)-4-acetoxy-5-methyl-6-phenylhexyl)-7-(tert-
butoxycarbonyloxy)-4,6-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (48).  
A solution of 4 mg (0.006 mmol, 1.0 equiv) of monoacetate 55 in 0.75 mL of dichloromethane 
under Ar was stirred and cooled to 0 °C.  A solution of 4-pyrrolidinopyridine (0.1 M in CH2Cl2, 
46 µl, 0.005 mmol, 0.8 equiv) was added followed by a solution of Et3N (115 µl, 0.2 M in 
CH2Cl2, 0.024 mmol, 4.0 equiv) and a solution of di-tert-butyl dicarbonate (66 µl, 0.1 M in 
CH2Cl2, 0.007 mmol, 1.15 equiv).  The solution was stirred for 6.5 hours at 0 °C.  The reaction 
was quenched with 1.5 mL 1.0 M KH2PO4 solution.  The aqueous layer was extracted with Et2O 
(5 x 2 mL).  The combined extracts were dried (Na2SO4) and concentrated in vacuo, affording the 
crude product.  The crude material was purified by flash chromatography (1:4 EtOAc:hexanes to 
1:1 EtOAc:hexanes, linear gradient), to afford 3.5 mg (77%) of the boc-protected product 48.  
Analytical data for 48: IR (thin film, cm-1) 3433 (broad), 2927, 2851, 1644, 1451, 1378, 1259, 
1171, 1113, 1026; 1H NMR (500 MHz, CDCl3) δ 7.27−7.24 (m, 2H), 7.17 (t, J = 7.0 Hz, 1H), 
7.12 (d, J = 7.0 Hz, 2H), 5.11 (d, J = 1.5 Hz, 1H), 4.87 (m, 1H), 4.72, (s, 1H), 4.63 (d, J = 1.5 Hz, 
1H), 3.95 (s, 1H), 2.84 (broad s, 1H), 2.75 (dd, J = 13.3, 5.5 Hz, 1 H), 2.30 (dd, J = 13.0, 9.5 Hz, 
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1H), 2.06 (s, 3H),  2.05-1.90 (m, 4H), 1.70-1.30 (m, 4H), 1.58 (s, 9H), 1.50 (s, 9H), 1.48 (s, 9H), 
1.45 (s, 9H), 0.83 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 171.0, 168.7, 165.9, 165.3, 
153.8, 140.9, 129.3, 128.4, 125.7, 104.0, 90.9, 85.6, 85.2, 84.1, 84.0, 83.4, 77.4, 75.4, 74.2, 39.5, 
38.0, 35.7, 34.4, 31.0, 29.9, 28.3, 28.2, 28.1, 27.8, 21.4, 19.0, 13.9; TLC (2:5 EtOAc:petroleum 
ether) Rf 0.59. HRMS (ESI) exact mass calculated for C41H62O15Na [M+Na]+: 817.3986. Found: 
817.3987. 
The spectroscopic data match those reported by Carreira9 and Armstrong.11  In addition to the 
published spectral data, we found the scanned spectrum in the Supporting Information for the 
Armstrong synthesis to be useful for comparison purposes. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 1-((4R,5R)-4-acetoxy-5-methyl-6-phenylhexyl)-7-(tert-
butoxycarbonyloxy)-4-hydroxy-6-((R,E)-6-methyl-9-phenylnon-4-enoyloxy)-2,8-
dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (48).  A solution of acyl side chain acid 12 (12 
mg, 0.049 mmol) and DCC (10 mg, 0.049 mmol) in 485 µl of CH2Cl2 was stirred under Ar for 15 
minutes.  To a solution of boc-protected 48 (8.0 mg, 0.010 mmol, 1.0 equiv) and DMAP (4 mg, 
0.035 mmol, 3.5 equiv) in CH2Cl2 (1.5 mL,) was added 120 µl (1.2 equiv) of the acyl side chain-
DCC solution.  The reaction was stirred at 23 °C under Ar in a sealed vial for 40 hours.  The 
reaction was quenched with 1.5 mL of 50% aqueous satd. NaHCO3 solution.  The aqueous layer 
was extracted with Et2O (4 x 2 mL).  The combined extracts were dried (Na2SO4) and 
concentrated in vacuo, affording the crude product.  The crude material was purified by flash 
chromatography (1:5 EtOAc:hexanes), to give product 49 as a colorless film 5.1 mg (51%) and 3 
mg (38%) of recovered boc-protected starting material 48.  Analytical data for 49: IR (thin film, 
cm-1) 3398 broad, 2929, 2851, 2347, 1724, 1594, 1451, 1377; 1172; 1H NMR (500 MHz, 
DCC, CH2Cl2,
DMAP, 40 hours
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CDCl3) δ 7.28−7.24 (m, 4H), 7.18-7.12 (m, 6H), 6.40 (d, J = 2.0 Hz, 1H), 5.39-5.28 (m, 2H), 4.91 
(s, 1H), 4.86 (d, J = 2.0 Hz 1H), 4.88-4.86 (m, 1H), 4.07 (s, 1H), 2.76 (dd, J = 15.0, 4.5 Hz, 1 H), 
2.56 (t, J = 7.5 Hz, 1H), 2.32-2.25 (m, 3H), 2.10-1.91 (m, 6H), 2.05 (s, 3H), 1.68-1.25 (m, 8H), 
1.61 (s, 9H), 1.47 (s, 9H), 1.45 (s, 9H), 1.44 (s, 9H), 0.93 (d, J = 6.5 Hz, 3H), 0.83 (d, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 170.8, 170.7, 168.7, 165.6, 164.1, 152.4, 142.8, 140.8, 
137.6, 129.2, 128.4, 128.3, 128.2, 126.1, 125.8, 125.6, 103.7, 89.8, 86.1, 84.0, 83.5, 83.4, 83.0, 
76.1, 75.2, 73.9, 39.3, 38.0, 36.6, 36.5, 36.1, 35.9, 34.1, 30.8, 29.3, 28.1, 28.2, 28.0, 27.9, 27.73, 
27.66, 21.3, 20.6, 18.9, 13.8; TLC (1:4 EtOAc: petroleum ether) Rf 0.29. HRMS (ESI) exact 
mass calculated for C57H82O16Na [M+Na]+: 1045.5500 Found: 1045.5501. 
The spectroscopic data match those reported by Carreira10 and Armstrong5.  In addition to the 
published spectral data, we found the scanned spectrum in the Supporting Information for the 
Armstrong synthesis to be useful for comparison purposes. 
 
Zaragozic Acid C (1).  To a solution of 49 (5.0 mg, 0.005 mmol, 1.0 equiv) in 2.55 mL of 
dichloromethane under Ar was added TFA (850 µl).  The solution was stirred for 16 hours at 23 
°C.  Volatiles were removed in vacuo.  The pale green residue was dissolved in 5 mL of toluene, 
concentrated in vacuo, and lyophilized from 1.5 mL of benzene to afford 3.6 mg (100%) of the 
product 1 as a white flocculent solid.  Analytical data for 1: IR (thin film, cm-1) 3427 broad, 
2929, 2360, 1717, 1646, 1378, 1268, 1171; [α]Na  +3.81 (c = 0.040, EtOH); 1H NMR (500 MHz, 
CD3OD) δ 7.23−7.21 (m, 4H), 7.14-7.10 (m, 6H), 6.23 (d, J = 1.5 Hz, 1H), 5.37 (m, 1H), 5.32 (m, 
1H), 5.23 (s, 1H), 4.90 (m, 1H, masked by solvent signal), 4.01 (s, 1H), 2.73 (dd, J = 13.5, 5.5 
Hz, 1 H), 2.56 (dd, J = 7.0 Hz, 12.5 Hz, 2H), 2.36-2.32 (m, 3H), 2.28-2.24 (m, 2H) 2.08-2.00 (m, 
2H), 2.05 (s, 3H)1.92-1.85 (m, 2H), 1.7-1.66 (m, 2H), 1.61-1.52 (m, 4H), 1.40-1.20 (m, 2H), 0.93 
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(d, J = 6.5 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.1, 173.06, 172.7, 
170.3, 168.7, 143.9, 142.0, 138.8, 130.2, 129.4, 129.3, 129.27, 127.7, 126.9, 126.6, 107.1, 91.1, 
82.3, 81.2, 78.1, 76.7, 75.7, 40.5, 39.7, 37.9, 37.6, 36.9, 36.3, 35.4, 32.5, 30.5, 28.8, 21.3, 21.1, 
20.1, 14.3; LRMS (ESI) exact mass calculated for C40H50O14 754.3 Found: 754.4 (376.2 [M-
2H]2-).  HRMS (ESI) exact mass calculated C40H50O14Na [M+Na]+: 777.3098 Found: 777.3068. 
The spectroscopic data match those reported by Carreira and Armstrong.  In addition to the 
published spectral data, we found the scanned spectrum in the Supporting Information for the 
Armstrong synthesis to be useful for comparison purposes.  An authentic sample of zaragozic 
acid C (<200 µg) was generously provided by Dr. Sheo Singh (Merck Research Laboratories).  
This sample also contains what we surmise to be the des-acetyl zaragozic acid C (LC-MS 
analysis).  Purification was not feasible due to the quantity provided.  The overlay spectra of the 
synthetic and natural material are provided below. 
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Fig 2.1 1H NMR Spectra Zaragozic Acid C 
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Fig 2.2 13C NMR Spectra Zaragozic Acid C 
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Fig 2.3 1H NMR Spectra Overlay: Synthetic Sample with Natural Sample 
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CHAPTER 3 
 
PROGRESS TOWARD THE TOTAL SYNTHESIS OF PACTAMYCIN  
 
 
 
3.1 Introduction 
 
Scheme 3-1 Pactamycin 
 
 
 Pactamycin was first isolated from a fermentation broth of Streptomyces pactum var 
pactum.1-3  It exhibits potent cytotoxicity showing in vivo and in vitro antitumor activity as well 
as antimicrobial activity.2,4  This biological activity is a consequence of the inhibition of protein 
synthesis.  Pactamycin exerts this effect through interaction with the small ribosomal subunit 
disrupting the action of translocation.5-7  The structure of pactamycin was first determined by 
NMR analysis in 19698 and then corrected by X-ray crystal structure in 1972.9 
 The unique structure of pactamycin seen in Scheme 3-1 consists of a densely 
functionalized cyclopentane core.  Stereocenters exist at all five carbons of the cyclopentane 
including three contiguous quaternary carbons that each contain O or N functionality.  Despite its 
potent biological activity and distinctive complex structure, little has been done in regards to the 
synthesis of pactamycin.  Currently, partial syntheses of the cyclopentane core by two groups 
represent the only efforts towards an artificial synthesis of this molecule.10,11 
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Scheme 3-2 Isobe Partial Core Synthesis 
 
 
 Isobe synthesized a key intermediate to a proposed total synthesis that contains some of 
the core functionality in 20 steps (Scheme 3-2).  Starting with a commercially available 
diacetonide-D-glucose 1, intermediate 2 was formed in four steps setting up formation of the 
quaternary C1 by means of an Overman rearrangement.12  Key enyne intermediate 4 is achieved 
in 12 subsequent steps.  The core cyclopentane was then formed with an intramolecular Pauson-
Khand reaction, isolated after 3 steps as bisacetate 5.13,14  The amino alcohol functionality at C1 
and C7 has been installed in the correct configuration but additional synthetic manipulation 
would be needed to finish construction of the core of pactamycin as well as the rest of the 
molecule. 
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Scheme 3-3 Knapp Partial Core Synthesis 
 
 
 A second synthesis undertaken by Knapp reaches a proposed precursor to the core of 
pactamycin in 16 steps (Scheme 3-3).  The main strategy was to conduct cyclopentane-face-
selective-transformations to setup the core configuration.  Stereochemistry was initially 
established with an asymmetric reduction of commercially available 2-methyl-2-cyclopenten-1-
one 6 using borane and catalytic (R)-2-methyl-CBS-oxazaborolidine.15 Protection of the alcohol 
as the tert-butyldimethyl silyl (TBS) ether allowed for a facially selective dihydroxylation 
establishing C5 of the core.  Subsequent manipulations then formed intermediate 8 that contained 
the necessary configuration for a directed epoxidation.  Epoxidation was followed by oxidation of 
the C1 hydroxyl, which occurred with concurrent epoxide opening to form the α,β-unsaturated 
ketone 9 with C4 in the correct configuration.  Additional steps bring the synthesis to a 
conclusion at 10, another proposed precursor to the pactamycin core.  As in the Isobe synthesis, 
additional synthetic transformation would be required to finish construction of the core from this 
point. 
 Given the lack of synthetic attention pactamycin has received and the possible challenges 
associated with construction of such a densely functionalized molecule, pactamycin is an ideal 
target for total synthesis.  The goal of our synthesis is to efficiently assemble pactamycin in a 
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manner that rapidly builds complexity while minimizing functional group manipulation. Key to 
our synthesis will be formation of the cyclopentane ring through an intramolecular cyclization. 
 
3.2 Results and Discussion 
 
3.2.1 Retrosynthetic Analysis 
 
Scheme 3-4 Retrosynthetic Analysis of Pactamycin 
 
 
 Our initial retrosynthetic analysis envisioned formation of the core by means of an 
intramolecular attack of a carbanion at C3 on a carbonyl at C4 initiated by deprotonation of a 
functionalized precursor such as 11, which would originate from synthetic manipulation of diazo 
compound 12.  It was envisioned that diazo functionality at C4 could work as a blocking group to 
allow functionalization of the rest of the molecule prior to formation of the requisite carbonyl at 
C4 by oxidation.  The stereocenter at C1 could be formed with two Michael additions of the 
diketone moiety of 12.  The first Michael addition to an azodicarboxylate would form the C−N 
bond at C1.  The second Michael addition to a nitroalkene would install C2 and C3. The nitrate at 
C3 would provide the required C–N bond at C3 and act as an electron-withdrawing group to 
facilitate formation of a carbanion for the intramolecular cyclization.  Methylation with an 
organometallic species such as MeMgBr and selective reduction would establish C5 and C7 
respectively.  This proposed strategy begins with a simple compound and rapidly builds up 
molecular complexity. 
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3.2.2 Diazo Blocking Strategy 
 
 Investigation of our initial strategy began with the synthesis of 15.  Direct formation by 
means of organolithium addition to diketene surrogate 14 was unsuccessful (eq 1).   
 
Opting to try a less direct approach starting from commercially available tert-butylacetoacetate, 
diazo functionality was simply installed using tosyl azide and triethylamine in acetonitrile to give 
16 in a 76% yield (eq 2). 
 
Attempts to homologate the additional carbonyl group in the correct oxidation state in 
one step proved unsuccessful.  Deprotonation of 16 with strong bases such as NaH and lithium 
diisopropyl amide (LDA) with subsequent addition to Weinreb or morpholine amides gave no 
formation of 15.  Instead, addition of the titanium enolate of 16 to acetaldehyde formed 17, which 
could be oxidized to 15, in 73% yield (eq 3).   
 
A survey of oxidation protocols led to identification of Dess-Martin periodinane16 as 
being uniquely capable of forming compound 15 in a 56% yield (Table 3-1). 
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Table 3-1 Oxidation Conditions for Diazo Compound 
 
entry conditions result 
1 MnO2, CH2Cl2, rt no desired product 
2 PCC no desired product 
3 Ba(MnO4)2, CH2Cl2, rt no desired product 
4 Et3N, SO3, pyridine, DMSO 0 ° C → rt no desired product 
5 DMP 56% yield 
 
 With 15 in hand, Michael addition of the diketone moiety was pursued (Table 3-2).  
Since 15 appeared to exist as a mixture of tautomers, as indicated by the presence of enol by 1H 
NMR analysis, Michael addition was attempted by stirring 15 with a suitable electrophile.  This 
resulted in no reactivity.  Attempted deprotonation of 15 with both weak (entry 1) and strong 
(entries 2-5) bases followed by exposure to an electrophile yielded desired products only when 
the alkoxide base NaOMe was used in benzene.  These conditions gave desired product 18a in a 
41% yield as a 1:1 ratio of diastereomers. 
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Table 3-2 Michael Addition of diazo 15 
 
 
entry conditions El+ result 
1 Et3N, THF  no desired product 
2 LDA, THF   no desired product 
3 NaH, THF  no desired product 
4 NaOMe, benzene   
41% yield, 1:1 dr 
5 NaH, THF  no desired product 
6 NaOMe, benzene  no desired product 
 
With limited success using base promoted Michael addition, a Lewis acid approach using 
a system developed by Barnes was investigated.17  The original conditions, employing a 
Mg(OTf)2 catalyst with a spiro bis(oxazoline) ligand in the presence of the base N-methyl 
morpholine (NMM) in chloroform were unsuccessful.  Subsequent attempts using either benzene 
or toluene with copper triflate as the metal catalyst also led to no product formation. 
 
  While Michael addition of 15 was being investigated, we also explored the same 
possibility with lactone 21.  Formation of lactone 20 was achieved in good yield using 
trifluoroacetic acid in CH2Cl2 (eq 5).  Installation of the diazo functionality with para-
acetamidobenzenesulfonyl azide (pABSA) led to formation of a mixture of the desired diazo 
lactone 21 and the elimination product 22 (eq 6).   
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Observation of 22 made it appear likely that attempted deprotonation of the lactone 
would lead to elimination.  So instead we decided to pursue Michael addition to the α,β- 
unsaturated ketone 22 followed by electrophilic trapping of the intermediate enolate.  The 
elimination product 22 was obtained from 19 in an 85% yield by adding mesyl chloride to the 
reaction mixture following diazo transfer (eq 7).  A silyl cuprate was used as the nucleophile for 
the initial Michael addition18 in the hope that the C–Si bond formed could later be oxidized with a 
Tamao-Fleming oxidation to install the necessary oxygen functionality at that position.  This 
reaction was attempted with a nitro alkene and tert-butylazodicarboxylate as the secondary 
electrophile, and in both cases only successful 1,4-addition was observed with no desired capture 
of the enolate (eq 8 and 9). 
 
At this point it became apparent that this route was not a viable strategy for the synthesis 
of pactamycin.  Bis-substitution of 15 seemed unlikely given the poor results we observed with 
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mono-substitution, and development of a conjugate addition was unnecessarily complicating the 
synthesis.  Therefore we decided to pursue another line of attack. 
 
3.2.3 Second Generation Retrosynthesis 
 
Scheme 3-5 Second Generation Retrosynthesis 
 
 
 Our second-generation retrosynthesis again focuses on forming the cyclopentane core 
through the cyclization of a fully functionalized linear compound (Scheme 3-5).  The new 
strategy calls for an intramolecular cascade reaction initiated by Michael addition of an azide 
nucleophile to 24.  Subsequent intramolecular attack of the resultant enolate on the C4 ketone 
would result in successful formation of a pactamycin core precursor with the three contiguous 
quaternary centers at C4, C5 and C1 established.  The proposed synthesis begins with 26.  A 
stereoselective allylation, developed by Ito for a compound analogous to 26, would provide C1 in 
the correct configuration.19 From there, 25 could be transformed into 24 through a 
diastereoselective reduction of the ketone at C7, conversion of the C5 ester to the methyl ketone, 
and a diastereoselective addition of an organolithium diazo compound.  Manipulation of the allyl 
group on C1 would provide the Michael acceptor while the carbonyl at C4 would be revealed 
through diazo oxidation to give 24.  This revised synthesis again rapidly builds up functionality 
from a simple starting material.  While the proposed cyclization may be difficult in such a 
complex system there is the possibility that Thorpe-Ingold effects may promote the 
intramolecular reaction.20,21 
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3.2.4 Synthesis of the Cyclization Precursor 
 
 Starting with methylacetoacetate diazo transfer was accomplished with pABSA to form 
27 in 83% yield (eq 10).  Compound 28 was then synthesized by rhodium(II)-catalyzed N–H 
insertion of the diazo compound into N,N-dimethyl urea in 75% yield (eq 11).22  Catalyst loading 
in the reaction was 2 mol%, but it is possible to run the reaction with as little as 0.3 mol% over a 
longer period of time. 
 
Application of 28 to the Ito protocol proved successful.  The reaction uses a π-allyl PdII 
chloride dimer with the chiral bisphosphine ligand 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
(BINAP) to form the π-allyl electrophile from allyl acetate.  The nucleophile is formed by 
potassium tert-butoxide deprotonation of 28.  The stereoselective reaction calls for chiral BINAP 
ligand and a temperature of -30 °C.  At the time of writing there was greater interest in 
throughput than selectivity so the reaction was run at room temperature with a racemic ligand to 
give the racemic product 29 in 82% yield. 
 
The next step of the synthesis is diastereoselective reduction of the ketone.  Ito was able 
to reduce a substrate similar to 28 with an acetamide rather than a 1,1-dimethylurea in good yield 
and high diastereoselectivity with L-Selectride.  Application of these conditions achieved 
successful reduction in a 70% yield, but with a diastereomeric ratio of only 3.4:1.  If the relative 
configuration of the major diastereomer matches the similar substrate Ito used it should give us 
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the correct configuration at C1 and C7.  The diastereomers of 30 are easily separated by flash 
column chromatography but other methods for reduction will need to be investigated to improve 
the diastereomeric ratio.   
 
Protection of alcohol 30 as the silyl ether was accomplished with standard conditions 
using 4-dimethylaminopyridine (DMAP), TBSCl and triethylamine in CH2Cl2 over 16 h in 54% 
yield (eq 14).  Alternate conditions using triethylamine with TBSOTf, which have tended to work 
better for sterically hindered alcohols, improved the yield of the protection to 71% and shortened 
the reaction time to 2 h (eq 15). 
 
 We next sought to protect the free amide nitrogen of 31 as the N-tert-butoxycarbonyl 
(Boc) derivative.  Conditions involving di-tert-butyl dicarbonate(Boc2O) used to protect amides 
adjacent to quaternary carbons were employed for the protection (Table 3-3).23,24  This hindered 
amide was unreactive and starting material was recovered in all cases. 
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Table 3-3 Attempted Amide Protection 
 
entry conditions result 
1 Boc2O 2 equiv, 10 % DMAP, THF recovered starting material 
2 Boc2O 2 equiv, 1 equiv DMAP, 1 equiv Et3N, THF 
recovered starting material 
3 Boc2O 2 equiv, 1 equiv Me4N
+ 
-OH, CH3CN 
recovered starting material 
 
 Since the hindered amide appeared to be shielded from reactivity we postulated that 
protection might be unnecessary.  Initial attempts to form the methyl ketone directly from 31 with 
MeMgBr appeared to lead to saponification of the methyl ester based on 1H NMR analysis (eq 
16).  Saponification may occur because of the intermediate formation of an α-lactam or 
oxazolinone between the methyl ester and the free urea that becomes hydrolyzed upon aqueous 
workup.  Formation of the methyl ketone from 31 was also attempted using trimethylsilylmethyl 
lithium (eq 17).25  This would form the α-silyl ketone that could easily be hydrolyzed to the 
desired methyl ketone under acidic or basic conditions, but the reaction led only to the recovery 
of starting material.  
conditions
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3.3 Conclusions and Future Directions 
 
Scheme 3-6 Status and Future Directions 
 
 
Currently the synthesis of pactamycin is in the early stages (Scheme 3-6).  Attempts to 
use diazo compound 15 as a nucleophile for a Michael addition were unsuccessful.  This led to 
development of a second approach.  We began with an application of an allylation protocol to our 
desired substrate 28 which formed the challenging quaternary center at C1.  A diastereoselective 
reduction with L-Selectride formed 30, which should contain the correct the configuration of C7.  
Further optimization of this reduction is necessary to boost the selectivity and increase the yield 
of the desired diastereomer.  Protection of the hydroxyl group of 30 as the TBS ether has proven 
to be facile, but efforts to protect the urea have thus far been unsuccessful.  Protection of the urea 
seems necessary based on observations made during attempts to transform the methyl ester to the 
methyl ketone in the presence of the free amide.   
Assuming successful urea protection and formation of the methyl ketone, the next step 
will be to test addition of 38 to the methyl ketone and subsequent oxidative conversion of the 
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diazo moiety to a ketone.  If we can achieve this we could then follow the plan proposed in 
Scheme 3-5.  The allyl group would be isomerized using a transition metal catalyst to form the 
internal olefin26,27, which would then be cleaved oxidatively by ozonolysis.  Formation of the 
Michael acceptor through a Wittig reaction would then bring us to the desired precursor to the 
cyclization.  There are a number of methods we could use to achieve azide Michael addition such 
as TMSN3 in the presence of F- or various (salen)Cr-N3 and (salen)Al-N3 complexes.28-30 
The current work represents a promising start and once core formation has been achieved 
the total synthesis of pactamycin will be pursued.  The hindered nature of this molecule 
represents a synthetic challenge but realization of the proposed synthesis would efficiently form 
the core of pactamycin.  It would also represent a new strategy for the formation of densely 
functionalized cyclopentane rings. 
 
3.4 Experimental 
 
General Information. Infrared (IR) spectra were obtained using a Nicolet 560-E.S.P. infrared 
spectrometer.  Proton and carbon nuclear magnetic resonance spectra (1H and 13C NMR) were 
recorded on the following instruments: Bruker model Avance 400 (1H NMR at 400 MHz and 13C 
NMR at 100 MHz) and Varian Gemini 300 (1H NMR at 300 MHz and 13C at 75 MHz) 
spectrometers with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.24 ppm and 
13C NMR: CDCl3 at 77.0 ppm).  1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sep = septet, m = 
multiplet), coupling constants (Hz), and integration.  Analytical thin layer chromatography (TLC) 
was performed on Whatman 0.25 mm silica gel 60 plates.  Visualization was accomplished with 
UV light, aqueous KMnO4 solution followed by heating and aqueous ceric ammonium molybdate 
solution followed by heating.  Purification of the reaction products was carried out by flash 
chromatography using Sorbent Technologies silica gel 60 (32-63 µm).    Air sensitive reactions 
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were carried out under an atmosphere of nitrogen in oven-dried glassware.  Yield refers to 
isolated yield of analytically pure material.  Toluene, CH2Cl2 and pentane were dried by passage 
through a column of neutral alumina under nitrogen prior to use.31  Et3N and 1,2 dichloroethane 
was distilled from CaH2 prior to use.  Benzene was distilled from sodium prior to use.  Potassium 
tert-butoxide was sublimed prior to use.  Lactone 20 was prepared according to the literature 
procedure.32  Silyl cuprates were prepared according to the literature procedure.33  Tert-butyl 
diazo acetate was prepared according to the literature procedure.34  (E)-(2-nitrovinyl)benzene was 
prepared according to the literature procedure.35  Dess-Martin periodinane was prepared 
according to the literature procedure.36,37 Yields and diastereomer ratios are reported for a specific 
experiment and as a result may differ slightly from those found in the tables, which may be 
averages of at least two experiments.  Unless otherwise noted, reagents were obtained from 
commercial sources and used without further purification. 
 
tert-butyl 2-diazo-5-hydroxy-3-oxohexanoate (17).  A round bottomed flask equipped with a 
stirbar, purged with nitrogen and charged with 500 mg (2.7 mmol, 1 equiv) of 16 and dry CH2Cl2 
(18 mL).  The solution was cooled to -78 °C and treated with 302 µL (3 mmol, 1.1 equiv) of Et3N 
and 327 µL (3 mmol, 1.1 equiv) of TiCl4 dropwise via syringe.  The resultant red solution was 
stirred for one hour and then 254 µL (2.7 mmol, 1 equiv) of acetaldehyde in CH2Cl2 (2 mL) was 
added via cannula.  The resultant solution was stirred for 2 h.  The reaction was quenched with 
saturated aqueous NH4Cl (10 mL) stirring for 30 min while warming to 23 °C.  The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2 x 10 mL).  The organic layer was 
dried (Na2SO4) and concentrated in vacuo.  The crude product was purified by flash 
chromatography (5:1 petroleum ether:EtOAc) to furnish 469 mg (76%) of diazo compound 17.  
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O
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Analytical data for title compound: 1H NMR (400 MHz, CDCl3)  δ 4.29 – 4.20 (m, 1H), 3.07 (dd, 
J = 17.5, 2.2 Hz, 1H), 2.84 (dd, J = 17.5, 9.3 Hz, 1H), 1.51 (s, 9H), 1.22 (d, J = 6.3 Hz, 3H); TLC 
(5:1 petroleum ether/EtOAc) Rf of   0.20. 
 
tert-butyl 2-diazo-3,5-dioxohexanoate (15).  A round bottomed flask equipped with a stirbar, 
purged with nitrogen and charged with 50 mg (0.2 mmol, 1 equiv) of 17 and dry CH2Cl2 (3 mL).  
The solution was stirred and treated with 139 mg (0.3 mmol, 1.5 equiv) of Dess-Martin 
periodinane.  The resultant solution was stirred for 2 h.  The reaction was quenched with 1:1 
saturated aqueous NaHCO3/aqueous Na2S2O3 (3 mL).  The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (2 x 10 mL).  The organic layer was dried (Na2SO4) and 
concentrated in vacuo.  The crude product was purified by flash chromatography (10:1 petroleum 
ether:EtOAc) to furnish 28 mg (56%) of diazo compound 15.  Analytical data for title compound: 
1H NMR (400 MHz, CDCl3)  δ 14.93(enol) (s, 1H), 6.39(enol) (s, 1H), 3.92 (s, 2H), 2.23 (s, 3H), 
2.00(enol) (s, 3H), 1.48(enol) (s, 9H), 1.47 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 184.46, 
180.50, 160.36, 96.85, 83.53, 83.16, 54.66, 29.66, 28.25, 28.21, 22.28; TLC (10:1 petroleum 
ether/EtOAc) Rf of   0.25. 
 
tert-butyl 4-acetyl-2-diazo-6-nitro-3-oxo-5-phenylhexanoate (18a).  A flame dried shell vial 
was equipped with a stirbar, purged with nitrogen and charged with 25 mg (0.11 mmol, 1 equiv) 
of 15, 6 mg (0.11 mmol, 1 equiv) of NaOMe, 16,4 mg (0.11 mmol, 1 equiv) of (E)-(2-
nitrovinyl)benzene and dry CH2Cl2 (3 mL).  The solution was stirred and monitored by TLC for 
16 h.  The reaction was quenched with distilled H2O (3 mL).  The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (2 x 10 mL).  The organic layer was dried (Na2SO4) and 
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concentrated in vacuo.  The crude product was purified by flash chromatography (5:1 petroleum 
ether:EtOAc) to furnish 17 mg (41%) of diazo compound 18a as a 1:1 mixture of 
diastereomers(determined by 1H NMR).  Analytical data for title compound: 1H NMR (400 MHz, 
CDCl3)  δ 7.36 – 7.19 (m, 4H), 5.29 (d, J = 8.9 Hz, 1H), 4.86 (dd, J = 13.1, 9.8 Hz, 1H), 4.71 (dd, 
J = 13.1, 4.1 Hz, 1H), 4.30 (td, J = 9.4, 4.1 Hz, 1H), 1.97 (s, 3H), 1.47 (s, 9H); TLC (10:1 
petroleum ether/EtOAc) Rf of   0.30. 
 
tert-butyl 2-diazo-3-oxohex-4-enoate (22).  A round bottomed flask was equipped with a stirbar, 
and charged with 400 mg (2 mmol, 1 equiv) of 19, 475 mg (2 mmol, 1 equiv) of pABSA and  
CH3CN (20 mL).  The solution was cooled to 0 °C and 1.1 mL (8 mmol, 4 equiv) of Et3N was 
added and the solution was stirred and slowly warmed to 23 °C.  After 16 h of stirring, 453 mg (4 
mmol, 2 equiv) of mesyl chloride were added and stirring was continued for 3 h.  The crude 
reaction mixture was concentrated in vacuo.  The crude product was purified by flash 
chromatography (5:1 petroleum ether:EtOAc) to furnish 354 mg (85%) of diazo compound 22.  
Analytical data for title compound: 1H NMR (400 MHz, CDCl3)  δ 7.15 – 6.86 (m, 2H), 1.85 (d, 
J = 6.7 Hz, 3H), 1.46 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 181.80, 160.45, 142.67, 126.61, 
82.95, 28.11, 18.19; TLC (10:1 petroleum ether/EtOAc) Rf of   0.25. 
 
tert-butyl 2-diazo-5-(dimethyl(phenyl)silyl)-3-oxohexanoate (23).  Analytical data for title 
compound: 1H NMR (400 MHz, CDCl3)  δ 7.60 – 7.28 (m, 5H), 2.80 (dd, J = 16.3, 3.9 Hz, 1H), 
2.66 (dd, J = 16.3, 10.6 Hz, 1H), 1.61 – 1.55 (m, 1H), 1.48 (s, 9H), 0.92 (d, J = 7.3 Hz, 3H), 0.27 
(d, J = 2.1 Hz, 6H).; TLC (20:1 petroleum ether/EtOAc) Rf of   0.30. 
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methyl 2-(3,3-dimethylureido)-3-oxobutanoate (28).  An oven-dried round bottomed flask was 
equipped with a stirbar, and charged with 290 mg (2 mmol, 1 equiv) of 27, 268 mg (3 mmol, 1.5 
equiv) of N,N-dimethyl urea and  1:1 toluene/1,2 dichloroethane (20 mL).  The suspension was 
stirred and heated to 80 °C. A suspension of 32 mg (0.04 mmol, 0.02 equiv) of rhodium octanoate 
dimer in toluene (4 mL) was added to the solution in portions over 10 minutes.  During addition a 
gas was evolved.  The solution was stirred for 50 min during which time the color changed from 
green to yellow.  The crude reaction mixture was cooled to 23 °C and concentrated in vacuo.  The 
crude product was purified by flash chromatography (1:1 petroleum ether:EtOAc with 3% Et3N) 
to furnish 299 mg (75%) of compound 28.  Analytical data for title compound: 1H NMR (400 
MHz, CDCl3)  δ 5.55 (d, J = 6.0 Hz, 1H), 5.03 (d, J = 6.5 Hz, 1H), 3.64 (s, 3H), 2.79 (s, 6H), 2.21 
(s, 3H).; 13C NMR (101 MHz, CDCl3) δ 199.57, 167.43, 156.62, 63.99, 52.65, 35.74, 27.51; TLC 
(1:1 petroleum ether/EtOAc) Rf of 0.2; HRMS (ESI) exact mass calculated C8H14N2O4Na 
[M+Na]+: 225.0845 Found: 225.0851. 
 
methyl 2-acetyl-2-(3,3-dimethylureido)pent-4-enoate (29).  An oven-dried round bottomed 
flask was purged with nitrogen, equipped with a stirbar, and charged with 0.9 mg (0.002 mmol, 
0.005 equiv) of allyl palladium chloride, 3 mg (0.005 mmol, 0.010 equiv) of BINAP and  toluene 
(1 mL).  A separate oven-dried round bottomed flask was equipped with a stirbar purged with 
nitrogen and charged with 100 mg (0.5 mmol, 1 equiv) of 28, 67 mg (0.6 mmol, 1.2 equiv) of 
KOtBu and  toluene (1 mL). The suspensions were stirred at 23 °C for 10 minutes and then 74 mg 
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(0.7 mmol, 1.5 equiv) of allyl acetate was added via syringe to the palladium catalyst solution.  
Stirring was continued for an additional 10 minutes and then the catalyst solution was transferred 
to the suspension of substrate via cannula transfer (0.5 mL wash).  The solution was stirred for 16 
h.  Upon consumption of starting material, as indicated by TLC, the reaction was quenched with 1 
N HCl (1 mL).  The aqueous layer was extracted with EtOAc (3 x 3 mL).  The organic layer was 
washed with brine (3 mL), dried (Na2SO4) and concentrated in vacuo.  The crude product was 
purified by flash chromatography (3:1 petroleum ether:acetone) to furnish 98 mg (82%) of 
compound 29.  Analytical data for title compound: 1H NMR (400 MHz, CDCl3)  δ 5.90 (s, 1H), 
5.56 – 5.35 (m, 1H), 5.10 – 4.96 (m, 2H), 3.71 (s, 3H), 3.11 (dd, J = 14.6, 6.8 Hz, 1H), 2.94 (dd, J 
= 14.7, 7.8 Hz, 1H), 2.87 (s, 6H), 2.12 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 199.97, 169.47, 
156.02, 131.60, 119.19, 71.94, 53.15, 36.83, 35.99, 24.54; TLC (3:1 petroleum ether/acetone) Rf 
of 0.25; HRMS (ESI) exact mass calculated C11H18N2O4Na [M+Na]+: 265.1161 Found: 
225.1164. 
 
methyl 2-(3,3-dimethylureido)-2-(1-hydroxyethyl)pent-4-enoate (30).  An oven-dried round 
bottomed flask was purged with nitrogen, equipped with a stirbar, and charged with 50 mg (0.2 
mmol, 1.0 equiv) of 29 and THF (1.5 mL).  The solution was stirred, cooled to -78 °C and 0.31 
mL (0.3 mmol, 1.5 equiv) of L-Selectride (1 M in THF) was added dropwise via syringe.  The 
solution was stirred for 2 h.  Upon consumption of starting material, as indicated by TLC, the 
reaction was quenched with, in order, 0.2 mL H2O, 0.2 mL EtOH, 0.2 mL NaOH (3 M), and 0.2 
mL H2O2 (30% aqueous solution).  The solution was stirred for 10 min at 23 °C.  Excess H2O2  
was quenched with saturated aqueous Na2S2O8 (1 mL) and the reaction was diluted with H2O.  
The aqueous layer was extracted with EtOAc (3 x 5 mL).  The organic layer was washed with 
brine (3 mL), dried (Na2SO4) and concentrated in vacuo.  The crude product was purified by flash 
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O O
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Me2N O
MeO
O
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chromatography (3:1 petroleum ether:acetone) to furnish 27 mg (54%) of compound 30 (major 
diastereomer) and 8 mg (16%) of compound 30 (minor diastereomer).  Analytical data for title 
compound (major diastereomer): 1H NMR (400 MHz, CDCl3)δ 6.15 (d, J = 10.3 Hz, 1H), 5.64 – 
5.50 (m, 1H), 5.18 (dd, J = 21.2, 13.3 Hz, 2H), 4.85 (s, 1H), 4.04 (dq, J = 12.9, 6.4 Hz, 1H), 3.76 
(s, 3H), 2.91 (s, 6H), 2.74 (dd, J = 13.7, 4.9 Hz, 1H), 2.34 (dd, J = 13.7, 10.0 Hz, 1H), 1.17 (d, J = 
6.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 172.80, 158.71, 132.62, 120.66, 71.48, 68.23, 52.55, 
40.24, 36.67, 18.18; TLC (5:2 petroleum ether/acetone) Rf of major 0.45, minor 0.55. 
 
methyl 2-(1-(tert-butyldimethylsilyloxy)ethyl)-2-(3,3-dimethylureido)pent-4-enoate (31).  An 
oven-dried round bottomed flask was purged with nitrogen, equipped with a stirbar, and charged 
with 81 mg (0.33 mmol, 1.0 equiv) of 29 and CH2Cl2 (1.5 mL).  The solution was stirred, cooled 
to 0 °C and 0.18 mL (1.3 mmol, 4 equiv) of Et3N followed by 175 mg (0.66 mmol, 2 equiv) of 
TBSOtf were added dropwise via syringe.  The solution was stirred for 2 h.  Upon consumption 
of starting material, as indicated by TLC, the reaction was quenched with saturated aqueous 
NaHCO3 (2 mL).  The aqueous layer was extracted with CH2Cl2 (3 x 5 mL).  The organic layer 
was dried (Na2SO4) and concentrated in vacuo.  The crude product was purified by flash 
chromatography (5:1 petroleum ether:acetone) to furnish 102 mg (86%) of compound 31.  
Analytical data for title compound: 1H NMR (400 MHz, CDCl3) δ 7.24 (s, 1H), 5.89 – 5.74 (m, 
1H), 5.31 (s, 1H), 5.06 – 4.91 (m, 2H), 3.71 (s, 3H), 3.06 – 2.96 (m, 1H), 2.87 (s, 6H), 2.76 (d, J 
= 8.0 Hz, 1H), 1.12 (d, J = 6.3 Hz, 3H), 0.86 (s, 9H), 0.05 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 
134.59, 117.27, 72.09, 52.25, 36.21, 35.46, 25.67, 18.81, 17.81, -4.02, -5.04; TLC (10:1 
petroleum ether/acetone) Rf of major 0.15. 
Et3N 4 equiv
TBSOTf 2 equiv
DCM
0 °C ! rt
2 h
MeO2C
NH
Me2N O
HTBSO
MeO
O
NH
Me2N O
HHO
71%
30 31
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2-(1-(tert-butyldimethylsilyloxy)ethyl)-2-(3,3-dimethylureido)pent-4-enoic acid (33).  An 
oven-dried round bottomed flask was purged with nitrogen, equipped with a stirbar, and charged 
with 27 mg (0.08 mmol, 1.0 equiv) of 31 and THf (1.0 mL).  The solution was stirred, cooled to 0 
°C and 0.05 mL (0.15 mmol, 2 equiv) of MeMgBr (3 M in THF) was added dropwise via syringe.  
The solution was stirred for 2 h.  Upon consumption of starting material, as indicated by TLC, the 
reaction was quenched with saturated aqueous NaHCO3 (2 mL).  The aqueous layer was extracted 
with Et2O (3 x 5 mL).  The organic layer was dried (MgSO4) and concentrated in vacuo.  The 
crude product was relatively pure and 24 mg (100%) of compound 33 was recovered.  Analytical 
data for title compound: 1H NMR (400 MHz, CDCl3) δ 5.73 – 5.55 (m, 1H), 5.16 – 4.97 (m, 2H), 
3.98 (q, J = 6.2 Hz, 1H), 3.75 – 3.66 (m, 1H), 2.90 (d, J = 17.3 Hz, 6H), 2.41 – 2.32 (m, 2H), 1.22 
– 1.14 (m, 3H), 0.79 (s, 9H), -0.01 (t, J = 7.8 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 156.45, 
131.86, 119.27, 78.13, 77.32, 77.00, 76.68, 72.20, 37.98, 36.80, 25.53, 17.77, 17.65, -5.39.; TLC 
(5:1 petroleum ether/acetone) Rf of major 0.63. 
 
MeMgBr 2 equiv
THF
0 °C ! rt
2 h
MeO2C
NH
Me2N O
HTBSO
HO2C
NH
Me2N O
HTBSO
3331
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